You are on page 1of 188

121912015

State of Ulltl Mall. Dugway arIITax Incident

Allyn

Nakashima

<anakashlma@utah.gov>

Dugway anthrax incident


1 message
Allyn Nakashima <anakashima@utah.gov>
To: Peter Taillac <ptalllac@utah.gov>
Through your military contacts,

Thu, May 28,2015

at 1:22 PM

have you heard anything about what DoD or CDC are planning In response to this?

We have heard nothing but what is in the media-interesting


happened.
http://www.washingtonpost.com/news/checkpol

to read in the Washington Post that they are planning a joint investigation

ntlwp/20 15/05/27/pentagon.army-laboratory

here to see what

-inadvertently -dlstri buted-live-anthrax/

Thanks,
Allyn

Allyn K Nakashima, MD
State Epidemiologist
Bureau of Epidemiology
Utah Department of Health
PO Box 142104
Salt Lake City, Utah 84114-2104
Tel: (801) 538-6191
Fax: (801) 538-9923

SLTRIB.COM

httpsJ/mall.google.com/mail/u'onul=2&lk=68925163Od&vlew=pt&q=antIYax%2Odugway&qs=

true&seerch= query&th= 14d9b19f8f21bcaa&si m 1=14d9b19f8f21beaa

1/1

121912015

State cJ Ula'l Mall. Dugway antITax laboratory Irddent

Allyn

Nakashima

<anakashlma@utah.gov>

Dugway anthrax laboratory incident


1 message
Allyn Nakashima <anakashima@utah.gov>
Thu, May 28, 2015 at 3:04 PM
To; Robert Rolfs <rrolfs@utah.gov>,
Jennifer Brown <jenniferbrown@utah.gov>,
Crlstie Chesler <cchesler@utah.gov>,
Melissa Dimond
<melissastevens@utah.gov>,
Angela Dunn <angeladunn@utah.gov>,
Tom Hudachko <thudachko@utah.gov>,
Charla Haley <chaley@utah.gov>,
Rebecca
Ward <rward@utah.gov>, Robyn Atkinson <rmatklnson@utah.qov>,
Wei Hou <whou@utah.gov>, Daan Penovlch <dpenovlch@utah.gov>,

"

')0

HI Folks,

SLTRIB.COM

I am sure you are wondering what communication we have had with CDC regarding this incident. There was no proactive effort to contact us on CDC's
part and I spent the day tracking down who we needed to talk to. I just got off the phone with Dan 50S in, head of the Select Agent Unit, and Kate
Hendricks, anthrax countermeasures medical epi In the CDC EOC, who is managing CDC's response. There seems to be a lot of confusion about this
incident because of both DoD and CDC are Involved. Here Is what I found out:
1. CDC has already visited the Dugway lab on Sunday (we were not notified of this visit) and determined that they don1 think there was any risk to
personnel there. DoD and CDC will be following up with the lab to determine why the radiation procedures that were supposed to inactivate the agent
didn1 work completely.
2. The main concem is with the laboratories that DoD contracts with that received specimens. Many of these are commercial labs and located in the
states publicized In the Washington Post article. What the lab staff did with the specimens determines their exposure risk. Most labs handle these
specimens using BSL II or BSL II standard procedures and their staff are not at risk. Nationally, so far they have determined that 4 laboratory staff
needed prophylaxis due to unsafe specimen handling processes.
3. We have one lab: __
" that received the specimens and they have been communicating with CDC by email and so far they think that their staff
are not at risk. However, CDC wants us to follow-up with them to ensure this using a systematic questionnaire, which they will send us. If the
questions look like lab expertise is needed, Robyn, I hope I can involve Kim or Annette?
4. There is no risk to our general population.
Klnda scary on how well they communicate!
Allyn

Allyn K Nakashima, MD
State Epidemiologist
Bureau of Epidemiology
Utah Department of Health

Media talking points have not been prepared yet, but they plan to do that and send them out tomorrow.
I suggested they develop a more coordinated systematic

state notification

protocol In the future.

121912015

State c:i Utah Mell- Dl.W/ay anttrex laborauy Incident

PO Box 142104
Salt Lake City, Utah 84114-2104
Tel: (801) 538-6191
Fax: (801) 538-9923

httos:"mail.QCXX)le.canfm8ir/liOl?ui~2&lk:::68925163Od&vlfm~ ot&a~8ntlYax%2OdUONwv&os=true&search=ouerv&th=

14d9c5784ceefb98&sim

1=14d9c5784ceefb98

212

S- c:I Utah

.,1V9fZ015

Mall-

R.:Dugway

anthrax labcfetQ-y

Irddent

Allyn Nakashima

<anakashlma@utah.gov>

Re: Dugway anthrax laboratory incident


1 message

Tom Hudachko <thudachko@utah.gov>

Fri, May 29, 2015 at 3:46 PM

To: Allyn Nakashima <anakashima@utah.gov>


Thanks - I certainly have no plans to mention them! We were asked early about labs In Utah that may have received samples. I answered that I could
only speak for our lab and that we had not received any.
Appreciate the updates!
On Fri, May 29, 2015 at 3:43 PM, Allyn Nakashima <anakashima@utah.gov>
wrote:
There is a lot of confusion about this incident and communication to states was not well-<:oordinated (-we should have been getting regular
conference call updates as with any ICS Incident). Partly, though this does not excuse CDC, there is a confusion about who Is in the lead on this
event DoD or CDC. Apparently, many more labs received specimens from this lot than they Initially thought. Yesterday, when I talked with Dan
Sosln, he told me no Utah labs had received them and 5 minutes later I got a call from Kate Hendricks saylng' __
, was one of the labs. There Is
also some concem about another lot of B. anthracis that may have some issues as well as processing was the same. So I think things are rapidly
changing as we would expect with any Investigation. My main issue, though, is that if they would just do a better job with communication and
coordination, we would all be on the same pagel

So I will do my best to keep everyone updated as I hear. Also, _'on


they should not be named in any media releases from here for now.

teday's conference callis

extremely concemed about confidentiality

SLTRIB.COM

so

On Fri, May 29, 2015 at 3:30 PM, Tom Hudachko <thudachko@utah.gov>


wrote:
So, Utah was never listed as one of the nine states that had labs that received samples. Do you know if there was just initial confusion, or what the
deal was?
Thanks
Tom
On Fri. May 29. 2015 at 2:02 PM, Allyn Nakashima <anakashima@utah.gov>
Here is a quick update:

wrote:

We had a conference call with the _


'Management staff this moming. We interviewed them with the questions that CDC provided. We
and
. offered to do followo{Jp with lab staff if they provide contact info, but they declined this saying that they did not think anyone was
exposed. From the responses to questions, It appeared there was very little risk of exposure so most staff won1 need prophylaxis.
I called Kate Hendricks at CDC and they want the remaining, unautoclaved specimens shipped to them early next week. Kim Chrlstensen in
our lab went over there today to help them with packaging.
Instructions for de-contamlnation of the lab and re-opening will be forthcoming early next week.
hltDs ://mall.ooool . ccrn/m ai I/uIllI?uI-2&lk-

68925163Qd&vl",,-

01&0- anth"ax %2llduaNav&as-true&searCh-

ouerv&tIF 14da 1a42d9668db9&s1 m 1-14da1 a42d9668dbS

1/4

12i!ho15

State ci Ul<i1 Mail- Ro: Dugway onthrax lalxratcry Irddent

Thanks,
Allyn
On Thu, May 28, 2015 at 3:04 PM, Allyn Nakashima
HI Folks,

<anakashima@utah.gov>

wrote:

I am sure you are wondering what communication we have had with CDC regarding this incident. There was no proactive effort to contact us
on CDC's part and I spent the day tracking down who we needed to talk to. I just got off the phone with Dan Sosin. head of the Select Agent
Unit, and Kate Hendricks, anthrax countermeasures medical epi in the CDC EOC, who is managing CDC's response. There seems to be a lot
of confusion about this incident because of both 000 and CDC are involved. Here is what I found out:
1. CDC has already visited the Dugway lab on Sunday (we were not notified of this visit) and determined that they donl think there was any
risk to personnel there. DoD and CDC will be following up with the lab to determine why the radiation procedures that were supposed to
inactivate the agent didnl work completely.
2. The main concern is with the laboratories that DoD contracts with that received specimens. Many of these are commercial labs and
located in the states publicized in the Washington Post article. What the lab staff did with the specimens determines their exposure risk.
Most labs handle these specimens using BSL II or BSL II standard procedures and their staff are not at risk. Nationally, so far they have
determined that 4 laboratory staff needed prophylaxis due to unsafe specimen handling processes.
3. We have one lab 1_ --l that received the specimens and they have been communicating with CDC by email and so far they think that
their staff are not at risk. However, CDC wants us to follow-up with them to ensure this using a systematic questionnaire, which they will send
us. If the questions look like lab expertise is needed, Robyn, I hope I can involve Kim or Annette?
4. There is no risk to our general population.
tomorrow.
Kinda scary on how well they communicatel

Media talking points have not been prepared yet, but they plan to do that and send them out

I suggested they develop a more coordinated systematic

state notification

protocol in the future.

Allyn

Ailyn K Nakashima, MD
State Epidemiologist
Bureau of Epidemiology
Utah Department of Health
PO Box 142104
Salt Lake City. Utah 84114-2104
Tel: (801) 538-6191
Fax: (801) 538-9923

https:/lmoJl.googlo.com/moil/u'G'?u1=2&ik=6892516:n:l&vlow=pt&q=ontlYox%2Odugway&qs=lruo&soarch=query&ih=

14da1a42d9666db9&slm 1=14dal a42d9668db9

2/4

..

Sla19 cI Utah Mall- Ro: Dugway anthrax labcr-r

121912015

Incident

.,

Allyn K Nakashima, MD
State Epidemiologist
Bureau of Epidemiology
Utah Department of Health
PO Box 142104
Salt Lake City, Utah 84114-2104
Tel: (801) 538-6191
Fax: (801) 538-9923

~.~

IMPORTANT

MESSAGE

.~.~.~.

This message, Including any attachments, may contain confidential information intended for a specific individual and purpose, and is protected
by law. If you are not the Intended recipient, delete this message, including from trash, and notify me by telephone or email.
If you are not the intended recipient, any distribution or copying of this message, or the taking of any action based on Its content Is strictly
prohibited.

Tom Hudachko I Public Information Officer


Utah Department of Health
(0) 801-538-6232
(m) 801-560-4649
www.health.utah.gov
www.twitler.com/utahdepofhealth
htlps ://www.facebook.com/UtahDepOfHealth

.. ,,* IMPORTANT MESSAGE This message, including any attachments, may contain confidential information intended for a specific individual and purpose, and Is protected by
law. If you are not the intended recipient, delete this message, including from trash, and notify me by telephone or email.
If you are not the Intended recipient, any distribution or copying of this message, or the taking of any action based on Its content is strictly
prohibited.

Allyn K Nakashima, MD
State Epidemiologist
Bureau of Epidemiology
Utah Department of Health
hItos:llmall.aooaJe.can/majlfulOl7ul=2&Jk=68925163:ld&vlew=ot&o=anth"ax%2Oduawav&os=lrue&seerch=ouerv&lh=

14dala42d9668db9&sim 1='4dala42d9668d~

314

,zh1S

State rJ Ul>il Mall. Ra: Dug,yay anthrax laboratory Irddent

PO Box 142104
Salt Lake City, Utah 84114-2104
Tel: (801) 538-6191
Fax: (801) 538-9923

"""'.,.. **'"

IMPORTANT

MESSAGE

."""'
. **u

This message, includin9 any attachments, may contain confidential information intended for a specific individual and purpose, and is protected by
law. If you are not the intended recipient, delete this message, including from trash, and notify me by telephone or email.
If you are not the intended recipient, any distribution

or copying of this message, or the taking of any action based on its content is strictly prohibited.

Tom Hudachko I Public Information Officer


Utah Department of Health
(0) 801-538-6232
(m) 801-560-4649
www.health.utah.gov
www.twitter.com/utahdepofhealth
https ://www.facebook.com/UtahDepOfHea
_ _ IMPORTANT

Ith
MESSAGE

_._

This message, including any attachments, may contain confidential information Intended for a specific Individual and purpose, and is protected by law.
If you are not the intended recipient, delete this message, including from trash, and notify me by telephone or email.
If you are not the intended recipient, any distribution or copying of this message, or the taking of any action based on its content is strictly prohibited.

https:l/mall.google.can/mail/ulOl?ul'2&lk'6892S1

630d&vlaw'pI&q'anltYax%2Odugway&qs'lrue&search'quary&lh'14da1a42d9668db9&slm

1"4da1a42d9668db9

4/4

1219/'".<ill5

Stat. cJ Utah Mall. R.: Dugway onthrax laboroby

Incident

Allyn Nakashima

<anakashlma@ulah.gov>

Re: Dugway anthrax laboratory incident


1 message
Thu, May 28,2015

al 5:08 PM

To: Allyn Nakashima <anakashlma@ulah.gov>


Thanksl

On May 28, 2015, al 5:05 PM, Allyn Nakashima <anakashima@ulah.gov>

Please include

on Ihe conference cailiomorrow

wrole:

a I 9:00.

Thanks,
Allyn

Fnrw<>mon message -From: ~ .


Dale: Thu, May 28, 2015 al 5:00 PM
Subject: Re: Dugway anlhrax laboralory incidenl
To: Allyn Nakashima <anakashima@ulah.gov>
--

Cc:

We would like 10 participale,

given Ihe faci thai the lab

On May 28, 2015, a14:15 PM, Allyn Nakashima <anakashima@utah.gov>

wrote:

We will set up the conference call 10 ask the lab questions lomorrow. One of our lab people will be participating because
the questions are mostly about laboratory procedures. Do you want one of your epis to lislen in or can we jusllel you know
Ihe results?
On Thu, May 28, 2015 at 3:09 PM,
htlps1fmeJl.googl . can/mail/l>IY7ul'2&lk'68925163Od&vlaw'

pl&q.Ougway%2OantlTax&qs.true&s

wrole:
cIl.'I-'l'Y&lt1. l4d9cc92d591na2&slml.14d9cc92d591na2

1/4

1=15

Stat.

cr Uta'l Mall-

R.: Dugway anIt1rax I.bormay

Incident

Thanks Allyn I Is

From: Allyn Nakashima [mailto:anakashima@utah.gov]


sent: Thursday, May 28, 2015 3:05 PM

To: Robert Rolfs; Jennifer Brown; Cristie Chesler; Melissa Dimond; Angela Dunn; Tom Hudachko; Charla Haley; Rebecca
Ward; Robyn Atkinson; Wei Hou; Dean Penovich:
Subject: Dugway anthrax laboratory incident

Hi Folks,

I am sure you are wondering what communication we have had with CDC regarding this incident. There was no proactive
effort to contact us on CDC's part and I spent the day tracking down who we needed to talk to. I just got off the phone
with Dan Sosin, head of the Select Agent Unit, and Kate Hendricks, anthrax countermeasures medical epi in the CDC
EOC, who is managing CDC's response. There seems to be a lot of confusion about this incident because of both DoD
and CDC are involved. Here is what I found out:

1. CDC has already visited the Dugway lab on Sunday (we were not notified of this visit) and determined that they don't
think there was any risk to personnel there. DoD and CDC will be following up with the lab to determine why the radiation
procedures that were supposed to inactivate the agent didn~ wor!< completely.

2. The main concem is with the laboratories that DoD contracts with that received specimens. Many of these are
commercial iabs and located in the states publicized in the Washington Post article. What the lab staff did with the
specimens determines their exposure risk. Most labs handle these specimens using BSL II or BSL II standard
procedures and their staff are not at risk. Nationally, so far they have determined that 4 laboratory staff needed
prophylaxis due to unsafe specimen handling processes.

3. We have one lab


. that received the specimens and they have been communicating with CDC by email and so
far they think that their staff are not at risk. However, CDC wants us to follow-up with them to ensure this using a
systematic questionnaire. which they will send us. If the questions look like lab expertise is needed, Robyn, I hope I can
involve Kim or Annette?

4. There is no risk to our general population.


and send them out tomorrow.
httnq'llmtllll OlYlnlA r.rm/mAlllIlllll?ul=?ItJk=AAQ?fi1

Media talking points have not been prepared yet. but they plan to do that

R:YlrI&vIAIN=nt~=ntnNAV%?IlAntfyAXAom=trLlAo\!'iAAl"('.h=r'lJAI"vAth=1~1

nA?A..qlml= 1~~177rt")

?I'

12JS12615

State ci Util Mail. Ro: Ougway anthrax labaatcry Incident

Kinda scary on how well they communicate!


protocol in the future.

I suggested they develop a more coordinated systematic

state notification

Allyn

Allyn K Nakashima,

MD

State Epidemiologist
Bureau of Epidemiology
Utah Department of Health
PO Box 142104
Salt Lake City, Utah 84114.2104
Tel: (801) 538-8191
Fax: (801) 538.9923

."'***** * IMPORTANT

MESSAGE

_ .

This message, including any attachments, may contain confidential Information intended for a specific individual and
purpose, and is protected by law. If you are not the Intended recipient, delete this message, including from trash, and
notify me by telephone or email.

If you are not the intended recipient, any distribution or copying of this message, or the taking of any action based on its
content is strictly prohibited.

hltpSJlmail.google.canJmaillliOl?1Jl:2&lk"=68925163Od&vlow:

pl&q:oug.yay%2OenttYax&qs:uue&seercl>oquery&lt1:

14dScc92d59177e2&slml:'4dScc92d59177e2

3/4

1219120'5

Stat. ri Utah Moll. R.: D_oy

..

OI1lhrox laborot<:<y Incldonl

Allyn K Nakashima, MD
State Epidemiologist
Bureau of Epidemiology
Utah Department of Health
PO Box 142104
Sail Lake City, Uteh 84114-2104
Tel: (801) 538-<'1191
Fax: (801) 538-9923

_._ IMPORTANT

MESSAGE

_._

This message, including any attachments, may contain confidential information intended for a specific individual and
purpose. and is protected by law. If you are not the Intended recipient, delete this message. Including from trash, and notify
me by telephone or email.
If you are not the intended recipient, any distribution or copying of this message, or the taking of any action based on its
content is strictly prohibited.

Allyn K Nakashima. MD
State Epidemiologist
Bureau of Epidemiology
Utah Department of Health
PO Box 142104
Sail Lake City, Utah 84114-2104
Tel: (801) 538-6191
Fax: (801) 538-9923

_ - IMPORTANT

MESSAGE

._

This message, including any attachments, may contain confidential Information intended for a specific Individual and purpose, and Is
protected by law. If you are not the Intended recipient, delete this message, Including from trash, and notify me by telephone or email.
If you are not the intended recipient, any distribution or copying of this message, or the taking of any action based on its content is
strictly prohibited.

httnot. /lml4ll

t"ln"YllA

I":nm

1m ~j III tIOI?t II = ?R.lk= FiAR?~,


R.':r'lI"1JtvIAW= nt.'tn= nl

ON

AVOk ?nAnthrAY A.ncl =trl lAIt.u:~,.r.h=n lAt'vAth= 14rt!=rr.A?r1fiCl1 nA?A'O, Im 1= 1~R?rl~1

nA?

.,.

Stat. rj Utah Mall- R.: Dugway ontl1rax Irddent

121912015

Allyn Nakashima

<anakashlma@utah.gov>

Re: Dugway anthrax incident


1 message

-- -- ---------------_._---

---- ---- -

Thu, May 28, 2015 at 5:44 PM

Allyn Nakashima <anakashima@utah.gov>


To: Peter Taillac <ptalllac@utah.gov>

Sadly, I had to figure at who to call at CDC to get the scoop. I should have cc'd you on my summary to the higher ups here. I will forward In a minute.
On Thu, May 28, 2015 at 5:37 PM, Peter Taillac <ptaillac@ulah.gov> wrote:
No, I havenl heard anything. My military contacts are more related to the National Guard, somewhat separate from the active Army at Dugway.
If I hear anything, I'll pass It along.
I miss talking to you!
Peter
Peter Taillac, MD
Medical Director
Utah Bureau of EMS and Preparedness
Utah Department of Health
801-273-6646 office
801-<303-3217cell
ptaillac@utah.gov
On May 28,2015, at 1:22 PM, Allyn Nakashima <anakashlma@utah.gov>

wrote:

Through your military contacts, have you heard anything about what DoD or CDC are planning in response to this?
We have heard nothing but what Is in the media-interesting
here to see what happened.
http://www.washinglonpost.com/news/c

to read In the Washington Post that they are planning a joint invesllgation

heck pol nVwp/20 15/05/27/penlagon-army-laboratory

~nadvertenlly -dIstri buled-Ilve-anthraxl

Thanks,
Allyn
Allyn K Nakashima, MD
State Epidemiologist
Bureau of Epidemiology
Utah Department of Health
httpsl/mall.googl . can/mall/uJOl?ul=2&lk=6892516:lOd&vlew=pl&q=

Dugway%2Oanth'ax&qs=truo&soarch='IJOfy&th=

14d9ce9a7675b21'3&s1m I= 14d9ce9a7675b2f3

1/2

Stat. a Ula'1Mall. R.: ougw.y ontt1roxIrddont

121912015

PO Box 142104
Salt Lake City, Utah 84114-2104
Tel: (801) 538-6191
Fax: (801) 538-9923

._ _. IMPORTANT

MESSAGE

._ _.

This message, Including any attachments, may contain confidential information intended for a specific individual and purpose, and Is
protected by law. If you are not the intended recipient, delete this message, Including from trash, and notify me by telephone or email.
If you are not the Intended recipient, any distribution
strictly prohibited .

ft

"

or copying of this message, or the taking of any action based on its content Is

IMPORTANT MESSAGE .

This message, including any attachments, may contain confidential information intended for a specific individual and purpose, and is protected by
law. If you are not the intended recipient, delete this message, including from trash, and notify me by telephone or email.
If you are not the intended recipient, any distribution or copying of this message, or the taking of any action based on its content is strictly prohibited.

Allyn K Nakashima. MD
State Epidemiologist
Bureau of Epidemiology
Utah Department of Health
PO Box 142104
Salt Lake City, Utah 84114-2104
Tel: (801) 538-6191
Fax: (801) 538-9923

httM ",/mAIl ,rr:noIA,r:nm/mAIIIl~ul=:?&lk=6AA25163Q:j&vleoN=

ot&o= DUCM'9V%2OanttYAX&as=true&sewch=o.JBrv&th=

14d9ce9A7875b2t3&slm

1=14d9ce9a7875b2t3

212

.'

Stat. cI Ula'l Mail- R.: Dugway anthrax leborBUjl IrdderJt

1:w12015

Allyn Nakashima <anakashlma@utah.gov>

Re: Dugway anthrax laboratory incident


1 message
Jeff <jcoombs@tooelehealth.org>
Fri, May 29, 2015 at 2:57 PM
To: Allyn Nakashima <anakashima@utah.gov>
Cc: Robert Rolfs <rrolfs@utah.gov>, Jennifer Brown <jenniferbrown@utah.gov>, Cristle Chesler <cchesler@utah.gov>, Melissa Dimond
<melissastevens@utah.gov>, Angela Dunn <angeladunn@utah.gov>, Tom Hudachko <thudachko@utah.gov>, Charia Haley <chaley@utah.gov>, Rebecca
Ward <rwardl1ilutah.oov>. Robvn Atkinson <rmatklnson(Qlutah.gov>, Wei Hou <whou@utah.gov>, De"" PAnnvi"h <dpenovich@utah.gov>,

Thanks for uodate, if there Is anything


to
residents.

_.

l_

.,

can do to help, please let me know. Especially if their maybe any potential exposures

Sent from my IPhone


On May 29, 2015, at 2:02 PM, Allyn Nakashima <anakashima@utah.gov> wrote:
Here Is a quick update:
We had a conference call with the
Management staff this moming. We Interviewed them with the questions that CDC
provided. We and
Jffered to do follow-up with lab staff if they provide contact Info, but they declined this saying that they did
not think anyone was exposed. From the responses to questions, it appeared there was very little risk of exposure so most staff won1
need prophylaxis.
I called Kate Hendricks at CDC and they want the remaining, unautoclaved specimens shipped to them early next week. Kim
Christensen in our lab went over there today to help them with packaging.
Instructions for de-<:ontamlnatlonof the lab and re-openlng will be forthcoming early next week.
Thanks,
Allyn
On Thu, May 28, 2015 at 3:04 PM, Allyn Nakashima <anakashima@utah.gov> wrote:
Hi Folks,
I am sure you are wondering what communication we have had with CDC regarding this incident. There was no proactive effort to
contact us on CDC's part and I spent the day tracking down who we needed to talk to. I just got off the phone with Dan Sosln, head of
the Select Agent Unit, and Kate Hendricks, anthrax countermeasures medical epl in the CDC EOC, who Is managing CDC's response.
hlIpsJ/mail.googl can/mailfliOl?ul=2&Ik=6892516:lOd&view=pI&q=Ougway%2OantITax&qs=~ue&s

ch='IJO'Y&th= 14de177bace75093&sIml= 14da177bece75093

113

121912015

..

S1ateci UIli1 Mall. Re: Dugway anthrax labaatory Incident

There seems to be a lot of confusion about this incident because of both DoD and CDC are involved. Here is what I found out:
1. CDC has already visited the Dugway lab on Sunday (we were not notified of this visit) and determined that they don' think there was
any risk to personnel there. DoD and CDC will be following up with the lab to determine why the radiation procedures that were
supposed to Inactivate the agent dldn' work completely.
2. The main concem is with the laboratories that DoD contracts
located in the states publicized in the Washington Post article.
risk. Most labs handle these specimens using BSL II or BSL II
they have determined that 4 laboratory staff needed prophylaxis

with that received specimens. Many of these are commercial labs and
What the lab staff did with the specimens determines their exposure
standard procedures and their staff are not at risk. Nationally, so far
due to unsafe specimen handling processes.

3. We have one lab


that received the specimens and they have been communicating with CDC by email and so far they think
that their staff are not at risk. However, CDC wants us to follow.up with them to ensure this using a systematic questionnaire, which
they will send us. If the questions look like lab expertise is needed, Robyn, I hope I can involve Kim or Annette?
4. There is no risk to our general population.
out tomorrow.
Kinda scary on how well they communicate!
future.

Media talking points have not been prepared yet, but they plan to do that and send them

I suggested they develop a more coordinated systematic

state notification protocol in the

Allyn

Allyn K Nakashima, MD
State Epidemiologist
Bureau of Epidemiology
Utah Department of Health
PO Box 142104
Salt Lake City, Utah 84114.2104
Tel: (801) 538.6191
Fax: (801) 538-9923

Allyn K Nakashima, MD
State Epidemiol09ist
Bureau of Epidemiology
Utah Department of Health
PO Box 142104
Salt Lake City, Utah 84114.2104
Tel: (801) 538-6191
Fax: (801) 538-9923
httnc; 'JlmAllonnoIA.r.nm/mAlI/l.M'OI?ul~2&lk:=

BAA251~vlew=ot&o=

Dl.ONAv%2OanttYax&as=true&seAl"ch=WArV&th=

14dR171bAce75093&sIml=

14dA1 nbAcA750A3

2/3

"

12[>11'<015

Stat. riUtM Mall. R.: Dugway anthrax laboroltry Incident

._ ..- IMPORTANT MESSAGE _ .This message, including any attachments, may contain confidential information intended for a specific individual and purpose, and is
protected by law. If you are not the intended recipient, delete this message, including from trash, and notify me by telephone or email.

If you are not the intended recipient, any distribution or copying of this message, or the taking of any action based on its content is
strictly prohibited.

hnpsJlmall.googl . cam/m.ll/uJ0f7ul=2&lk=68925163Od&vlow= pt&q= Dugway%200ntlYax&qs=lruo&soarch=quory&th= 14da177baco75093&sIml= 14dal nbaco75093

313

Stat. ci Ula'l Mall. R.: Dugway onthrax laborota'y Incident

" lV9i2Cii5

Allyn Nakashima <anakashlma@utah.gov>

Re: Dugway anthrax laboratory incident


1 message
Fri, May 29, 2015 at 3:43 PM

Allyn Nakashima <anakashima@utah.gov>


To: Tom Hudachko <thudachko@utah.gov>

There is a lot of confusion about this incident and communication to states was not well-{)oordinated (-we should have been getting regular conference
call updates as with any ICS incident). Partly, though this does not excuse CDC. there is a confusion about who is in the lead on this event DoD or
CDC. Apparently, many more labs received specimens from this lot than they initially thought. Yesterday, when I talked with Dan Sosin, he told me no
Utah labs had received them and 5 minutes later I got a call from Kate Hendricks saying
'laS one of the labs. There is also some concem
about another lot of B. anthracis that may have some issues as well as processing was the same. So I think things are rapidly changing as we would
expect with any investigation. My main issue, though, is that if they would just do a better job with communication and coordination, we would all be on
the same page!
So I will do my best to keep everyone updated as I hear. Also,
should not be named in any media releases from here for now.

on today's conference call is extremely concerned about confidentiality so they

On Fri, May 29. 2015 at 3:30 PM. Tom Hudachko <thudachko@utah.gov> wrote:
So, Utah was never listed as one of the nine states that had labs that received samples. Do you know if there was just initial confusion, or what the
deal was?
Thanks
Tom
On Fri. May 29, 2015 at 2:02 PM, Allyn Nakashima <anakashima@utah.gov> wrote:
Here is a quick update:
We had a conference call with the _
staff this moming. We interviewed them with the questions that CDC provided. We
and
offered to do follow-up with lab staff if they provide contact info. but they declined this saying that they did not think anyone was
exposed. From the responses to questions. it appeared there was very little risk of exposure so most staff wont need prophylaxis.
I called Kate Hendricks at CDC and they want the remaining, unautoclaved specimens shipped to them early next week. Kim Christensen in
our lab went over there today to help them with packaging.
Instructions for de-{)ontamination of the lab and re-opening will be forthcoming early next week.
Thanks,
Allyn
On Thu, May 28. 2015 at 3:04 PM, Allyn Nakashima <anakashima@utah.gov> wrote:
Hi Folks,
httos:llmall.aooole.com/mall/ulOl?uI=2&lk=68925163Od&vlew=pI&q=

DLogWay%2OanttTax&qs=true&s ch=query&ltl= 14da1.14a7067bf4&slm 1=14dal.14a7067bf4

113

121912015

Stat. r:t Utah Mall- R.: Dugway onltTax laboratory Irddont

I am sure you are wondering what communication we have had with CDC regarding this Incident. There was no proactive effort to contact us on
CDC's part and J spent the day tracking down who we needed to talk to. I just got off the phone with Dan Sosin, head of the Select Agent Unit,
and Kate Hendricks, anthrax countermeasures medical epi In the CDC EOC, who is managing CDC's response. There seems to be a lot of
confusion about this Incident because of both DoD and CDC are involved. Here Is what I found out:
1. CDC has already visited the Dugway lab on Sunday (we were not notified of this visit) and determined that they don~ think there was any risk
to personnel there. DoD and CDC will be following up with the lab to determine why the radiation procedures that were supposed to inactivate
the agent didn~ worn completely.
2. The main concem is with the laboratories that DoD contracts with that received specimens. Many of these are commercial labs and located
in the states publicized in the Washington Post article. What the lab staff did with the specimens determines their exposure risk. Most labs
handle these specimens using BSL II or BSL II standard procedures and their staff are not at risk. Nationally, so far they have determined that
4 laboratory staff needed prophylaxis due to unsafe specimen handling processes.
3. We have one lab.
. hat received the specimens and they have been communicating with CDC by email and so far they think that their
staff are not at risk. However, CDC wants us to follow-up with them to ensure this using a systematic questionnaire, which they will send us. If
the questions look like lab expertise is needed, Robyn, I hope I can involve Kim or Annette?
4. There is no risk to our general population.
tomorrow.
Kinda scary on how well they communicatel

Media talking points have not been prepared yet, but they plan to do that and send them out

I suggested they develop a more coordinated systematic

state notification

protocol In the future.

Allyn

Allyn K Nakashima, MD
State Epidemiologist
Bureau of Epidemiology
Utah Department of Health
PO Box 142104
Salt Lake City. Utah 84114.2104
Tel: (801) 538.6191
Fax: (801) 538-9923

Allyn K Nakashima, MD
State Epidemiologist
Bureau of Epidemiology
Utah Department of Health
PO Box 142104
Salt Lake City, Utah 84114-2104
hllDs:l/maJ I.aoool . cam/m .1I'u'0I?u1 = 2&lk=689251 630d&vlow= ot&o= Doow OV%2OanttT8X&as= ~ue&soarch= auorv&th= 14da 1a 1407067bf4&s1m 1=14da1a1407067bf4

213

Stat. ci Utah Mail. R.: Dugway anthrax laboratory Incident

, 121912O,~

Tel: (801) 538-6191


Fax: (801) 538-9923

IMPORTANT

MESSAGE

This message, including any attachments, may contain confidential information intended for a specific individual and purpose, and is protected by
law. If you are not the intended recipient, delete this message, including from trash, and notify me by telephone or email.
If you are not the intended recipient, any distribution or copying of this message, or the taking of any action based on its content is strictly
prohibited.

Tom Hudachko I Public Information Officer


Utah Department of Health
(0) 801-538-6232
(m) 801-560-4649
www.health.utah.gov
www.twitter.com/utahdepofhealth
https://www.facebook.com/UtahDepOfHealth
IMPORTANT MESSAGE
This message, Including any attachments, may contain confidential information intended for a specific individual and purpose, and is protected by
law. If you are not the intended recipient, delete this message, including from trash, and notify me by telephone or email.
If you are not the intended recipient, any distribution or copying of this message, or the taking of any action based on its content is strictly prohibited.

Allyn K Nakashima, MD
State EpidemiOlogist
Bureau of Epidemiology
Utah Department of Health
PO Box 142104
Salt Lake City. Utah 84114-2104
Tel: (801) 538-6191
Fax: (801) 538-9923

hltpsJ/mail.googl . ccm/maillu'Ol?ul=2&ik=68925163Od&vlow=

pl&q=Dugway%2OanttYax&qs=~ue&soarc!1=quory&th=

14da1a14a7067bf4&slml= 14da1a14a7067bf4

313

121912015

State a Utah Mall- RE: FW: PotentIal Exposure to BacIllus lOl1tTeclsln ala!la81cry In VA

Allyn Nakashima <anakashlma@utah.gov>

RE: FW: Potential Exposure to Bacillus anthracis in a laboratory in VA


1 message
Hendricks Walters, Katherine (Kate) (CDClOID/NCEZID) <kah1@cdc.gov>
To: 'Nakashima, Allyn (CDC utah.gov)' <anakashima@utah.gov>, 'jlcrep2@cdc.gov' <jicrep2@cdc.gov>

Sat, May 30, 2015 at 7: 18 AM

Allyn, I'll pass this on to the "information" people. I'm sure they are working on these Important issues. Kale
From: Nakashima, Allyn (CDC utah.gov)
Sent: Friday, May 29, 20157:30 PM
To: Hendricks Walters, Katherine (Kate) (CDClOID/NCEZID); Engel, Jeff (CDC cste.org)
Subject: Re: FW: Potential Exposure to Bacillus anthracis In a laboratory in VA
Hi Kate,
1. We just got a call from an urgent care clinic about a. .._ . mployee who has a sore throat, aches, and fever. He was told by FedEx that he was
possibly exposed to anthrax because of handling boxes being shipped to labs. I had asked Dan Sosin earlier if you guys were putting out talking points
for all of us to use. I think it would be great to wn", "Vitha PIO to get these out because the rumor mills are spinning out all kinds of misinformation.
Another earlier rumor here was that residents in'
Dugway lab
Here being screened by the local health department for
anthrax-also false information.
'0

2. The lab reiterated that they really need to re-open so they are eagerly awaiting the de-contamination recommendations that Von McClee promised.
I think both these issues are probably important for all states with labs involved and should be addressed on Monday's all-.;tate epl call.
Thanks,
Allyn
On Fri, May 29,2015 at 4:23 PM, Hendricks Walters, Katherine (Kate) (CDrJOID/NCEZID) <kah1@cdc.gov<mallto:kah1@cdc.gov
wrote:
The second lot number to assess
lot number Potential exposures need to be assessed for both lots. Kate
From: Hendricks Walters, Katherine (Kate) (CDC/OID/NCEZID)
Sent: Thursday, May 28, 20154:38 PM
To: Nakashima, Allyn (CDC utah.gov<http://ulah.gov>)
Cc: Bower, William (CDClOID/NCEZID); Sergienko, Eric M. (CDC/OPHPRlOD); Papagiotas, Stephen (CDC/OID/NCEZID); Weber, Angela
(CDClNIOSHlOD); Sosin, Dan (CDClOPHPRlOD)
Subject: FW: Potential Exposure to Bacillus anthracls in a laboratory In VA
State Partner in Utah (Dr. Nakashima),
httpsJlmell.googIe.com/mall/<>'Ol?u1'2&lk.68925163Od&vlow'pl&q.ant!Yex%2Odugway&qs'lrue&searctl"Query&th:

14da4tge40a46792&s1m 1'14da4t9840a46792

liS

121912015

Stale of Utah Mall - RE: FW: Potential Exposura to BacIllus anttYacls In a labc<atay

Here is a bMel Msk assessment

tool that you can use when you interview the people who worked with the samples.

First assess the most recent date that Bacillus anthracis Ames, lot number
days, go ahead and do a Msk assessment lor each person who worked with it.
Include as part

in VA

was used in the laboratory.

II it was in the last 60

01 your assessment,

the dates that they worked with the antigen (please include in your wMtten summary),

where they worked with the antigen (i.e., biosalety cabinet, benchtop)
anyone else who may have been in the immediate vicinity (within 6 leet) duMng the time they worked with the specimen .

assess what PPE was wom duMng the time they were working with the specimen.

II you check items in the Potential Risk column, you cannot rule out possible (probably low dose) exposure. Therelore, that person should be
considered to receive postexposure prophylaxis (PEP [antimicrobials and anthrax vaccine]) in consultation with an occupational health physician,
are available lor consultation.

We

Procedure
Potential
Risk
Risk Very Unlikely

1,

IIyou centMluged ...

a.

was it in an aerosol-tight

__

rotor?

No
Yes

b.
__

was it centMluged in a BSC?


No

httnc::-11m Ai I nrY'lnll=l,...,."."1m ~1I/1 JnJ? .i = 'R.IIt= AAQ?l:i1R?J1rlR.vl

RlN=

ntR.n= ;:InthrAw% ?rJr1IInWAVR.M= trl JP.Jl,C1,AArr:h= nl N=lrVR.th= 1dt1A4~7Q?,IlC1,1 m 1= 1M::l4mP.4OA4fi79?

')IF!

12!!li2015

__

Slaw of Utah Mall. RE: FW: Potantial Exposure to BacIllus i<11tTacisln elaboralr:J:y In VA

Yes

c.

if not centrifuged in a SSC, was the rotor opened in a SSC?

__

No

__

Yes

2.

If you vortexed...

a.

was the vortex outside of a SSC?

__

Yes

__

No

i.
__

No

__

Yes

ii.
__

Yes

__

No

3.

if outside of a SSC, were the vials sealed with an O-ring?

if outside of a SSC, did you then open a flip-top tube?

Did you create a splash or drop/break a tube?


Yes

__
4.
__

No
Did you do any other potentially aerosol-generaling procedures (dry specimens by blowing nitrogen across them, vaporize them in a mass spec)
Yes

https1/mall.google.cem/mali/uJllI?ul=2&lk=68925163Od&vlf1N=

pt&q=anltYex%2Odugway&qs=true&search=query&lh=

14da41984Oa46792&slm 1=14da41984Oa46792

315

121912015

__

Stale

a Utah Mall-

RE: FW: Potantlii Exposur. to Bacillus "'ltTacls In a laboratory In VA

No

Second, once you have finished assessing the risk, you will also need to assess what, if anything has been done for decontamination.
questions are somewhat open ended,

What, if any, surface decontamination


The solution, concentration,

was done for surfaces where samples were processed?

These

Be specific .

pH, and contact time?

How was waste disposed of?

What PPE was wom during testing, decontamination,

and disposal?

Please send us a write up of your risk assessment.


If there are any exposures that may require PEP. send a copy to Dr. Kate Hendricks at kah1@cdc.gov<mailto:kah1@cdc.gov>
<mailto: kah 1@cdc.gov<mallto:kah1@cdc.gov

If the sample was used at all, a copy should also be sent to a copy to Angela Weber at amw1@cdc.gov<mailto:amw1@cdc.gov>
<mailto:amw1@cdc.gov<mailto:amw1@cdc.gov
as she Is our POC for the contamination issues here at CDC

Kate
Hendricks. MD, MPH&TM
Medical Officer
Bacterial Special Pathogens Branch
Division of High Consequence Pathogens and Pathology
Centers for Disease Control and Prevenlion
1600 Clifton Road. MS A-30
Atlanla, GA 303294027
Office: 404.639.3153<lel:404.639.3153>
Fax: 404.315.2488<lel:404.315.2488>
email: kah1@cdc.gov<mailto:kah1@cdc.gov><maillo:
kah1@cdc.gov<maillo:kah1@cdc.gov
CDC EOC #: 770.488.7100<tel:770.488.7100>

httM'lImAll t'YY"Il"llA N'YTl/m

111111l11nJ?J
Ii= ?R.lk=AAQ?l:i 1Fi:Vll'iR.vi

PIoN=

nt&1=

AntrvAY%XlrlIIl"Ml~R-n.cl= trllAAc;.Mrl":~nllA"V'\th=

1dti::1d~7q?A.c;.i m 1= 14r1A4f'!:lfl.4fb:lA.79?

""

12/Ml)15

State of Utah Mall- RE: FW: Potential Exposuroto Bacillus on1tTacis In a laboralllry In VA

Allyn K Nakashima, MD
State Epidemiologist
Bureau of Epidemiology
Utah Department of Health
PO Box 142104
Salt Lake City, Utah 84114-2104
Tel: (801) 538-6191
Fax: (801) 538-9923

_._.

IMPORTANT

MESSAGE

This message, including any attachments, may contain confidential information intended for a specific individual and purpose, and is protected by law.
If you are not the intended recipient, delete this message, Including from trash, and notify me by telephone or email.
If you are not the intended recipient, any distribution or copying of this message, or the taking of any action based on its content is strictly prohibited.

-.J

wlnmail.dat

15K

httpsJlmall.googlo.com/mail/u'\ll?ul=2&lk=68925163Od&vlow=

pl&q=anth'ax%2Odugway&qs=truo&saarch=query&lh=

14da41984Oa467l12&slm1=14da41984Oa40792

5/5

S1ato ci Utah Mail. Ro: Dugway enthrax laboraillry Incident

121912015

Allyn Nakashima <anakashlma@utah.gov>

Re: Dugway anthrax laboratory incident


1 message

-------

Tom Hudachko <thudachko@utah.gov>


To: Allyn Nakashima <anakashima@utah.gov>

------ -------- --- -

Fri. May 29. 2015 at 3:46 PM

Thanks - I certainly have no plans to mention them! We were asked early about labs in Utah that may have received samples. I answered that I could
only speak for our lab and that we had not received any.
Appreciate the updates!
On Fri. May 29. 2015 at 3:43 PM. Allyn Nakashima <anakashima@utah.gov> wrote:
There is a lot of confusion about this incident and communication to states was not well-coordinated (-we should have been gelling regular
conference call updates as with any ICS incident). Partly. though this does not excuse CDC. there is a confusion about who Is in the lead on this
event DoD or CDC. Apparently. many more labs received specimens from this lot than they Initially thought. Y"Q1erdav. when I talked with Dan
Sosin. he told me no Utah labs had received them and 5 minutes later I got a call from Kate Hendricks saying
one of the labs. There Is
also some concem about another lot of B. anthracis that may have some issues as well as processing was the same. So I think things are rapidly
changing as we would expect with any investigation. My main Issue. though. is that if they would just do a beller job with communication and
coordination. we would all be on the same pagel
So I will do my best to keep everyone updated as I hear. Also,
they should not be named in any media releases from here for now.

_ conference callis extremely concerned about confidentiality so

On Fri. May 29. 2015 at 3:30 PM. Tom Hudachko <thudachko@utah.gov> wrote:
So, Utah was never listed as one of the nine states that had labs that received samples. Do you know if there was just initial oonfusion, or what the
deal was?
Thanks
Tom
On Fri, May 29. 2015 at 2:02 PM, Allyn Nakashima <anakashima@utah.gov> wrote:
Here is a quick update:
We had a conference call with the
_
staff this morning. We interviewed them with the questions that CDC provided. We
and
offered to do follow-up with lab staff if they provide contact info. but they declined this saying that they did not think anyone was
exposed. From the responses to questions. it appeared there was very little risk of exposure so most staff won~ need prophylaxis.
I called Kate Hendricks at CDC and they want the remaining, unautoclaved specimens shipped to them early next week. Kim Christensen in
our lab went over there today to help them with packaging.
Instructions for de-contamination of the lab and re-openlng will be forthcoming early next week.
httpsJlmail.googlo.can/mail""Qrlul'2&Ik'58925163Od&vlow'pl8oq=dugway%2Oa-1thrax&qs.truo&soarch:

quory&tIF 14001a42dS668db9&si m 1'14da1 a42d9668dC/l

1/4

1:Y9r.2015

Stat. cI

Ulltl

Mall- R.: Dugway anthrax labcnltlry Incident

Thanks,
Allyn
On Thu, May 28, 2015 at 3:04 PM, Allyn Nakashima <anakashima@utah.gov>
Hi Folks,

wrote:

I am sure you are wondering what communication we have had with CDC regarding this incident. There was no proactive effort to contact us
on CDC's part and I spent the day tracking down who we needed to talk to. I just got off the phone with Dan Sosin, head of the Select Agent
Unit, and Kate Hendricks, anthrax countermeasures medical epi in the CDC EOC, who is managing CDC's response. There seems to be a lot
of confus ion about this incident because of both DoD and CDC are involved. Here is what I found out:
1. CDC has already visited the Dugway lab on Sunday (we were not notified of this visit) and determined that they don~ think there was any
risk to personnel there. DoD and CDC will be following up with the lab to determine why the radiation procedures that were supposed to
inactivate the agent didn~ work completely.
2. The main concem is with the laboratories that DoD contracts with that received specimens.
Many of these are commercial labs and
located in the states publicized in the Washington Post article. What the lab staff did with the specimens determines their exposure risk.
Most labs handle these specimens using BSL II or BSL II standard procedures and their staff are not at risk. Nationally, so far they have
determined that 4 laboratory staff needed prophylaxis due to unsafe specimen handling processes.
3. We have one lab
received the specimens and they have been communicating with CDC by email and so far they think that
their staff are not at risk. However, CDC wants us to follow-up with them to ensure this using a systematic questionnaire, which they will send
us. If the questions look like lab expertise is needed, Robyn, I hope I can Involve Kim or Annette?
4. There is no risk to our general population.
tomorrow.
Kinda scary on how well they communicate!

Media talking points have not been prepared yet, but they plan to do that and send them out

I suggested they develop a more coordinated systematic

state notification

protocol in the future.

Allyn

Allyn K Nakashima, MD
State Epidemiologist
Bureau of Epidemiology
Utah Department of Health
PO Box 142104
Salt Lake City, Utah 84114-2104
Tel: (801) 538-6191
Fax: (BO 1) 538-9923

httD!li"/Imall.oooole.c:an/m All/u/GI?ul = 2&Jk= 689251 fn:ki&vlfNi=

ot&o= ci..la'N SV%2OMthrax&09=

Irue&saArch=cUEW'V&Ih=

14da 1a42d9668db9&s

im 1=14dA 1A42dQ668db9

".

12/912015

State ci Ulm Mall. Re: Dugway entl1rax leba.tory

incident

Allyn K Nakashima, MD
State Epidemiologist
Bureau of Epidemiology
Utah Department of Health
PO Box 142104
Salt Lake City, Utah 84114-2104
Tel: (801) 538-6191
Fax: (801) 538-9923

_.- IMPORTANT MESSAGE ._


This message, includin9 any attachments, may contain confidential infonnation intended for a specific individual and purpose, and is protected
by law. If you are not the intended recipient, delete this message, including from trash, and notify me by telephone or email.
If you are not the intended recipient, any distribution or copying of this message, or the taking of any action based on Its content Is strictly
prohibited.

Tom Hudachko I Public Infonnation Officer


Utah Department of Health
(0) 801-538-6232
(m) 801-560-4649
www.health.utah.gov
www.twitter.com/utahdepofhealth
https:llwww.facebeok.com/UtahDepOfHealth
_ IMPORTANT MESSAGE
This message, including any attachments, may contain confidential infonnation intended for a specific individual and purpose, and is protected by
law. If you are not the intended recipient, delete this message, including from trash, and notify me by telephone or email.
If you are not the Intended recipient, any distribution or copying of this message, or the taking of any action based on its content is strictly
prohibited.

Allyn K Nakashima, MD
State Epidemiologist
Bureau of Epidemiology
Utah Department of Health
hltpsJ/m a11.google.can/m .lI/li01?u1"2&1k" 689251 630d&vl """ pt&q"dugway%2Oanthrax&qs"true&search-

query&th" 14da1a42d966&lb9&s1 m I" 14da 1a42d966&lb9

314

Stateci Uta'lMall. R.: Dugwayanthrexlabamay Incident

12191201S

PO Box 142104
Salt lake City, Utah 84114-2104
Tel: (801) 538-6191
Fax: (801) 538-9923

IMPORTANT

MESSAGE

This message, including any attachments, may contain confidential information intended for a specific individual and purpose, and is protected by
law, If you are not the intended recipient, delete this message, including from trash, and notify me by telephone or email,
If you are not the intended recipient, any distribution or copying of this message, or the taking of any action based on its content is strictly prohibited.

Tom Hudachko I Public Information Officer


Utah Department of Health
(0) 801-538-6232
(m) 801-560-4649
www.health.utah.gov
www.twitter.com/utahdepofhea
Ith
https: Ilwww.facebook.com/UtahDepOfHea

*****'**-*

Ith

IMPORTANT MESSAGE ...


**..
u*"'*

This message, including any attachments, may contain confidential information Intended for a specific individual and purpose, and is protected by law.
If you are not the intended recipient, delete this message, including from trash, and notify me by telephone or email.
If you are not the intended recipient, any distribution or copying of this message, or the taking of any action based on its content is strictly prohibited.

nit,.... '/1m

11111nrYV'l11' I"fYTl/m

.llI111it1rV?l ~ = ?,ltlk= AAQ?1i\1 f\.'),("lrlR,,,IFllN= ntJl.n=

rlI1O\oVAV%

?OAnthr.llllt Jl.nq;=trllAR.~Mrr.~nJ wv,ll, th= 14t1A 1 A4?rt!=lfiRAtil"Altql

m 1= 14tUl1 A4?rIQARP.rlhA

.,.

Stat. of U1ah Mall. Tltl.: Anth,ox lobcrotory InvooUga1ioo [cuIl1n typlng] ,ooults

12191'Z015

Allyn Nakashima <anakashlma@utah.gov>

Title: Anthrax laboratory investigation [culture/typing] results


Hoffmaster. Alex (CDC/OID/NCEZID) <amh9@cdc.gov>
Sat, May 30, 2015 at 7:22 PM
To: "Nakashima, Allyn (CDC utah.gov)" <anakashima@utah.gov>, "steven.m.luo.civ@mail.mil" <steven.m.luo.civ@mall.mil>
Good day,
Attached are the final results for samples sent on 5/28/15 from Dugway.
If you have any questions about these results, please send an email to bspb@cdc.gov<mallto:bspb@cdc.gov> or call 404-<539.1711and someone will
call you back.
Thanks,
Alex
Alex R. Hoffmaster, Ph.D.
Team Lead, Zoonoses and Select Agent Laboratory
Bacterial Special Pathogens Branch
Division of High-Consequence Pathogens & Pathology
Centers for Disease Control and Prevention
Tele/fax 404-<539-085213023

'7:3

Dugway report.pdf
181K

hltDsJ/mall.aooole.ccrnJm all/"lY7uI =2&Ik= 68925163Od&vl= pt&q= dugw ay%2Oanthrox&qs= lruo&soorch=quory&m sg= 14da790420d52f7c&slm 1=14da790420d52f7c

1/1

Submitter to CDC:

Diseases (NCEZID)

Centers for Disease Control & Prevention


National Center for Emerging and Zoonotic Infectious
Division of High-Consequence Pathogens and Pathology (DHCPP)

Date Received:
5/30/15

5/29/ 15

1160

CFll/llll

Investigation

:::..

..

'0" n

~~~ ..- ............

c ...

Report Status: Final

Date Reported:

Date sent to CDC: 5/28/15

Date Collected:

Original Submitter:

Zoonotic and Select Agent Laboratory

Bacterial Special Pathogens Branch (BSPB)

Dugway-Life Sciences Test Facility


Dugway. lltah

Submitter Specimen 10:

~ec!men

1 ml Antigen

I I '"

CDC _DOD_Anthrax

This fonn is to be used solely for the purposes of the

CDC Specimen 10: 3000015433

I Culture:

B. anthracis detected as reported in other preparations

Reviewed by:

:>f patient data should be maintained in accordance w:th C.IA and HIPAA
Page: of

Phone: 404-639.2053
Fax: 404-639-3022
Mailstop G'34, 1600 Clifton Rd, NE, Atlanta, GA 30333

security, and integrity

--~n

Note: Low concentrations of

Reported by:

Confidentiality.

-,

State a Utltl Mail. Re: Potential Exposure 10BacIllus anthracls In elaba"atory In VA

1219121115

Allyn Nakashima <anakashlma@utah.gov>

Re: Potential Exposure to Bacillus anthracis in a laboratory in VA


1 message
Sun, May 31, 2015 a110:49 PM
To: "Hendricks Wall",rs, Katherine (Kale) (CDC/OID/NCEZID)" <kah1@cdc.gov>
Co: "Nakashima, Allyn (CDC ulah.gov)" <anakashima@ulah.gov>, "Bower, William (CDC/OID/NCEZI~)"_<wab4@cdc.gov>, .
Hi Kate,
Yes, we're in UT.
was lhe firsl and only lime lhe

lube was opened. We slopped all spore work on Thursday after Dugway hit the news.

The work area has been bleach de-conned and swabs of the lab were all negalive (PCR) for Ba.
I would like to speak wilh you Monday aboul resuming our non-Ba relaled work in lhe lab.
Thanks,
Senl from my iPad
On May 31, 2015, at 5:23 PM, Hendricks Wallers, Kalherine (Kale) (CDC/OID/NCEZID) <kah1@cdc.gov> wrole:
HI, Good to confirm you have no potentially aerosolizing exposures at the
UT (not VA, right [probably courtesy of "copy
and paste"]). Was
. the last time you opened the
tube or the only time? Kate

From:
Sent: Saturday, May 30, 2015 9:34 PM
To: Hendricks Walters, Katherine (Kate) (CDC/OID/NCEZID)
Cc: Nakashima, Allyn (CDCulah.gov); Bower, William (CDC/OID/NCEZID);
Subject: Re: Potential Exposure to Bacillus anthracis in a laboratory in VA

Hi Kale,
httpsJlmail.google.com/maillu'Ql?ui=2&lk=68925163Od&vlew=pt&q=anttvax%2Odugway&qs=trua&search=query&th:

14dad73fel2b8aa5lml=

14dad73fe12b8ee5

1fT

121912015

Stater:I Utm Mell- Re: _oJ

ExpoeureloBacillusenthreclsln a laIxJr~

In VA

Both lots were opened.


We have 2 stock lubes of the

The

lot. 1 of the 2 has been opened, aliquoUed and assayed by PCR on

stock lube was received and opened about

, ago. II has not been used since.

All work wilh lhese malerials has been performed in a BSL2 laboralory wilhin a BSC by slaff wearing double gloves, disposable lab coals,
and booties.

We roulinely work wilh clinical samples and pathogens. We lreal all biological malerial, live or inaclivaled,

as if it is infectious.

Please leI me know if you have any further questions.

Senl from my iPhone

On May 30, 2015, al 7:24 AM, Hendricks Walters, Kalherine (Kale) (CDClOID/NCEZID)
Thanks Allyn, Since I think I sent you word of the two lots in "reverse"
unopened?

order.

<kah1@cdc.gov>

wrole:

Can you be specific about which lot went

Kate

From: Nakashima, Allyn (CDC utah.gov)


Sent: Friday, May 29, 2015 6:30 PM
To: Hendricks Walters, Katherine

(Kate) (CDC/OID/NCEZID)

Cc: Bower, William (CDC/OID/NCEZID);


Subject: Re: FW: Potential

CheryI.Baird@biofiredx.com

Exposure to Bacillus anthracis in a laboratory

in VA

Hi Kate,
htt.-11m All rY"Il'V1J~NYTl/m Ail" tiN?llI

= ?R.lk=AA.Q?!i 1fi:V.lr1A.vlFM/: ntR.n= AntfvAX%2OnlJC7oNAV&as=true&s9Arch=

ouerv&th=

14dad73t'at2b8aa5&slm

1= 14dad73fet'2b8aa5

2!7

State ci Utah Mall. Re: Potential Exposure to Bacillus entl1racls In a laboratory In VA

1219121115

As per our phone conversation,


' found and is enclosing the specimens from this second lot as well as the
specimens from the initial lot on Monday. As I understand it from
the specimens from the second lot were not
opened
'so there is no risk of exposure to their staff.

, if this is not correct, please let us know.

Thanks,

Allyn

On Fri, May 29, 2015 at 4:23 PM, Hendricks Walters, Katherine (Kate) (CDC/OID/NCEZID) <kah1@cdc.gov> wrote:
The second lot number to assess is
assessed for both lots. Kate

lot number

Potential exposures need to be

From: Hendricks Walters, Katherine (Kate) (CDC/OID/NCEZID)


Sent: Thursday, May 28, 20154:38 PM
To: Nakashima, Allyn (CDC utah.gov)
Cc: Bower, William (CDC/OID/NCEZID); Sergienko, Eric M. (CDClOPHPRlOD); Papagiotas. Stephen
(CDC/OID/NCEZID); Weber, Angela (CDC/NIOSH/OD); Sosin, Dan (CDClOPHPRlOD)
Subject: FW: Potential Exposure to Bacillus anthracis in a laboratory in VA
State Partner in Utah (Dr. Nakashima),
Here is a brief risk assessment tool that you can use when you interview the people who worked with the samples.
First assess the most recent date that Bacillus anthracis
, lot number
was used In the
laboratory. If it was in the last 60 days, go ahead and do a risk assessment for each person who worked with it.
Include as part of your assessment,

the dates that they worked with the antigen (please include in your written summary),

where they worked with the antigen (i.e., biosafety cabinet, benchtop)

anyone else who may have been in the immediate vicinity (within 6 feet) during the time they worked with the
specimen.
https:llmall.goagle.can/mall/liOl?ul=2&lk=68925163Od&vlew=

pt&q=antIYax%2Odugway&qs=true&search=query&th=

14dad73fef2b8aa5&slm 1=14dad73fef2bSaa5

3f7

121912015

Stat. r:i U""' Mall. R.: Pontial Exposur.1D BacIllus onthrocls In a lallaatory In VA

assess what PPE was wom during the lime they were working with the specimen.

If you check items in the Potential Risk column, you cannot rule out possible (probably low dose) exposure. Therefore,
that person should be considered to receive postexposure prophylaxis (PEP [antimicrobials and anthrax vaccine]) in
consultation with an occupational health physician. We are available for consultation.

Procedure
Potential
Risk
Risk Very Unlikely
1.

If you centrifuged...

a.

was it In an aerosol-llght rotor?

__

No

__

Yes

b.

was It centrifuged in a SSG?

__

No

__

Yes

c.
__

No

__

Yes

2.

httnl:l'l1moll

ntVVtlt>

if not centrifuged in a SSG, was the rotor opened In a SSG?

If you vortexed ...

I"'tYTl/rn 1lI111l
Jnrh oI~'.tIIt=AAQ?"i1R?1'rltvloClW=nt}tn::Anthr':::1l(0I.. ?l'\o1'I1"'WAV.tne:.=trl

~<I_,,..h:,,,""",Jtth= 1~~~"Yt~lm

1= 1.4tiJ:ll'lnf~ol\

."

121912015

Slate c:A Utah Meil- Re: Potentiel ExposurelD BacIllus anthracls In a laboratory In VA

a.

was the vortex outside of a SSG?

__

Yes

__

No

__

No

__

Yes

__

Yes

__

No

3.

i.

if outside of a SSG, were the vials sealed with an O-ring?

ii.

if outside of a

sse, did you then open a flip-top tube?

Did you create a splash or drop/break a tube?

__

Yes

__

No

4.
Did you do any other potentially aerosol-generating procedures (dry specimens by blowing nitrogen across them,
vaporize them in a mass spec)
Yes
__

No

Second, once you have finished assessing the risk, you will also need to assess what, if anything has been done for
decontamination. These questions are somewhat open ended.

What, if any, surface decontamination was done for surfaces where samples were processed? Se specific .

o The solution, concentration, pH, and contact time?


httos:J/mail.oooole.com/m aillu'Ol?ul= 2&lk= 68925163Od&vlf!N= pl&q= anttvax%2Odugway&qs=true&search=

query&lh= 14dad73fef2b8aa5&slm 1=14dad73fef2b8aa5

5f7

121912015

SlBte

a Ut31 Mall.

Re: Pctontial Exposure'"

How was wastB disposed of?

What PPE was wom during testing, decontamination,

Beelllus anttvacls In a laboratory In VA

and disposal?

Please send us a write up of your risk assessment.


If there are any exposures that may require PEP, send a copy to Dr. Kate Hendricks at
kah 1@cdc.gov<mailto:kah1@cdc.gov>
If the samplB was used at all, a copy should also be sent to a copy to Angela Weber at
amwl@cdc.gov<mailto:amw1@cdc.gov>
as she Is our POC for the contamination Issues here at CDC

Kate
Hendricks, MD. MPH&TM
Medical Officer
Bacterial Special Pathogens Branch
Division of High Consequence Pathogens and Pathology
Centers for Disease Control and Prevention
1600 Clifton Road, MS A-30
Atlanta. GA 303294027
Office: 404.639.3153
Fax: 404.315.2488
email: kah1@cdc.gov<mailto:kah1@cdc.gov>
CDC EOC #: 770.488.7100

nttnc:..lfm "II nt"VVlll:lo N'VTI/m Rllb Jrlnt II = ,,It Ik= AAQ7l:i 1fVI'Irl.ltvll>N= ntR.n= Rnt!vR",% ?l"'rl,nAlAVR.M=trl

IAl\ClAAr(';h::

nl Il=W'VAth=

1dt1::vtn~ClI

m 1= 1.dt+.:vf7:":W'~'\

FJ7

Slate cI Utah Mall. R.: _aI

121912015

Allyn K Nakashima.

Exposur. to Baclll anthracls In alalJorotory In VA

MD

State Epidemiologist
Bureau of Epidemiology
Utah Department of Health
PO Box 142104
Salt Lake City, Utah 84114-2104
Tel: (801) 538.Q191
Fax: (801) 538-9923

.u
,.

IMPORTANT

MESSAGE

..u ....

This message. including any attachments, may contain confidential information Intended for a specific individual and
purpose. and is protected by law. If you are not the Intended recipient. delete this message, including from trash, and notify
me by telephone or email.

If you are not the intended recipient, any distMbution or copying of this message, or the taking of any action based on its
content is stMctly prohibited.

hltps:Jlmall.googlcomlmalllullll7ul =2&Ik=68925163Od&vl",,= pt&q=anttrax%2Odugway&qs=truo&s_ch=

quory&th= 14dad73fel2b8aa5&sim 1=14dad73fef2b8aa5

717

-.....

1219f2015

Statec:A UtahMall. EPAExemption


Update

Allyn

Nakashima

<anakashlma@utah.gov>

EPA Exemption Update


1 message
Canzler, Erica <Canzler.Erica@epa.gov>
Fri, Jun 5, 2015 at 6:49 PM
To: "gilberto.chavez@cdph.ca.gov"
<gilberto.chavez@cdph.ca.gov>,
"gwendolyn.hammer@cdph.ca.gov"
<gwendolyn.hammer@cdph.ca.gov>,
"deborah. hoi mes@cdph.ca.gov"
<deborah.holmes@cdph.ca.gov>,
"steven.blessing@state.de.us"
<steven. blessi ng@state.de.us>, "awele. madukaezeh@state.de.us" <awele .maduka-ezeh@state.de.us>,
"alfred.demaria@state. maous" <alfred.demaria@state.ma.us>,
"david .blythe@maryland.gov"
<david. blylhe@maryland.gov>,
"robert .myers-phd@maryland.gov"
<robert. myers-phd@maryland.gov>,
"tabeth .jiri@doh.state.nj.u"
<tabeth.jiri@doh.state.nj.u>,
"Nelson. Delgado@doh.state.nj.us"
<Nelson. Delgado@doh.state.nj.us>,
"edward .lifshitz@doh.state.nj.us"
<edward.lifshitz@doh.state.nj.us>,
"christina.egan@health.ny.gov"
<christina.egan@health.ny.gov>,
"john.dunn@tn.gov" <john.dunn@tn.gov>,
"linda. gaul@dshs.state.tx.us"
< linda.gaul@dshs.state.tx.us>,
"Tom. Sidwa@dshs.state.lx.us"
<Tom .Sidwa@dshs.state.lx.us>
,
"Rita. Es pinoza@sanantonio.gov"
<Rita. Es pinoza@sanantonfo.gov>,
"j undawoo@sanantonfo.gov"
<jundawoo@sanantonio.gov>,
"anakashima@utah.gov"
<anakashl ma@utah.gov>, "laurie. foriano@vdh.virginia.gov"
< laurie. forlano@vdh.virginia.gov>,
"Diane. Woolard@vdh.virginia.gov"
<Diane. Woolard@vdh.virginia.gov>,
"krista.rietberg@kingcounty.gov"
<krista.rietberg@kingcounty.gov>,
"Marcia.Goldoft@DOH.WA.GOV"
<Marcia. Goldoft@doh.wa.gov>,
"5 uzanne.gibbonsburgener@wf.gov"
<suzanne.gf bbonsburgener@wi.gov>,
"sfisher@naccho.org"
<sfis her@naccho.org> ,
"CAldridge@naccho.org"
<CAldridge@naccho.org>,
"dpatel@cste.org" <dpatel@cste.org>, "eric.blank@aphl.org"
<eric.blank@aphl.org>,
"gbakker@astho.org" <gbakker@astho.org>,
"jengel@cste.org" <jengel@cste.org>, "jlemmings@cste.org"
<jlemmings@cste.org>,
"jblumenstock@astho.org"
<jblumenstock@astho.org>,
"jtalkington@astho.org"
<jtalkington@astho.org>,
"scott.becker@aphl.org"
<scott.becker@aphl.org>,
"ktalkington@astho.org"
<ktalkington@astho.org>,
"tis1@cdc.gov" <tis 1@cdc.gov>, "guh2@cdc.gov" <guh2@Cdc.gov>,
"htv4@cdc.gov" <htv4@cdc.gov>,
"jiclead2@cdc.gov"
<jiclead2@cdc.gov>,
"iwg9@cdc.gov" <iwg9@cdc.gov>, "kjt1@cdc.gov" <kjt1@cdc.gov>,
"amh9@cdc.gov" <amh9@cdc.gov>,
"crd7@cdc.gov" <crd7@cdc.gov>,
"amw1@cdc.gov" <amw1@cdc.gov>,
"gnfO@cdc.gov" <gnfO@cdc.gov>,
"vmoO@cdc.gov" <vmoO@cdc.gov>, "dms8@cdc.gov" <dms8@cdc.gov>,
"faq1@cdc.gov" <faq1@cdc.gov>, "parO@cdc.gov" <parO@cdc.gov>,
"fsu6@cdc.gov" <fsu6@cdc.gov>,
"eocsctfdeputy@cdc.gov"
<eocsctfdeputy@cdc.gov>,
"eup2@cdc.gov" <eup2@cdc.gov>,
"vkx7@cdc.gov"
<vkx7@cdc.gov>,
"wab4@cdc.gov" <wab4@cdc.gov>, "pdm3@cdc.gov" <pdm3@cdc.gov>,
"hfw3@cdc.gov" <hfw3@cdc.gov>,
"Don.Boyce@hhs.gov"
<Don.Boyce@hhs.gov>,
"hvy1@cdc.gov"
<hvy1@cdc.gov>,
"knk8@cdc.gov" <knk8@cdc.gov>,
"goj8@cdc.gov" <goj8@cdc.gov>, "hfa2@cdc.gov"
<hfa2@cdc.gov>, "jsa9@cdc.gov" <jsa9@cdc.gov>, "mja4@cdc.gov" <mja4@cdc.gov>, "bzb8@cdc.gov" <bzb8@cdc.gov>,
"iqs3@cdc.gov"
<iqs3@cdc.gov>, "zoa6@cdc.gov" <zoa6@cdc.gov>,
"gtg1@cdc.gov" <gtg1@cdc.gov>, "vzc6@cdc.gov"
<vzc6@cdc.gov>,
"cjy1@cdc.gov"
<cjy1@cdc.gov>, "kdI8@cdc.gov" <kdI8@cdc.gov>, "Kathryn.Delaurentis@fda.hhs.gov"
<Kathryn.Delaurentis@fda.hhs.gov>,
"dtd7@cdc.gov"
<dtd7@cdc.gov>, "DSNS.Teamroom@cdc.gov"
<DSNS.Teamroom@cdc.gov>,
"dhe1@cdc.gov" <dhe1@cdc.gov>, "Joseph.Foster@hhs.gov"
<Joseph.Foster@hhs.gov>,
"kkg2@cdc.gov"
<kkg2@cdc.gov>,
"huq2@cdc.gov" <huq2@cdc.gov>, "kxh9@cdc.gov"
<kxh9@cdc.gov>,
"rzh7@cdc.gov"
<rzh7@cdc.gov>, "mlh2@cdc.gov" <mlh2@cdc.gov>,
"kah1@cdc.gov" <kah1@cdc.gov>,
"anh5@cdc.gov" <anh5@cdc.gov>,
"hhh1@cdc.gov"
<hhh1@cdc.gov>, "mai9@cdc.gov" <mai9@cdc.gov>,
"czk7@cdc.gov"
<czk7@cdc.gov>,
"lpI3@cdc.gov" <lpI3@cdc.gov>, "clo2@cdc.gov"
<clo2@cdc.gov>, "frh6@cdc.gov" <frh6@cdc.gov>, "stm2@cdc.gov"
<stm2@cdc.gov>,
"hok4@cdc.gov" <hok4@cdc.gov>,
"bbo9@cdc.gov"
<bbo9@cdc.gov>, "rcoO@cdc.gov" <rcoO@cdc.gov>, "scr1@cdc.gov" <scr1@cdc.gov>,
"bsrO@cdc.gov" <bsrO@cdc.gov>, "dmzO@cdc.gov"
<dmzO@cdc.gov>, "fzi6@cdc.gov" <fzi6@cdc.gov>,
"byy3@cdc.gov"
<byy3@cdc.gov>,
"gqw6@cdc.gov" <gqw6@cdc.gov>,
"ahe8@cdc.gov"
<ahe8@cdc.gov>, "zoz8@cdc.gov"
<zoz8@cdc.gov>,
"cIi9@cdc.gov" <cIi9@cdc.gov>, "rsw2@cdc.gov" <rsw2@cdc.gov>,
"eocevent42@cdc.gov"
<eocevent42@cdc.gov>,
"eocafteract2@cdc.gov"
<eocafleract2@cdc.gov>,
"klq4@cdc.gov" <klq4@cdc.gov>, "esz2@cdc.gov"
<esz2@cdc.gov>,
"hsz3@cdc.gov" <hsz3@cdc.gov>,
"debra.blog@health.ny.gov"
<debra.blog@health.ny.gov>,
"vxj1@cdc.gov" <vxj1@cdc.gov>,
"jfv3@cdc.gov"
<jfv3@cdc.gov>, "jiclead@cdc.gov"
<jfclead@cdc.gov>,
"CheryI.Stariing@cdph.ca.gov"
<CheryI.Starling@cdph.ca.gov>,
"Jason.Baker@cdph.ca.gov"
<Jason.Baker@cdph.ca.gov>,
"dqc5@cdc.gov"
<dqc5@cdc.gov>.
"Joseph.Cordova@dhs. wisconsin.gov" <Joseph.Cordova@dhs.wisconsin.gov>,
https:llmall.googIe.canJmall/tM'OI?uI=2&lk=68S25163O:l&view=pl8oq=anltrax%2IldugNay&qs=true&seerch=query&1tl=
14dc65832dbSb75d&si
m1=14dc65832dbSb
75d

1/4

121912015

State d Utal1 Mall- EPA Examplloo Updata

"Lisa.Pentony@dhs.wisconsln.gov"
<Lisa.Pentony@dhs.wisconsin.gov>,
"jill. taylor@health.ny.gov"
<jill.taylor@health.ny.gov>,
"ellzabeth.cavosie@health.ny
.gov" <elizabeth.cavosie@health.ny.gov>,
"apeB@cdc.gov" <apeB@cdc.gov>, "jbf7@cdc.gov" <jbf7@cdc.gov>,
"Tabatha. Offutt -Powell@state.de.us"
<Tabatha. Offutt -Powell@state.de.us>,
"peter.s hull@sth.wisc.edu" < peter.shull@slh.wisc.edu>,
"hnq9@cdc. gov"
<hnq9@cdc.gov>, "Juan. Ruiz@cdph.ca.gov"
<Juan.Ruiz@cdph.ca.gov>,
"Monica. Gamez@dshs.slale.lx.us"
<Monica.Gamez@dshs.slale.lx.us>,
"lisa. comelius@dshs.stale.lx.us"
<lisa .comelius@dshs.state.lx.us>.
"Sieve. Hannemann@dshs.state.lx.us"
<SIeve. Hannemann@dshs.slale.lx.us>
,
"Linda. Kaufman@sananlonio.gov"
<Linda. Kaufman@sananlonio.gov>,
"mel inda. hergert@dshs.slale.lx.us"
< mel inda. hergert@dshs.slale.lx.us>,
"Junda. Woo@sananlonio.gov"
<J unda. Woo@sananlonio.gov>,
"emcGowan@aslho.org"
<emcGowan@aslho.org>,
"AniI.Mangla@sanantonio.gov"
<Anll. Mangla@sanantonio.gov>,
"Donnie. Diaz@sananlonio.gov"
< Donnie. Diaz@sananlonio.gov>
Cc: "Cruz, FranciscoJ" <Cruz.FranciscoJ@epa.gov>,
"Ryan. Shawn" <Ryan.Shawn@epa.gov>,
"Calfee, Worth" <Calfee.Worth@epa.gov>,
"Sayles,
Gregory" <Sayles.Gregory@epa.gov>,
"Nalipinski, Mike" <Nalipinski.Mike@epa.gov>,
"Mclain, Jennifer" <Mclain.Jennifer@epa.gov>,
"Reaves, Elissa"
<Reaves.Elissa@epa.gov>,
"Rosenblatt, Daniel" <Rosenblalt.Dan@epa.gov>,
"Housenger, Jack" <Housenger.Jack@epa.gov>,
"Cheal ham, Reggie"
<chealham.reggie@epa.gov>,
"Tulis, Dana" <Tulis.Dana@epa.gov>,
"Andreadis, Joanne (CDC/OPHPRlOD)" <jsa9@cdc.gov>,
Angela Weber 1
<amw1@cdc.gov>

Good Evening Everyone,

As a follow up to the conference call held this afternoon, I wanted to reach out and share with you a draft application
package that you can use to apply for the FIFRA crisis exemption to use an unregistered pesticide for anthrax
decontamination. EPA's intention is for applicants to use this document as a plug and play form that will expedite the
process for participating State Agencies. The most direct process for decontamination would be for the states to use
products currently registered for use against Bacillus anthrac;s. However, the State can declare a crisis exemption under
FIFRA for use of ethylene oxide, paraformaldehyde, hydrogen peroxide, peracetic acid, and sodium hypochlorite. The
attached Word file has an example of how to ask EPA for such a crisis. It has a few placeholders for the state agency to fill
in and then send back to EPA Office of Pesticide Programs. The outline in the file has the details on the products and use
directions that would need to be followed for use of these products for the decontamination of anthrax spores.

EPA does not typically prepare the applications for a state or federal agency to fill in, but we are trying to do everything we
can to expedite the process so that labs can reopen as soon as possible while still abiding by applicable regulations. If
anything needs to happen this weekend, the states/applicants can e-mail Dan Rosenblatt at rosenblatt.dan@epa.gov or call
his mobile at

The background regulatory context on this is that under section 18 of the Federal Insecticide, Fungicide, and Rodenticide
Act and in accordance with 40 Code of Federal Regulations (CFR) 9166.40 the head of a Federal or State agency, the
Governor of a State, or their official designee, may issue a crisis exemption in situations involving an unpredictable pest
emergency.
httos:llmall.aooale.can/maJl/ulO/?ul=2&lk=68925163OO&vlew=

ot&o=anttYax%2OdlDNav&os=true&search=auerv&th=

14dc65832db5b75d&slm

I:::l'

14dc65B32db5b75d

?I'

-.

1~'5

Slala

a Utah Mail-

EPA Exemption Update

In accordance with 40 CFR ~166.43, the State or Federal Agency issuing the crisis exemption must notify the Administrator
in advance of utilization of the crisis provisions. If states would like to decontaminate labs under the crisis provision
from June 5, 2015 through June 7, 2015, the state can e.mail their crisis declaration to, Dan Rosenblatt, Deputy
Director of the Registration Division, Office of Pesticide Programs (Rosenblatt.Dan@epa.gov).
If the state will be
declaring the crisis exemption after June 7,2015 the state can e-mail MarionJohnson.Chief of the Minor Use and
Emergency Response Branch (Johnson.Marion@epa.gov). In accordance with 40 CFR ~166.45 the crisis exemption may
be authorized for as long as is necessary to control the conditions causing the emergency; but no longer than 15 days.

If additional time is needed the state should contact the EPA, Office of Pesticide Programs regarding an application for a
specific, quarantine, or public health exemption for this use.

I hope you find this information useful in expediting the process.

Best,
Erica

Erica Ganzler
Director, CBRN Consequence Management Advisory Division
Office of Emergency Management
U.S. EPA
(0) 202-564-2359
(c) 202-431-3146
canzler. erica@epa.gov

httpsJlmail.googl . com/maiIMl/?ui=2&Ik=689251S3Od&vl =pt&q=ent!Yax%2lldug.vay&qs=true&search=query&lh=

'4O'65632db5b75d&sim 1='4dc65832db5b75d

3/4

State of Utah Mall- Confererce Call: Laboratory Update and DeeootaminatlO'l RecommermtiO'lS

1219i'-'l15

Allyn Nakashima <anakashlma@utah.gov>

-------_._---------- -Conference Call: Laboratory Update and Decontamination Recommendations


1 message
Allyn Nakashima <anakashlma@utah.Qov>
Tue, Jun 9, 2015 at 12:24 PM
To:
_..,
Robyn Atkinson <rmatklnson@utah.gov>, Klmber1yChristensen <kchriste@utah.gov>, '
Wei Hou <whou(g)utah.gov>, Melissa Dimond <mellssastevens@utah.gov>, Stephanie Saperstein <stephaniesaperstein@utan.gov>
HI All,
We are having a conference call with _.
2:00 p.m. to Inform them of the latest laboratory results and provide them with CDC/EPA
recommendations for decontamination. Please attend if you can.
Wei, please find a room for the call and set up the conference line and passcode. Then send out a calendar Invitation to everyone.
Thanks,
Allyn
Allyn K Nakashima, MD
State Epidemiologist
Bureau of Epidemiology
Utah Department of Health
PO Box 142104
Salt Lake City, Utah 84114-2104
Tel: (801) 538-6191
Fax: (801) 538-9923

4 attachments
~

---------

EPA Emergency Exemption Example Application for State Health Depts.June 2015.doc
99K

'7:J

CDC FAQs for Dugway 000 Event. June2015.pdf


~ 289K

'7:J

'7:J
.

EPA Emergency Use Authorization


1440K

for 000 Incldent.June 2015.pdf

GuldanceforLabDecontam Inati on .DoDantraxevent.Ju ne2015.pdf


506K

httpsJlmall.google.com/mall/..-onu1=2&lk=68925163Od&vl<m=pt&q=dugway%2Oanthrax&qs=trua&search=

query&ll1= 14dd9901083c11el>&slm 1=14dd9901083c1 1eo

1/1

Application Package: FIFRA Crisis Exemption to Use an Unregistered


Decontamination of Bacillus allthracis Spores

Pesticide for

The {list authorized agency in state declaring the emergency} hereby issues crisis exemptions
under the provisions of section 18 of the Federal Insecticide, Fungicide, and Rodenticide Act.
The {list authorized agency in state declaring the emergency} is authorizing the use of multiple
products containing the following active ingredients: ethylene oxide, parafonnaldehyde,
hydrogen peroxide, peracetic acid, and sodium hypochlorite to inactivate Bacillus anthracis
(anthrax) spores on interior and exterior inanimate, non-food contact surfaces in laboratories that
processed potentially viable Bacillus al1thracis spore-containing samples originating from
Dugway Proving Ground's Lot AGDOOO1667. These crisis quarantine exemptions will ensure
that responders have effective antimicrobial pesticide products for decontamination.
{list authorized agency in state declaring the emergency} has determined that an emergency
condition exists and a crisis exemption is necessary, according to 40 C.F.R S I66.40(b).

2.

I.

When fumigation is complete, air filtering and testing will be conducted to ensure that
levels of the decontamination chemicals remaining in the air are at acceptable levels prior
to allowing re-entry by unprotected persons.

The public will not be permitted in areas undergoing treatment or allowed to re-enter areas
until the anthrax decontamination is complete.

Therefore, {list authorized agency in state declaring the emergency}, herby authorizes the use of
ethylene oxide, paraformaldehyde, hydrogen peroxide, peracetic acid, and sodium hypochlorite
to decontaminate the following facilities (provide name and location of each lab to be
decontaminated). This crisis program will be conducted under the following conditions:

3.

Disposable uncoated Tyvek@ (or similar) suit with integrated hood and booties
Rubber or nitrile gloves.

Decontamination Workers conducting decontamination activities will wear Personal


Protective Equipment (PPE). At a minimum, workers will wear the following to prevent
skin contact and inhalation of Bacillus al1thracis spores:

NIOSH-approved half-face elastomeric respirator with an appropriate cartridge or


a filtering facepiece respirator (e.g. N95)'
Indirect vented goggles

All PPE will be used in accordance with OSHA regulations found at 29 CFR 1910 Subpart
I (Personal Protective Equipment). Workers will receive training on and demonstrate an
understanding of when to use PPE; what PPE is necessary; how to properly put on, use,
take off, properly dispose of, and maintain PPE; and the limitations of PPE. Any reusable
PPE will be properly cleaned, decontaminated, and maintained after/between uses. Filter
cartridges will be discarded after use.

I Note that the use of sporicides and sterilizers may pose a chemical hazard. Therefore, appropriate PPE, including
elastomeric respirators with combination particulate/chemical cartridges, may be necessary to protect workers from
exposure to the chemicals in addition to Bacillus anthracis spores. Disposable N95 respirators and certain cartridges
for elastomeric respirators may be adversely affected by an increase in moisture and spray from certain work tasks.
This may include the cleaning and decontamination process when significant amounts of liquid sporicides and
sterilizers are used. In such instances, or during other tasks to improve worker comfort, a powered air purifying
respirator (PAPR) equipped with appropriate cartridges may be an alternative.

Page 2 of7
Respirator use will follow a complete respiratory protection program in accordance with
the OSHA Respiratory Protection standard (29 CFR 1910.134) and other requirements.
Staff wearing NIOSH-approved respirators will be medically-cleared, trained, and fittested for respirator use. Detailed information on respiratory protection programs,
including fit testing procedures, can be accessed at OSHA's Respiratory Protection eTool.

6.

5.

4.

The Crisis Exemption expires on (list date 15 days from start of program).

Use of the products will begin (list date in which first decontamination will take place).

Applications will be made using the EPA registered products and decontamination use
directions found in the tables I and 2 below.

Any additional PPE required for the use of the product as listed on the EPA registered
product label must be worn.

7.

The EPA registered product label and this order will be in the possession of the user at the
time of application.

Page 3 of7

-,
Page40f7

Tahles I and 2 below list the liquid and gaseous/vapor products, respectively, which are supported by available safety and efficacy data and
which may be used under the crisis exemptions declared. The last column of these tables details the required directions for decontamination
use under these crisis exemptions. Use of all products will be in accordance with all applicable precautions and directions specified on the
registered labels and the requirements listed above.
TABLE

1.

Use Directions

for Liquid

Antimicrobial

Pesticides

for Inactivation

of Bacillus al/tlrracis (Anthrax)

Spores

(limited to pre-cleal/ed,

!lard, I/ol/porous surfaces al/d items)


Product Name
Oxonia Active

Vortexx

2.

EPA
Registration
EPA Reg. No.
1677-129

EPA Reg. No.


1677-158

Company

Active Ingredient(s)

Ecolab Inc.

Ecolab Inc.

Hydrogen peroxide and


peracetic acid

Directions for Decontamination


Dilute 9.7 oz. of product per gallon of water to obtain a 7.6%
solution. Apply by fine mist or flood the surface. The
minimum contact time is 60 minutes at 68 F, with
reapplication as needed to keep the surface wet.'
Dilute 30 oz. of product per 4 gallons of water to obtain a 6%
solution. Apply by fine mist or flood the surface. The
minimum contact time is 30 minutes at 68 F, with
reapplication as needed to keep the surface wet.'

Source: EPA (2009), "Evaluation of Liquid and Foam Technologies for the Decontamination of B. anthracis and B. Sllblilis Spores on Building
and Outdoor Materials," EPA/600/R-091l50.
3. Source: EPA registered label for Vortexx.

Page50f7

TABLE

I. (col/t'd.)

Usc Direetiuns fur Liquid Antimieruhial


IIl/rd, I/OIlPOrollS slIrfaces ami items)

Pesticides

fur Inactivation

of Bacilllls 11IIt!lracis (Anthrax)

Spores (limited to pre-c1el/l/ed,

I. For immersion applications - immerse items in undiluted


product for a minimum contact time of30 minutes at 68 F'
Spor-Klenz Ready EPA Reg. No.
o Use
1043-119

STERIS Corporation

Hydrogen peroxide and


peracetic acid

2.

For surface decontamination applications - Apply the


product as a tine mist spray or flood the surface. The
minimum contact time is 30 minutes. The surface must
remain wet for the entire contact time, reapply as
necessary.

4. Sources: (a) EPA registered label for Spor-Klenz (b) M. Worth Calfee et al (2011). Lab-Scale Assessment to Support Remediation of Outdoor Surfaces
Contaminated with Bacillus anthracis Spores. Journal of I3ioterrorism and Biodefense, 2 (3), 1-9. (c) EPA/600/R-1 0/087 (2010) Biological Agent
Decontamination Testing

Page 6 of7

CAS No.
7681-52-9

IBleach

Use of an EPA
registered product

Sodium hypochlorite
(5.25%-6%)

Products with (5.25%-6% sodium hypochlorite should be


diluted with 5% acetic acid (white vinegar) and water I: 1:8.
Bleach should not be mixed directly with acetic acid, but
rather diluted with water (add the one part bleach to 5
parts water) then add the one part vinegar, then bring to
total volume (or correct pH) with remaining water
Measure with Hach test to assure pH = 7. Apply by pouring,
wiping or spraying. The minimum contact time is 10-60
minutes at 68F.' Reapply as needed to keep surface wet.
If the sodium hypochlorite concentration in the product is
greater than 6%, adjust the pH accordingly to assure a pH=7.
Bleach products are not effective on wood or heavily soiled
surfaces.

TABLE

2.

Use Directions for GaseousNaporized


Antimicrobial
Pesticides for Inactivation
of Bacillus
pre-clealled porous, or combillatioll of porous alld IIOIlPOrous, surfaces alltl items)

Ethylene oxide
100%

EPA Reg. No.


36736-2

ARC Specialty
Products Balchem
Corporation

Ethylene oxide (gas)

allthracis

(Anthrax)

Spores

(limited to

Sterilization/fumigation must be performed only in vacuum


or gas tight chambers and must be applied by commercial
applicators. Follow the manufacturer's
manual. On the

5. Sources: (a) Unpublished EPA data from OPP Microbiology Laboratory, 2002. (b) EPA (2006), "Technology Evaluation Report, Evaluation
of Spray-Applied Sporicidal Decontamination Technologies." (c) EPN600/R-06/146. EPA (2009), "Evaluation of Liquid and Foam
Technologies for the Decontamination of B. all/hracis and B. subtilis Spores on Building and Outdoor Materials," EPA/600/R-09!l50. (d) "Lab
Scale Assessment to Support Remediation of Outdoor Surfaces Contaminated with Bacillus anthracis spores" Calfee et al (2011) Journal of
Bioterrorism and Biodefense (e) "Systematic investigation of liquid and fumigant decontamination efficacy against Biological agents deposited
on test coupons of Common indoor materials" EPN600/R-11f076 (20 II) (I) "Efficacy of liquid spray decontaminants for inactivation of
Bacillus anthracis spores on building and outdoor materials" Wood et a!. (20 II) Journal of Applied Microbiology

Page 7 of7

completion of fumigation ventilate fumigated equipment to


open air for at least 12 hours before reuse" Please refer to
report listed in footnote for specific time/temperature ranges.

Envirosystems
Ethylene Oxide
Sterilant

EPA Reg. No.


58779-5

Corporation

Oxyfume 2002

EPA Reg. No.


67470-2

Honeywell
International, Inc.

SunPac

EPA Reg. No.

Parafonnaldehyde (gas)

4972-43

Protexall Products,
Inc.

Heat paraformaldehyde to achieve a concentration of at least


10.6 gim] (0.3 gift]) for 2-4 hrs'.

EPA Reg. No.


58779-4

STERlS
Corporation

Hydrogen Pcroxide
(vapor)

For stcrilization of empty, pre-cleaned, sealed enclosures, up


to 40 ft], apply 2.2 grams of product per minute for
90 mins'.

Vaprox
Hydrogen
Peroxide Sterilant

STERIS

6. Source: "Evaluation of Ethylene Oxide for the Inactivation of Bacillus anlhracis" EPA/600/R-13/2201 December (2013)
7. Source: FIFRA Quarantine Exemption issued by EPA to the U.S. Army Medical Research Institute for Infectious Diseases (USAMRIID),
September, 30, 2008. EPA # 08-00-01.
8. Sources: (a) "Systematic investigation of liquid and fumigant decontamination efficacy against Biological agents deposited on test coupons of
Common indoor materials" EPA/600/R-II/076 (2011) (b) U.S. EPA. "Evaluation of Hydrogen Peroxide Fumigation for HVAC Decontamination."
U.S. Environmental Protection Agency, Washington, DC, EPA/600/R112/586 (2012) (c) U.S. EPA. "Determining the Efficacy of Liquids and
Fumigants in Systematic Decontamination Studies for Bacillus anthracis Using Multiple Test Methods." U.S. Environmental Protection Agency,
Washington, DC, EPA/6001R-10/088 (2010)

Frequently Asked Questions for "Interim Decontamination


Recommendations for Laboratories that Opened and
Processed Bacillus anthracis Spore Samples from Lot

- - - - - - - - - -7'

.
apply to?

-- --- ---Audience: State and Local Health Departments, Laboratory Directors and
Managers
Date: Current as of June 6,2015
1. What laboratories do these recommendations
These recommendations are for laboratories that opened and processed samples of live Bacillus
anthracis from Dugway Proving Ground Lot AGD0001667 and received confirmation from CDC that
their samples contain low colony counts.

2. How is a determination of "low colony counts" made?


"Low colony count" determination is made by CDC through laboratory analysis (culture) of samples.
3. Is there an established timeframe that these recommendations for decontamination apply?
There are no established timeframes for spore survival in settings where routine cleaning and
disinfection occurs as part of standard laboratory practice. CDC supports a conservative approach and
recommends decontamination of laboratories that opened and processed Lot AGD0001667.

4. What disinfectants can be used for decontamination of laboratory spaces and equipment?
Of the three products EPA registered for decontamination of Bacillus anthracis spares, Diklor-G
Chlorine Dioxide Sterilant Precursor EPA Reg No. 73139-3 (Sabre Oxidation Technologies) is currently
marketed.

Vor1eXX@(Ecolab), EPA Reg No. 1677-158

Oxonia Active@) (Ecolab Incorporated), EPA Reg No. 1677-129

Spar-Klenz@) Ready to Use (STERIS@), EPA Reg No. 1043-119

Additional EPA registered products that are not registered specifically for Bacillus anthracis have been
shown to be effective against Bacillus anthracis. State and local public health officials will have to work
with the site(s) and apply for a Federal Insecticide. Fungicide, and Rodenticide Act (FIFRA) Section 18
quarantine exemption. The EPA has expedited the process for state or local health officials to apply for
a Section 18 exemption, allowing them to use the following products (http://www2.epa.gov/pesticideregistrationlpesticide-emergency-exemptions).
For information, please contact EPA's Emergency
Response Team at 703-308-9356 or 703-308-8050.

EPA registered sodium hypochlorite products (CAS No. 7681-52-9), when used in accordance to
the decontamination directions described in the EPA's Office of Emergency Management (OEM)
exemption.

5. Who will determine that decontamination was perfonned appropriately and when it is safe to
reoccupy the laboratory?
State and local health departments with jurisdiction over laboratories, in conjunction with laboratory
directors and managers, will work with laboratories to develop site-specific decontamination protocols
and will make decisions regarding reopening the laboratories. The "Interim Decontamination
Recommendations for Laboratories that Opened and Processed Bacillus anthracis Spore Samples from
DoD Lot AGD0001667" can guide these decisions; however, state and local officials may choose to
exceed these recommendations and may require different standards for decontamination. CDC and
EPA do not have regulatory authority for determining decontamination efficacy.

6. What rate does CDC play in ensuring that site-specific decontamination procedures were
satisfactory?
CDC's role is to work with EPA to provide these recommendations to assist state and local health
departments and laboratory directors. CDC's role is not to set standards for decontamination. The
state and local heallh departments in reviewing the process would make the determination when the
process has been completed and the laboratory can reopen.

7. How was the 12-foot radius around the work area established as an acceptable standard for
spot decontamination?
The 12-foot radius was chosen for this response based upon a conservative doubling of the 3--0 foot
area of defined risk for droplet contact transmission established through epidemiologic and simulated
studies in healthcare settings.5.6

8. How was the 3-foot radius established as an acceptable standard for spot decontamination?
The 3-foot radius around the work area was chosen for this response based upon a conservative
estimate of usual contact with contaminated surfaces.

9. How should electronics and porous materials that are not disposed of as waste be
decontaminated?
Rarely would a laboratory or biological safety cabinet (SSG) need to be decontaminated by fumigation
(see Attachment 2). A SSC may be fumigated when it requires servicing. Fumigation may be
appropriate in situations where hard surface spot decontamination is not an option, such as for porous
materials, electronic equipment, and hard-ta-reach areas.

A fumigant produel for use against Bacillus anthracis may be considered. EPA's Office of Emergency
Management (OEM) provides an example of alternative fumigation products under the Seelion 18
exemption.

What is the appropriate procedure for disposing of porous material generated and PPE used
during the decontamination process?

workers

wear PPE for decontamination?

Disposal of PPE or other waste materials is a state-by-state decision based on state and local
requirements. State authorities should be consulted to determine options, including waste acceptance
criteria for treating the waste as regular solid waste.

10. Why must decontamination


CDC recommends the protection of workers from exposure to biological organisms whenever a building
has been closed due to contamination or there has been enough suspicion of contamination to warrant
environmental sampling. The use of PPE is recommended for this response to reduce exposures to
potential cutaneous and inhalational B. anthracis spores that may be disturbed during the disinfeelion
process and to protect from any chemicals contained in the disinfection solution.
CDC recommendations for the selection and use of respirators and protective clothing for protection
against biological agents are based upon the anticipated level of exposure risk associated with different
response situations (http://www.cdc.gov/niosh/docsl2009-1321defaull.html).
These CDC
recommendations allow for downgrading to respiratory protection for the decontamination workers
when the following is known about the contaminated area: source and extent of contamination is low,
the level of uncertainty is low in the risk assessment, specific activities to be conducted during
decontamination will not aerosolize the spores, contingency/backup plans are in place, length of time in
the contaminated area will be minimal, and the provision of immunization and PEP are in place. Based
on known information from this event, CDC determined a NIOSH-approved half-face elastomeric
respirator with an appropriate cartridge or a filtering facepiece respirator is adequate to protect
decontamination workers from B. anthracis spores. However, consideration needs to be given to
chemical exposures from the decontamination solution, which may require a higher level of respiratory
proteelion.

11. Where can I find more information on the requirements of a respiratory protection program?
The Occupational Safety and Health Administration (OSHA) provides detailed information on
respiratory protection programs, including medical requirements, maintenance and care of respirators,
fit testing, and a writlen program in the Respiratory Protection eTool on the web at
htlps://www.osha.gov/SLTC/etoolslrespiratory/index.html.
Laboratory direelors are encouraged to
review this eToolto betler understand the requirements of the OSHA Respiratory Protection Standard.

12. Should facial hair be removed when using PPE?


Facial hair that crosses the respirator sealing surface or otherwise interferes with the facepiece-to-face
seal area can affeel the fit of an N95 respirator. Workers must be fit tested to ensure that facial hair will
3

not interfere with the safe use of an N95 or other tight-fllting respirators. Tight-fitting respirators cannot
be used by people with facial hair that comes between the sealing surface of the facepiece and the
face. Loose-fitting powered air purifying respirators (PAPRs) can be worn by workers with facial hair.

13. Do I need to take antibiotics or vaccine if I help with the decontamination?


In this event, all evidence to date indicates that only a very small amount of viable Bacillus anthracis
spores potentially contaminated the area. In this setting where risk of exposure is believed to be very
low but not zero, post-exposure prophylaxis (PEP) might not add additional protection over that already
provided by personal protective equipment. However, decontamination workers who have not been
fully vaccinated previously should have the option to take PEP. PEP should also be offered to
decontamination workers who have been fully vaccinated but whose use of PPE has been breached
during the course of responding. Additional information can be found at the CDC website:
http://www.cdc.gov/anthraxlmedicalcare/prevention/antibiotics.html.

14. What is the protocol for anthrax vaccination?


Anthrax immunization in a post-exposure setting is covered under an Investigational New Drug
application held by CDC. The immunization schedule consists of three subcutaneous injections given 2
weeks apart followed by three additional subcutaneous injections given at 6,12, and 18 months.
Additional information can be found at the CDC website: http://wwwnc.cdc.gov/eidlarticle/20/21130687 article and http://www.cdc.gov/vaccineslhcp/vislvis-statementslanthrax.pdf.

15. Are there adverse reactions to the anthrax vaccine?

for decontamination in this event compare to those used by

Mild local reactions occur in 30% of recipients and consist of slight tenderness and redness at the
injection site. Severe local reactions are infrequent and consist of extensive swelling of the forearm in
addition to the local reaction. Systemic reactions occur in fewer than 0.2% of recipients. Additional
information can be found at the CDC website: hltp:llwww.cdc.gov/vaccineslhcplvislvisstatements/anthrax.pdf .

16. How do the recommendations


CDC during 2014?

During the 2014 CDC anthrax laboratory incident, samples were dry and more susceptible to becoming
aerosolized than wet samples. During the current 000 investigation, decontamination of the samples is
different because the preparations are in a liquid state, and spore concentrations are known. In this
event surface contamination is less extensive. CDC performed surface and equipment
decontamination with either sodium hypochlorite (a 1:10 dilution of bleach) or the application of SporKlenz@(Steris). Laboratory equipment (MALDI-TOF instruments) were disinfected with vapor phase
hydrogen peroxide.

References:

2.

Cogan TA, Siader J, Bloomfield SF, Humphrey TJ. Achieving hygiene in the domestic kitchen:
the effectiveness of commonly used eleaning procedures. J Applied Microbiol2002; 92(5):885892.

1. Dunsmore DG, Twomey A, Whittlestone WG, Morgan HW. Design and performance of systems
for cleaning product contael surfaces of food equipment: a review. J Food Protection 1981;
44:220240.

3.

Moore G., Griffith C. A laboratory evaluation of the decontamination


cloths. J Hospital Infect 2006; 64(4): 379-385.

properties of microfibre

4.

Smith DL, Gillanders S, Holah JT, Gush C. Assessing the efficacy of different microfibre cloths
at removing surface micro-organisms associated with heaRhcare-associated infections. J
Hospital Infect 2011 ;78 (3): 182-186.

Bischoff WE, Swett K, Leng I, Peters TR. Exposure to influenza virus aerosols during routine
patient care. J Infect Dis 2013;207(7):1037-46.

5. Siegel JD, Rhinehart E, Jackson M, Chiarello L, and the HeaRhcare Infeelion Control Practices
Advisory Committee. 2007 Guideline for Isolation Precautions: Preventing Transmission of
Infectious Agents in HeaRhcare Settings. Can be accessed at:
http://www.cdc.gov/hicpaclpdflisolationilsolation2007
.pdf.
6.

(.llll

...
l,..l.jlll.:nc":l,,,"\lall.l~

'11f"" _ ...

Rl.." ... ,~

... n1l...J1t :\.1. :St'r:. I>i\ isi(ln


\lUll:l'."-"'l<.'nl

nrrlJlc.:rg(,.'llI":~

Prote<.:lhm :\!!l.'nc~

()f1i ...
l.'

I- ll\ ironl1lclltal

of Solid \\ ,\ fl".'and I ,- 'rt.I~'nc

l .\

(Jf!il'C

.\ulh",i/alion
Ilale: Jnn" -+.2015
F:, riralion I>al(': lun" -+. 2(11 S
'nlcdnl Rl"lOrl' I>ul': lun" -+. cl.l16
J IIn,'.l 20 I 7
fInal Reporl I>ul': [kc ..... 'x,.l. 2018

r u'mptin

and Dana

lulis

III

enl

-'HAL -

n~ for :\nthra\

Ill'cnnhl m ination

,..--.-,:"-

I d,' :-.~.lI1h"l" 1-+-1l(J-0.' letll\ kne '''"idc''. J .l-J)(J-O-+ It"" ,I,. ,"aldeh:"e!. 'j"
)_0'
r h~ Jr(l~",..n p,,:ro, iJc.: I. I L I )( l-Ob (pararclil: add I. and 1.1_J)( )-07 ( slId iUIll h: pll(,:hloritl.')
of <}uarantinl

('lIfl/l.or

Office of ElI1er~cnc~ .\Ianag(

l-riGI

r PA',

\uthe,ri.l.lfion

In
Attn:

)1'. ---

-.

I ill,.' I .S. f':-", inw~)l.'ntaJ ProtCl:tilln A~c:nc: i p.\ I Of'i;;l.' of Pesticide 1'( 2:ratns. hen.:h: i...
sues
quarantine L"t.'1l10tiNi . under the pn.)\ i:->ionsuf Sl ...:i llJ1 I X tlf thl.' Fedt.'ral InSe..'ct iciJc. !" WHo! il.:idlo!.
and R{)J~nliciJ\,.' .\l.."l. as amendeJ. to th~ l"P:\ ()flil.."c (.lfSoliJ \ ;l"k and i 1Ill.'rr:1.'nl.': RC"!'l)IlSc..'
()l1il.'e..'l\j" I II' .:rge..'lh.': \lana~l':"<..'nl )" \\"i P (II \ 1J !(lr thc 1I~{,.'tlf l1Iulliplc prodlh . 'h L'olltalIling
the..' llllln\\ing. al'li\c int!.rcd;, .:-.:c...thylt..'nc (\:~iJI..'.parafi~rl1~:llddl!dl'. h:dnw('n
pt.'rl)\idc. pl'n.h . 'c'lic..'
W..'Il!. :md .
odium It ["l..'hk":'-: t(1 in.h.'~i\ .ltl..' iJacill,'t.' LU7fl1'"'td.\ (anth" \ I :-porl..'~ ~l[\ lIllcril)r and

Jl"~nn.""'il"";""

(hi,.'

l.:onJ.itioll:-. ";l..'1l()nll

ill ~\Iur'"

IUL'SI. da~l..'J

l'\lc..'riur inanim<lte... Ilon ..li.md i..'ontal.:t ..t rful'cs incllldin1!. r.ut not limi't't! lo. huildint!:-. .... trlH...tllrl'~.
\"l'hide..'~. :trtidt.::-. iterns. personal pn.'tccti\e..' (.qll;pll1 ..
I\t. roao.s. siul..'\\'alJ..s. and surl\\,a~ "': ..;k'Hl:--."
I he..'se..'t1uaramint' c'\C'~1fltion~ '\'Ii ....n-iurc that rc...spondc...r.; hu\L' cll.:-cti\L' antimicfohial
pc .tiL"idl..'
tiJl1(," :nl! t:ithl.:r all al.:ddl..'ntalnr ilHt... (: ..... l! fe' ....l\.' ofanthr:J\
produl.'1:-. ll)r

:--p(ln:s. lilt ..' 4uarantinc l..'xt..t;'~pti~ms arl' ..~;h.il..'l..'l(0


\ugtl'l ~o. ~1I14,i.h \\t:'11 as th ....tl)J1.).\;n~.

1) I IlL' \ ()"'~':t..'orSolid \\',: '. and }~mc-q: ....;: Rl.'''ponsc. Otlkl,.' 01 I""~ 'nL": \1;111;1 1h..'111
I ()' \\ t- f{ { Ij , I, is n.:spon-.;ihlc..' 'i,;- l.nsuring that ,III pnn i~illns ~)flhe
. lraJ1!:""~'.
'C'~-~Ion
...
an ..'
t1lc..'1..()s\\'r I' ()j 1 is a' ~ n.:';;--!'.'(;;hlt.~for pro\ idiTll.! inJi.'r;"1ati":1 in ;:h..'COl\! '.H.T \\ ith ...
H.I ("ode ur

['c-dc'ral R,'guialitHl' It ' I.' J ~ ["h,2X(b) and ~ I 1>(" 121bJ. '\"co,din~I:.


imaim n:r"'h .," J it lil1al
fl.'pon "ulTlll1ari/il1~ thl." r,' "Its nfthis
rr'.. ~1.111l11'
. .,..
submi"d,l Ill' p.\ t,...!dquartc' .. .! tIll'
'k'ninl.'llt n".; \t1al pftil.'L"(sl h:- due..' d~ltt'o.: P " d abo\c llr prior tu ~.ql'" ':'H! 'iC! "'-1L ",' uU.....'Htlt1t..'
1,."L"lllfnioll'\
for th.:"tl.' U"'e..'S. In ~H.'l.:ordam.:t..' \, ith ~11 I i 1< J()6.J2 ta). [his llnil.:1..: shall als" ht.'
imllJc..'Jiatl'i~ intt.lnnl.'d ~lf an: al,.h ..~'~~~ni:l'IS,'~.:ltiIlU from the usc 1\1'Ifh::L' j"I..: ail.."iJl.... ill
L'Onlll'dilin \\ith t~".";..
\,..':"
"-ptinn, .. '\n: tiCI r.l'l.."orr~srond~I1L"C ft'L:'II' 'jill! thl.:sC L,~\".. :1tio!h
..;hnuld r..
ti1' III till' rilL- ,).t11h\)/s ~:i\.- ann\\...'.

2)

r~cislcrcd

Pac\,.' 2 of H

alk'nmti\l.:s

Iahds

or

mu:-;t h\,,'

an: dl'i~r:'1incJto hI.: unu\uilahlc

l"or thl,.' ..;ituatil'~n hcinl.! :llldn::-;sl.'J ("I ahk- 2 am..! .;).

(lnl~ hI....cmph'~Io.'d iflhc

il~ autlll)ri :d prodllct~ lish.:J in thi: n~i"t:mii\ may h\'" arr!it'o has.:d on ~lli':ahjlit\ for th.: action
plan, '" appr<'",d 11: lh~ Im:id~nt ('onllnan,kr \'nilkd C(lmllland. I'r(ldu~ls "hi,'h ar~ r~~jsl,'r~d
under S('ctil~1l .; (~r1 II i<..\ for J..:contamination of anlhr:l\ ~por.:s must !irs1 h\,,' ~;'.:~.,idio~;.:J
in aTl~
n:nH:diathm plan ilahh ..' 1). Ill~ lll~r'.:'~!i~tcr\',:d1I~1....'~
aUliHlri/cJ h~ thl.'~': qlWj;l~"tinc cX\"'ll1ptinll~
should

unsuitabk'
3) :\11.lrplk~lhk n::-'trkti.\ .... ~llldpn.:cautil~ns on thc ::PI\-rl.'l!iSil'''I,'d product

I'..ll!(>\\\.'.(i. c:xn:pt as ttwditil.:'d llf sUl'H:rsl:dl..'d b) :his illlll'''~ri/:l~il'n.l'r a ~c;~~,:diati()nAction Plan


(R:\/'l. Ineid~nt Actioll Plan II..\/' I (lr (lther apl'licahk d(l~:J:"ellll 'tleh as" Work PI"n I 'b
"pprowd h: th~ Ineid~111Command,"r or l'nili~d (',',"Hl1al1d I ,r anthrax d"e,)mamillali(ln th"
"'l)l,.'l,:ili\..'u~\,.'J.if\..~ti",ns it1l.:lueJcl1in thi;>:. "hlCIWh.'111IC.g .. a\".th~ in~rl.'dk';l' com.: .....
n~rations and
t1K' ll;r ..'cli()n~ 1(.)[ USI,.'('1'"'thlo.' product lahd \,"hen.' ~lH1111i:~in1!.
lntil~~nation
r..::~Hltacltin1l..:s1supers~dl.'

apP\,,'ar",.

phm..; in p!tllo."(.:.

-l) US\\ I I, ()L~l i:-. I"CSP(lllsihh.- for l'nsuring


lhat thl,,: I.kl:Olllalllinatinn
P;"\li,,:CSSr.:S ~l':"-:,.'~F7'i.:d(.lut
sard~ anJ that the.: p(*.'nti~tl ri'\ks to J(,~.llntmnil1alion PI.:'P,d11l1dfrpm \.:.'rt1SW ..7.1;":..' minimiLcd h~
ring u~(' \~fapf)OprtalC I ....~~..Jll;ll prollo.'cti\ \,,'cqui Pllll"t':! (p PI) du:-i!~~ ope rat illns. ,.\.....r:-orfiutc
ui
I'PI'. must ab\"l hI,.' l.I"-':u in thl.:'C'\'{:.;: lIt" (,.'11.::1\1
.un 01' an~ :--pilb anti h:ak .. in accordance \\ iih
n.'4

n:mcdiatiol1

6)

I >c(.'(~ntat11inatilln .leti, illc'S C1M-~...:Jllut under th ..~~': quarantine c~'Io.'ml"';i('\r" \\ ill hc in accordancr..:
\dth thl.' ~:.lti(lnal ('(H1t:71:':l':it::- Pl.m 11R'Sati ..
'nui lnci"kl:: \1i.l.tU1g\"jlH":~~ ~,,':cturc. and other
l:!l1idan~(.' and tCl.:hni(;ul J(\ct:n~C:l1brlo..:-:~~il1ing
to hlol()\!icul dl'l'lH1taminati(lB im:i"knts.

S) .\ppliratiplls \\iIll")\,,' madc 1


..\"trai ....l..:d:'~.r'l'!~ad
ullLkr the: SUflt:f\'isinn "rlhe 11l\".idt'71~
t '(\mm~1tH.k'r. as fJ:-; or ~1r\"'~plm:..t: illld r.,,:cu\ ...... errr>rt t"ollo\\ in\! c('~1ta;n;natinn of ilcm~ t)f an.:as
h:- /fadIiIl.\ (I/ulr,..lc.:is ...;p\~r\"'s. ,\r JUrilH..! trainiml tiI.:t,,-iti...::... lr...:aB1,!".~1t'iitcs \\\11 he c(~Jl1r,)lh:J and
i:hl:--l:d to th!'" plt~lic until ckan:J h~ lhe ltll:id;,..nt(\'mmand:~r.

7)

Dctaib of l..h:t..:ontaminati'ln :,:-:'c~dun.~~.Ii.'r ....


aeh Itlcatiol1 must hI.: outlim:u in a ..;il~ C:i"t'dlh: R:\P.
1:\1'. or nther ]Jlriicabk Jtl(.:U11lcnt as appn,J\cd h~ the Incident Cotntnandcr
or t illiti~d Command
Sut.:h d...:tails must indudf.' the pn)dllct( s l uscJ. a:H.i liSt: pi.lr:1I11t..Tt~r.ind\h.1in~th~ rm:thod of
uppl1cati,lt1.'pn1l.!uct \ISC I.Tn\"'f.'ntratlot1. co~~a::t tiaw. and other si~l1iJicanl parmr.,-'~('!' (such as
tt.:'mpc-ralUre and rdutl\l,.' hllInidit:). in aCCl)ntan~(,,' "ith Sih." ~llH.l~iluatilln-I.::t"'~citk n:'-luir(..rn ....uls
and l1\'ailahk dala on th~ d~~on:;J"':nanl ,~k~ld. Th~ si\~ s:,e~ili" plan should iI1dl1d~ pr(l<:~dllr~'
ti.lf tr~ating P~ln.l>..1Smaterials that cannot ht.' slll1icil:llth" dl'omlClminatt.:'o h: chemical means.
1')-.:
pnx\".dun..::-. ma~ im.:luJc n:;1~t.-\:.11.displl~al. itll,'incratioTl. autocia\'ill1! or other t{lni1 of
oCI.:(Hl1aminat i,Hl.

enlf~

by

mus!.lhlt

h~ rt'rml1tcd

unnrotc\,,'h.:d ~ersol1s.

I"hl: publil'

tn afC'as llnd~:-1.~oinc
tn:;\tm.:nt

or all(l\\cd

to rt'~.:'nlcrarea" until

H) \\.hen fumigation is ClHl1pkh':~ air tiltlo.'rin~ Jnrl :t'..:.~i:H! must hI: conducted to cn"'UiC that It.:\l'ls "I'
thl: dCt.:otlt\uuiIHltilln ch,,'r:ilt.:als rCJ1ll:l1nin1.!.in the air arc al acceptahle' Icn:ls prj" ...to aHowitH! p..:-

9)

lk.tt"t"tinll.

tht.' Incid~llt ('n:~'matllkr has .:.kt\..'rmin~d that the anthra.\ dl,.'c(ln~~lmillatil>n


ha:-. r.\.... :ll:n~cti\"(,:. ttl[
\,.'\.ampk. h~ p(I',n.T;~'atllh:nl satnnlin!!.. Arrrr'priutc '."T1\ inmmciltal snmpling should b.: sck\..'h.'d
H~si!r_~.~jnJ situalion-spl'lo.:itic r\".quir...
mcllts. tIsin1! the C\Ji."'cnt re"t a\'uilahle mdlllll..h. for

..ampling and

according

IPlh'~lIl'pt~

:o~()rS()t"tllL) ~,r. ;i~!\


I!Plll~"I.J

r~

I
.".

JP1:";1

..;1."

;P'''1I.''H,;i1V

..'ll'(J
lll)~l1!ll"lil.")H

I .
.

, -;
/

-;

(J .\.;! \\."'! I ur...;ns

thl!~ 1\:\1

~' .. I

Slh)!I.",'J!<1 '~~.llJl!\\'!pu."Xid\

I
'f

."'lsllPd"."'l}1
Jlll)': 11' 1111\.11

um;'ll

.lP~l'

.J;'ll}... l1
\llT~;l \Blj

:. JpU\

J'-lpr,)'llll1~.' ''''~llo<.h.'1}J\.''HI.'''':.l.'''lUI'

1 qlP.1Ull.)

~!LJli1l1!I)JI~f.~J :;lilJ!1,,:'lllb

.~.:l..)~t (,'Wlf'tOL

\1!J1l11~l!'"

..

J!,"'lIP

\W' ' ..
, _,'pt: ISl1m'

U! ."'1'11 lllj

"UO!~L_~~!i:'~ \'.. It/

\;'lU."'lI1J:'.U"

lln!l

:"''''!IUq ...

ptW

1l1~til

'\lIUllO!l!Pf'\'
."I11~11~
'".)urp~l1fi

,'.111111.1

.1ll.! qhl~ .~!{LItIIl'" ."Jllln

'p.l/JldqIT1t~

",."'I"U''''~'J''"I. )PIU ..~, ,.it,I1I."U! ~\:-Il~ l"IHU ..;uol's:

il:~h)!l!Ppl!.J1

."'li1Pd

; Il)411l1~'!1.11.I\) .'lllI1

. \ ..,IlW.1 ,'ql U! SI(1JllI(l;'J ~ \! 11.._;.'"~Il: pUl .. 11~;1(


U., ,I' \T.lt{HI1: th,l li
""."J
~jPpt:O"'p~l"nm ,t1P!"'''!luqn, ."'ll.! .
Utld~ \1~Jlplle.lll ",':lml!tut~llHl."'l,"'lr

';I:"lU.1rlhltf"'~JJO.1

..

....''11.1C

1.'t~Hin.1 ,"'lSP."'lld

,1t(1 JO l
\."U.);iJ;'llll"j

i .4.

'''UOPlJ.Ul.''l\,''l
";lll~niill()

i111!l!llh;lJ 'Utl!Wl1l1'
oI. lll:lJl

."l\IW)-"'lJ

.~:d"'~'u."uu Si,"IIlPO.ld

l:'>lllU"'~~ll ."'lI.;;JllI.1t~1 >;UO!ll1tl. ~'."" ."lllltl1~ ..1Pnh

.I(l

.i:1..;'''41
p."'lp! \\uJ
'l....
lItH\:'IJd 'l.)!lPlUU
I

. 'l~ lH'!ll:lI: :.aU('1~."'lr lplt~ ;HqllU(~lll~,:,.~l,'"IllIn.1nl'


r,"'ilt!';ll PUt:

"i.jl ."'l;1U!" p;lJ.Il1;).)O:

-',';1!
'''lh}!ltlll1il,'J

-'4

." 'r"l

,"tljl P;'LF'U III p.1il!pdn

.l<.i l"flllllW!ll!lIl'll1\."

. \ II'! 11!:1! Ill,

Ir \'l:.I(}';

IIt~11'tllt1ll11l1 \'.mSs:'l:'l:lU .I~

Il'.U ....
d .;'IllI!1.1.1l1U,".'11111111."\

\lddl:.~H
.)1: I

1'11":'.,'"

"HII ' .tH ...': IlO!)lUlIl'


1'11
'~.;'Illlll!tlI
'11:.1

f~(\l \' "!1H(l"

f.ln

)WIIll'

1"1111:."'I'lm

;"llllll PI~1110;"l1~.1:'\11\ I II ii' '., II

lIllllnl'''-

;1111"11

1'I.l~1\~\\.l" ..
lI\'II'~f

III

1111\\ ."""t:m.llll' P\\

~ '111" Pllpll.ld

111

I"~ /"

ll!\111 III ...


;'\I~Jlll
.I:\\ll;1l'\ p,'lldlh
:'lj.
111
lUt \;) J~\
IItl

:'\dl \\

."XII lHll

lU ...
].

. p.'I1;'1\\

.~

1'\ I"~
1

11111""

l'lll',l.Id

P!:'ll' .
.) I I . I .1 )

1,1I",J (llll!

1II'd

.'"lIIl~I"'(I.IP"I'11
.
. I

""""""'1

Vel I!

hI

,'lP"(\J.'"'ld tl.'1;1,IIp

'''111''\ I 'I~Jd ..... ii III .d. .II I' 11.... II,'.HI iilll",n til'! IIll' h.
,"""t . lq Ill'
III ',I.,d IIP(l p.Il~LJ
'1',"'Wl:'1I'l.,,,1
,'lllIllt1.'1I1 til \Illl l'UI' \

n:'l}j

'II 1'1~l'

lI."""t.P..I,..(.! I.'

'P....

.10 \lWI,

.\.11' II" .hl I

n,

.P'I~"'lI'l

""'.1

X-~l '.1 X
\'"(1 ,

'l''\ 'iLl);

'l:

'! H~lI!HW1Ih\;l.'( I

~-L:.lJIH'

1I."""t0l,I.lP'11

tLllI.l

1."'1'

til

:"'~P:"'l~
'\Iu."""tt.l "1)I\O.l~11

.'1111'( I

''':'lIlHl!H1 Ol ,l{l."""tIUP ~"I!I!IP' lI1111tllllll\

In!

1.""1.""11" 1ll'11I .. ""11I" ,'.'III'I"Q'I'

qll"!'t11

...
lll \\1 P;"lll!Il!1tIU!P '''"I

\1'1.1 . "

;'\"".1111'"

t1il'lli:'lll':t1lll

l\.t'l ,"\I,' 111'111.'1,1111 1~\11I" ,'WI I'll'

l.'d

W HW.\\ HI"!' I S(rl


;:"-1,1"

y \ ...
111\111111 0 I "! 'II! \\ ...
;')ll.l IP"
rlU! \l:.lll \q t1U~lnll)'" %t' lIll ,\

1!.IIl

1 \;'ldlJ ...
1S
.111"'.111;'.'.1(1

';)1)11'\

"llll~)'!;)t'l
UO

'1.'I)1=' I

I (IIlHllIIIIHI

;'llll.l"lltt,llllil"
It~.'lll'

,'q

,1111'1I

11IIhl tHIIH,"

1'.'\.1111'11'"I'q

1111111 .11111111
' 111til l'''ljl'i1II1111

I"lllll

.""IPI\"q' ...
\1110'1\1.

""'il

';)!t1' 'I'

llhl\l

fl' il,'lll'lllI.',\lI""'q

.
l~;i"I't\O!(

I ;"lll!.I\\11l

l"IIIl"!I'" 1""1 .1\!P\

.I!tJ SIIU!I.\.l.I!U

'tll~

Ilmp 1...1'I'l\"'(

\''\ ',b}l \ II I ;'IU!.IPllJ


un!lI:_II~!~.J~t

.1UlI!r\'

I')

10)\

ill I

Plll'o.l,1

".1 I

III!"

'\pn(lll.ld

'p.1..:n ."'1"1 'mll.tHlI ..


IU "'!lll
llL'!;11111l~ 1I! .11(FI!I!\l~.Il1

: ."~!.

.\tll:dultl.)

'('IU1-llUV) ',!,,>lUIf}lItJ '11 1~1I!'ti1l~s\U!UP ",qq

P.1.J,'IS!7l.'"'l.l"'l."llpo.ld

II

U\l!l1:I'!'C) ..Iqw.

)\
I

'1111 .,.,

."":II.!!!}!"t.;1011 .1Jll,r'llp(l.ld

PII1~.1",;"'I1I1,.~I O~

l)

.1" ~1'

."'Itll.ll 'l~.lU p".I."p'Slh);'I.:'Iq

\!,lIJ.If/IIiJ1

\1111:".'/)U

I'1l1tHI'

1'...l.ll .~;t.l.1V.I:.I .w. SUO!p.lJ!p .1';1

:-i

t1! P;llS!l""'1 ""I11plud

':HI.,fi.l ....
Lll.'"'l.'qlY'

.'"'lWP

1111\.1

.I,'tjll' .'tjl lI;",lP ."';"!l!llt1!nl

.illl pm:

,")1171' "HIl

1,1l!I~ih~...
,," .H~l .pnp\l.1l1 p.'"'lJ"1.lil.1J -;lUP"'!\.' ."tli SI~!1

tt""l.",\l,~~,

'\'I::ooq 1 .11t.11~.I.

J 'U 'x'I'u;,ddV
HIll t ,";ke!

V.I :.)."Jlh)~ .z
I ....I'~I.I.)II~1 11'\\1

\ \,) Itl \ It~J1,)ql~1 p.).I"I"!iU.I

'il-:.l !,j)'}llIWI
put

~IJIPpIiH Ill' '"\ldd.,

.'I

\//1/1111\

. (:\\\ ;"';')1'1
Ill' :'lqllf

q;
,11!

! ,,)fq II

.'l'I'j''''

1'1I11!1\; III

,'11

I' t1! I I'

jt' 1l"III!lI11tll'II/lI'.'(

, .'/

,npj

II

"'11'''"'

IUllllllUI

t. \

"

,'

IW!lml!1UI~l1Jn,)"<I

'II :,.,

Illl~d

1'1111 I

pIll'

I"

IIP~jl:lljl:\

II

, .. '(hllll~'j

In

.)IIIII(

1""' "1'''''1,'''

"
II,
I I

'!

'II

~1I1

1'1."\1:."\IP;'l'~J.'l(!l

.'1

"'~,1

'I

,I,ll

II'

I '

.'111 Q1!I".) I

I'll(

IUJ Sllfl!I_"l.II(1

''')III.llp.I,I;'i1l1

I'!J.'\

\'

i'b~1

l\~1

11'

'1I,:cllllll

,':':llI

'1

I..

"J

\".1

'.:.~'Jl

'ii"}1 \"'(1 II

.)'WI\

1I1111'~.11
'I ';t"}1

\ c'

,_.,,1

s,

11,'1

,,

,-'II ", I' "

1 ,'Iil 11'1".11,:,"1

1"'1'_"";',1' JllIlI!!."lI( hi""]

"\ll~j

"

I'

'I ',UIIIIl

If

1-'111"

.)'1:1

.lll
L.

III

1.'1
'1;1\\

,I)

'I

'111111111
(I.

ll"

"

"Ill'

\ d

'fill"

1:!IItI\(

PUpll.I,1

\ II
(\IIIIJ

\1l1l'11':I.P~ UO!U!\!J.l,ml.l0J

/!

P"" _\IJ,"~J.UH

"I.lP!.l!l',lflll:rll'll.\llllIIIlV

\110,10,1"11/1

IUJJI!

1'"i111I :Ul ~.,"t't!

"'.'II!.I.'1-1

'~1I1)(1

~I

.r.1;} 0: /J/1I/1111'

I: 11110\ I \, '1;.f1IIU/1

",l.ltllh "

I'q ~lW!p.l.l!(1 hi

'IIOIIlIIII.)\, .1l1IJ1If:1l:1I4)

'z :i 111\
I

I'Ul'tlltlll',)

!.Itl!I.'\"

t111111~~')'''1(l.1}

III .1q I,'


1":."llllIIIIlI1l1l11.-'

I.;

:,:I~-\ (I i

'lUI 'l.lllp\l.Id
I'P

1)~II'ln 'II \''''I'''~I ."llllll:

.)1

\;0j1''''

IW

.tLII-:V
.'lql~P;~\I'

U1'

II! I

III .1t..; ''';U\l!ld

'ljO

\q

''';11

'1\

.1.11 lI'IUll/n.):

.1t111lW,tl~1I

'~'O.'I

1'."lI,II),..I'n',1,Jr:II

,'l

j~.ll.11pl

.( 1(1
,ll\\'\

I'

'J'.V!Jllqllll:
...
'!1.1.1l

:'\;'1.111

! .It \

I'"II )I
1.11

1l~,(I0!lnl~''''''ld
I

,,;wlIld

I .'1 ...
111 ),Ii..! .Ind,~ \ \11\1')'1';1

I, .1

'! t

.'lllllm.ll'll
.11'

P!nh!

III

i'

I:

l.'t. .l:'lllllll
,)L,11

'I

l <I\'}I

III \\ .1:'l1ll~1
[I "'PI!I"1

\\lll."ll!

..

,1lj

Plll'

.,"1'1' ...

'l '11'\!pu.llld"
H

III

.,,<il~d

.:::
f

=-

,
::::
,
.r.

f -

2 ....

~
~ .~
.g

.,

:.0

.c

Z
~

-:E

- .f'_-'-

::: "':

.- . '.=

7"

..
J
J

.=

.'

.'1

:c,
c."'oL ~

r-.

~~----

('"I

.. "1
.. .:

_/

~ r

.,.

~
i:..

.S:

-~ ~

- .=: -: ---

>

L'~

...

'

-::

....::

--f

f.
.-.:

I:~

II

:::

:0<

'~

.2

_____ .5: ~

=:

;:

_:

~;'! -

-,'"

- .~?""'2

.-

~
;; .~
.~

...

..:: = ~ ..:.=

-t

'';

"

r.. :;

.-: ;-J

,,
"

:r -

.'; -

~~~
f~

'",;

,:
..,
~

~.

=
,-. :=--~-'

'~-.

;0-

r ;:: :.

'

~ /.

~'

'~-'

;:..
.'

r:.

_.

t..J

"

or:

, .;:
=

- -r.

r.

.'

"

..

r.

T-

,;::;:;

IJ

x~

",

'f

:'i :;...
f, :=::

,
~
~~
,
~

-;;

"

~
T
!

::."
= .~
::

= ....

"

- ....
~2
F _

.,I

.",

],
,

.;

--

.~ ~

- ~
:f

Interim Decontamination Recommendations


for Laboratories that Opened and Processed
Bacillus anthracis Spore Samples from DoD
Lot:
Page Summary
with jurisdiction over

Who this Is for: The Centers for Disease Control and Prevention (CDC)and the Environmental Protection Agency
to state and local health departments

that processed Bacillus anthrac;s spore samples originating from Dugway Proving Ground's lot

(EPA) are providing these recommendations


laboratories

. These recommendations
only apply to laboratories for which CDChas analyzed a specimen from
that laboratory and confirmed low colony counts.

reopening of laboratories.

Develop site-specific decontamination


and the laboratory director.

that should be

What this is for: These recommendations are intended to help state and local health departments when
working with laboratory directors in developing a site-specific decontamination protocol and determining

June 6, 2015

How to use: These recommendations describe a general approach to decontamination


considered before reopening a laboratory.
last updated:

Key Points
1.

Perform spot decontamination of hard nonporous surface areas such as the bench tops, biological safety
cabinets, and waste containers.

Sites should:

2.

Use products registered by EPA for use against Bacillus anthracis.

plans in coordination with the state and local health departments

3.

If sites elect to use products that are not registered for use against Bac;lIus anthrac;s (either the
products are not available or not appropriate), then the site(s) will have to work with state and local

is not an option, such as for porous materials, electronic equipment, and hard to

Although fumigation of the laboratories is not required, it may be used in situations where hard surface

18 quarantine exemption.

public health officials to apply for a Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA)Section

4.

5.

spot decontamination

(OEM) provides an example of alternative fumigation products under the

reach areas. A fumigant product for use against Bacillus anthrac;s may be considered. EPA's Office of
Emergency Management
Section 18 exemption.

6.

Protect decontamination
protective equipment

personal

protocol with

over laboratories that have closed during this incident can

product through the use of appropriate

workers from exposure to Bacillus anthracis spores and any chemical hazard

(PPE).

associated with the chosen decontamination

with jurisdiction

as a guide when discussing the site-specific decontamination

State and local health departments


use these recommendations
to assist with decisions regarding reopening

7. Consider these recommendations

team.

as a general approach to

may change if additional

testing of source

for which CDC has analyzed a specimen from that

in the risk assessment at each facility; and

only apply to laboratories


low colony counts. Recommendations

is

that have been closed due to the opening and processing of Bacillus anthrocis spore samples from

laboratory directors. They can also use the recommendations


laboratories
Dugway Proving Ground's lot
the following site-specific conditions:

Source material, concentrations,

based on understanding

Potential for contamination

decontamination

level of uncertainty

and material handling in the laboratories;

Site-specific activities to be conducted by the decontamination

processing;

during laboratory

and confirmed

These recommendations
laboratory

to the EPA's

for Quarantine

An example of EPA's Office of Pesticide Programs authorization

for sporicide and sterilizer usage are drawn from EPA's Authorization

samples show higher colony counts.


Recommendations
Exemption Section 18(6-4-15).

The attached Section 18 quarantine exemption example, cannot

and lists other products that may be considered in the clean-up

Office of Solid Waste and Emergency Response, OEM, under Section 18 of FIFRA for a quarantine exemption,
available as an accompanied document
referred to as the OEM exemption).
apply for a similar exemption.

Under the OEM exemption,

non-registered

be used by the responding sites as EPA is not leading the response to the laboratory cleanups. CDC recommends

(hereinafter
that state or local health departments

before

should first be given to the three EPA registered

for Decontamination
consideration

products are not


System EPA Reg No. 81073-2 [CET, llC) and Steriplex
Currently, the only one that is marketed is Diklor-G Chlorine Dioxide

Decontamination

as described in

satisfactorily

directors to ensure the above siteare intended to solely provide decontamination

work is completed and documented

should work closely with laboratory

sporicides and sterilizers would be used in accordance with the directions for decontamination
that document.

and Sterilizers

and do not create a legal obligation.

reopens. These recommendations

specific conditions are evaluated and decontamination

The state and local health departments


the laboratory
recommendations,

Sporicides

When selecting products for decontamination,


(Peridox with Electrostatic

products for use against Bacillus anthrocis spores. Two of the three registered decontamination
in production

Ultra EPA Reg No. 84545-8 [sBioMed]J.

EPA registered products (although not registered specifically for Bacillus anthrocisl have

Sterilant Precursor EPA Reg No. 73139-3 (Sabre Oxidation Technologies).


The following additional

been shown to be effective against Bacillus anthracis when used in accordance to the decontamination
directions described in the OEM exemption.

EPA registered sodium hypochlorite

Vortexx"

Oxonia Active" (Ecolab Incorporated),

Spor-Klenz"
EPA Reg No. 1677-129

Ready to Use ISTERIS"), EPA Reg No. 1043-119

spaces or the biological safety cabinets (BSC) is required, but may be

products (CAS No. 7681-52-9), when used in accordance to the OEM

(Ecolab), EPA Reg No. 1677-158

exemption
of these laboratory
is not an option, such as for porous
products that could be

and hard to reach areas. A fumigant product for use against Bacillus anthracis

in situations where hard surface spot decontamination

No fumigation
appropriate
provides examples of alternative

materials, electronic equipment,


may be considered. The OEM exemption
exemption.
products in accordance with

fumigation

approved under a Section 18 quarantine


workers must use all decontamination

product labels and safety data sheets. For products used under a quarantine exemption, the specific

To ensure their safety, decontamination


must be followed. Whenever possible, workers should apply the

products, and anthrax

waste management, and training

decontamination

PPE requirements,

of

surfaces that could result if

directions in the exemption


contaminated

decontamination
to prevent direct contact with potentially

products carefully using a spray bottle that produces a fine mist to avoid aerosolization

infectious particulates,

decontamination

procedures, areas to be decontaminated,

surfaces were wiped, and to limit skin contact. Laboratories will need site-specific plans detailing the
decontamination

If an aerosol-generating

procedure was performed

outside of a BSC,then the following

centrifuges, sonicators, or vortex

work with samples containing Bacillus anthracis spores outside of a BSCshould use

of Areas outside of a Biological Safety Cabinet (BSC)

to include the signs and symptoms of acute exposures to antimicrobial


disease.

Decontamination
Laboratories that performed
the following recommendations:

procedures include the use of blenders, non-self-contained

Aerosol-Generating Procedures
mixers.

Aerosol-generating

the area (hard, non-porous surface) where the sample was opened and processed and,

apply:

Decontaminate

a 12-foot radius around that location in the area that falls within the laboratory

Treat porous materials within the 12-foot radius during the sample opening or processing as waste, or

itself.'

at a minimum,

recommendations

procedures before use. Porous materials include laboratory notebooks,


porous materials, electronics, and hard to reach areas.

supplies, re-usable laboratory coats, chairs with fabric, and soft-sided partitions.

sterilize them using appropriate


papers, laboratory

product for use against Bacillus anthracis spores may be considered. The OEM exemption

Fumigation may be an option to decontaminate


A fumigant

I CDC/NIH. Biosafety in Microbiological and Biomedical laboratories. 5th edition. Department of Health and Human
Services, USPublic Health Service, Centers for DiseaseControl and Prevention and the National Institutes of Health, HH5
Publication No. (CDC)21-1112. Revised December 2009.
, A 12-foot radius is recommended for spot decontamination to ensure decontamination of areascontaminated either
through aerosol droplets or frequently touched surfaces near the source.

exemption.

fumigation

products that could be approved under a Section 18

the area (hard, non-porous surface) where the sample was opened and processed on

Procedures

provides examples of alternative


quarantine

A fumigant

procedures before re-use. Porous materials include laboratory


supplies, re.usable laboratory coats, chairs with fabric, and soft-sided

provides

porous materials, electronics, and hard to reach areas.

products that could be approved under a Section 18 quarantine

product for use against Bocillus anthracis may be considered. The OEM exemption

Fumigation may be an option to decontaminate

partitions.

notebooks, papers, laboratory

sterilize them using appropriate

Treat porous materials within the 3-foot radius during the sample opening or processing as waste or

the benchtop and, at a minimum, a 3-foot radius around that area.'

Decontaminate

Non Aerosol-Generating

fumigation

work with samples containing Bacillus anthracis spores from Lot

of Biological Safety Cabinets

examples of alternative
exemption.

that performed

Decontamination
laboratories

the inside of BSCwhere the sample was opened and processed in accordance with the

procedures before re-use. Porous materials include laboratory

papers and laboratory supplies.

of Waste Containers
waste containers using the following

of spores from non-porous

' as of June 6, 201S, are below the limit of detection

sampling for this event. The reason is because the Bacillus

waste container(s) as previously described, if the container(s) was not

recommendation.

Fumigation may be an option and products to consider are listed in the OEM exemption example.

notebooks,

sterilize them using appropriate

Treat porous materials that were inside the BSCduring the sample opening or processing as waste or

previously described procedures.

Decontaminate

inside a biological safety cabinet (BSC) should use these recommendations:

Decontamination
should decontaminate
the laboratory's

environmental

Sampling

already managed as waste.

Decontaminate

laboratories

Environmental
CDC and EPA do not recommend

found in Lot

or laboratory directors choose to perform environmental

(LaD) associated with the LRN-validated analytical method for the detection

anthracis spore concentrations

surfaces. If state and local health departments

sampling, they should follow the CDC's surface sampling procedures for Bacillus anthracis spores from smooth,
non-porous surfaces and the samples should be analyzed by an LRN laboratory following the LRN method for

Bacillus anthracis spores.

3-foot radius is recommended for spot decontamination to ensure decontamination of areas contaminated by spills or
cross-contamination.

3A

Workers
Workers

that places them at risk for exposure to Bacillus anthracis spores should

for Decontamination

Protection of Decontamination
decontamination

Personal Protective Equipment


Workers conducting

PPE, including

cartridge or a filtering facepiece

wear PPE. At a minimum, workers should wear the following to prevent skin contact with and breathing of

NIOSH-approved

Bacillus anthracis spores:

Indirect vented goggles


hood and booties

respirator with an appropriate

Disposable uncoated Tyvek'" (or similar) suit with integrated

half-face elastomeric

Rubber or nitrile glove

respirator (e.g. N9S)4

respirator with combination

cartridges, may be necessary to protect workers from exposure to the chemicals in

gloves, apron, and coverall and an elastomeric

Note that the use of sporicides and sterilizers may pose a chemical hazard. Therefore, appropriate
particulate/chemical

chemical-resistant

an understanding

of when

workers must use PPE in accordance with OSHA regulations found at 29 CFR 1910 Subpart I

addition to Bacillus anthracis spores.


All decontamination
(Personal Protective Equipment). Workers must receive training on and demonstrate

for Decontamination

Workers

and maintained

after and

programs, including fit testing procedures, can be accessed at OSHA's Respiratory

on

Staff that will wear NIOSH-approved

program in accordance with the OSHA

of PPE.Any reusable PPEmust be properly cleaned, decontaminated,

to use PPE; what PPE is necessary; how to properly don, use, doff, properly dispose of, and maintain PPE; and
the limitations
between uses. Discard filter cartridges after use.
Respirators must be used as part of a complete respiratory protection

Respiratory Protection standard (29 CFR 1910.134) and other requirements.


protection

respirators must be medically cleared, trained, and fit-tested for respirator use. Detailed information
respiratory
Protection eTool.

Medical Countermeasures

The option of taking PEPshould be offered to

over that already provided by PPE. CDC evaluated the risks and benefits of PEPwith

drugs and reached this recommendation:

protection

In this setting, when the risk of exposure is believed to be very low, post-exposure prophylaxis (PEP) might not
add additional
antimicrobial

Moisture

and spray from certain


and sterilizers

work tasks can adversely


are used. In such instances,

affect disposable
or during other

N95 respirators
tasks to improve

and certain
worker

cartridges
comfort,

for
a powered

air

decontamination
workers who have not been fully vaccinated previously and to decontamination workers who
have been fully vaccinated but whose use of PPE has been breached during the course of responding.s The

liquid sporicides

elastomeric respirators. Such tasks may include the cleaning and decontamination processwhen significant amounts of
purifying respirator (PAPR)equipped with appropriate cartridges may be an alternative.
s Hendricks KA,Wright ME, Shadomy SV, Bradley JS,Morrow MG, PaviaAT, Rubinstein E,Holly JC,Messonnier NE,Smith TL,
Pesik N, Treadwell TA, Bower WA. Centers for DiseaseControl and Prevention Expert Panel Meetings on Prevention and
Treatment of Anthrax in Adults. Emerg Infect Dis. 2014 Feb;20(2).

regimen should begin as soon as possible before work begins or after initial exposure. Vaccination can also be

Centers for Disease Control and Prevention. Use of Anthrax Vaccine in the United States: Recommendations of the

offered to workers through an occupational health program.'

Advisory Committee on Immunization PracticesIACIPl,2009. MMWR 2010; 59(No. RR-6):1-30.

121912015

Stat. r:t Utltl MoIl- Fwd: ROCIJE'ltFIFRA Crisis exempli,",

Allyn Nakashima

<anakashlma@utah.gov>

Fwd: Request FIFRA Crisis Exemption


1 message
Allyn Nakashima <anakashima@utah.gov>
To: Shelly Jensen <sbjensen@utah.gov>
Cc: David Mcknight <dmcknight@utah.gov>

Wed, Jun 10, 2015 at 1:10 PM

Hi Shelly.
As per our discussion, here is the email request from the lab asking for emergency authorization for use of the stated product.
Thanks for you help,
Allyn
-Forwarded message -From:
Date: Wed, Jun 10, 2015 at 11:01 AM
Subject: Request FIFRA Crisis Exemption
To: Allyn Nakashima <anakashima@utah.gov>

Cc: '

Hi Allyn,
Thank you for helping navigate the recall situation. While we do not believe we've had a contamination event because all our BSL2 procedures were
followed without incident and there is no detectable Ba nucleic acid in the laboratory. we will follow the CDC interim decontamination recommendations
for laboratories that opened and processed Ba spore samples from DoD Lot -

Please apply for a FIFRA Section 18 quarantine exemption for the use of EPA registered sodium hypochlorite products (CAS no. 7681-52-9) to perform
spot decontamination of hard nonporous surfaces (there are no porous surfaces in the BSL2 laboratory and no aerosol generating procedures were
performed). We will use this solution in accordance with the OEM exemption.

We'd like to schedule the cleaning for Friday aftemoon. The cleaning protocol is being drafted according to the guidelines provided. We will also follow
the guidelines for the protection of the decontamination workers; we have several employees who are compliant with OSHA respiratory protection
standard.

httpsJlmoll.googl . com/mall/IiOl?uI=2&lk=68925163Od&vlow=pt&q=opa%2Oomorgercy%2Ousoo/o2Oault'<>'lzatlon&qs=truo&soarch=quory&lh=

14ddoo1938cd6071&slml= 14ddao1938cd6071

112

Statect Uttl Mall. Fwd: RequestFIFRA Crisis Exempli",

121912015

I will send the protocol and completion documents

in an email for your records.

Thanks again for all your help.

Allyn K Nakashima. MD
State Epidemioiogist
Bureau of Epidemiology
Utah Department of Health
PO Box 142104
Salt Lake City, Utah 84114-2104
Tel: (801) 538-6191
Fax: (801) 538-9923

htta:;'lImAII.ooooIs.com/mall/ulQ/?ul=2&lk=68925163Od&vl8'N=

ot&a=eoa%2Oemeroencv%2Ouseo/o2Oauthorlzatlon&as=true&search=auerv&th=

14ddee1938cd6071&slm

1=14ddee1938cd6071

212

121912015

Stat. 01U""' Mail. Fwd: EPAExemptionUpdate

Allyn

Nakashima

<anakashlma@utah.gov>

Fwd: EPA Exemption Update


1 message
Allyn Nakashima <anakashima@utah.gov>
To: Shelly Jensen <sbjensen@utah.gov>
Cc: David Mcknight <dmcknight@utah.gov>

Wed, Jun 10, 2015 at 1:15 PM

Hi Shelly.
Here Is the email from EPA containing the example form for us to complete and send to Dan. Please let me know If you have any trouble tuming this
around quickly because I can get CDC to contact EPA if you run Into problems. The lab Is very anxious to re-open and are planning to do the cleaning
on Friday.
Thanks,
Allyn
-Forwarded message -From: Canzler, Erica <Canzler.Erica@epa.gov>
Date: Fri, Jun 5, 2015 at 6:49 PM
Subject: EPA Exemption Update
To: "gllberto.c havez@cdph.ca.gov"
< gllberto. chavez@cdph.ca.gov>,
"gwendolyn. hammer@cdph.ca.gov"
<gwendolyn .ham mer@cdph.ca.gov>o
"deborah. hoi mes@cdph.ca.gov"
< deborah. holmes@cdph.ca.gov>,
"steven. blesslng@state.de.us"
<steven. bless Ing@state.deous> 0 "awele. madukaezeh@state.de.us" <awele .maduka-ezeh@state.de.us>,
"alfred. demaria@state.ma.us"
<alfred. demaria@state.ma.us>,
"david .blythe@meryland.gov"
< david. blythe@maryland.gov>,
"robert .myers-phd@maryland.gov"
< robert. myers-phd@maryland.gov>,
"tabeth .jiri@doh.state.njou"
<tabeth.jlri@doh.state.nj.u>,
"Nelson.Delgado@doh.state.nj.us"
< Nelson. Delgado@doh.state.nj.us>o
"edward.llfshitz@doh.state.nj.us"
<edward.lifshitz@doh.state.nj.us>
0 "christlna.egan@health.ny.gov"
<christlna.egan@health.ny.gov>,
"john.dunn@tn.gov"
<john.dunn@tn.gov>,
"linda.gaul@dshs .state.tx.us" <linda.gaul@dshs.state.tx.us>,
"Tom.Sidwa@dshs.state.lx.
us" <Tom.Sldwa@dshs.state.tx.us>,
"Rita. Es plnoza@sanantonio.gov"
< Rita. Espinoza@sanantonio.gov>,
"jundawoo@sanantonio. gOY" <jundawoo@sanantonio.gov>,
"anakas hima@utah.gov" <anak as hima@utah.gov>, "laurie. forlano@vdh.virginia.gov"
<laurie. forlano@vdh.virginia.gov>,
"Diane. Woolard@vdh.virginia.
gOY" <Diane. Woolard@vdh.virginia.gov>,
"krista.rietberg@kingcounty.gov"
<krista.rietberg@kingcounty.gov>,
"Marcla.Goldoft@DOH.WA.GOV"
< Marcia. Goldoft@doh.wa.gov>,
"suzanne.gibbonsburgenar@wi.gov"
<suzanne.gibbonsburgener@wi.gov>,
"sfisher@naccho.org"
<sfisher@naccho.org>,
"CAldridge@naccho.org"
<CAldridge@naccho.org>,
"dpatel@cste.org" <dpatel@cste.org>,
"eric.blank@aphl.org"
<eric.blank@aphl.org>,
"gbakker@astho.org"
<gbakker@astho.org>,
"jengel@cste.org" <jengel@cste.org>o "jlemmings@cste.org"
<jlemmlngs@cste.org>,
"jblumenstock@astho.org"
<jblumenstock@astho.org>,
"jtalkington@astho.org"
<jtalkington@astho.org>,
"scott.becker@aphl.org"
<scotl.becker@aphl.org>,
"ktalkington@astho.org"
<ktalklngton@astho.org>,
"tis 1@cdc.gov" <tis 1@cdc.gov>o
"guh2@cdc.gov" <guh2@cdc.gov>o "htv4@cdc.gov" <htv4@cdc.gov>, "jiclead2@cdc.gov"
<jiclead2@cdc.gov>,
"iwg9@cdc.gov" <iwg9@cdc.gov>,
"kjt1@cdc.gov" <kjt1@cdc.gov>,
"amh9@cdc.gov" <amh9@cdc.gov>, "crd7@cdc.gov" <crd7@cdc.gov>, "amw1@cdc.gov" <amw1@Cdc.gov>o
"gnfO@cdc.gov" <gnfO@cdc.gov>o "vmoO@cdc.gov" <vmoO@cdc.gov>o "dms8@cdc.gov" <dms8@cdc.gov>o "faq1@cdc.gov" <faq1@cdc.gov>o
"partJ@cdc.gov" <partJ@cdc.gov>. "fsu6@cdc.gov" <fsu6@cdc.gov>,
"eocsctfdeputy@cdc.gov"
<eocsctfdeputy@cdc.gov>,
"eup2@cdc.gov"
httpsJlmail.googl
.canlmaJl/uIOI?uI=2&lk=68925163Od&vle.v=pl&q=l1Jgway%2Oanthrox&qs=trL<l&soarch=query&lh=1
4ddaa5a406baa1
3&sim1=l4ddaa5a406baa
13

1/4

121912015

Stat.cj UlBhMall- Fwd:EPAexemption


Update

"

<eup2@cdc.gov>,
"vkx7@cdc.gov"
<vkx7@cdc.gov>,
"wab4@cdc.gov" <wab4@cdc.gov>,
"pdm3@cdc.gov" <pdm3@cdc.gov>,
"hfw3@cdc.gov"
<hfw3@cdc.gov>,
"Don.Boyce@hhs.gov"
<Don.Boyce@hhs.gov>,
"hvy1@cdc.gov" <hvy1@cdc.gov>,
"knk8@cdc.gov"
<knk8@cdc.gov>,
"goj8@cdc.gov" <goj8@cdc.gov>,
"hfa2@cdc.gov" <hfa2@cdc.gov>,
"jsa9@cdc.gov" <jsa9@cdc.gov>,
"mja4@cdc.gov" <mja4@cdc.gov>,
"bzb8@cdc.gov"
<bzb8@cdc.gov>,
"iqs3@cdc.gov" <iqs3@cdc.gov>,
"zoa6@cdc.gov" <zoa6@cdc.gov>, "gtg1@cdc.gov" <glg1@cdc.gov>,
"vzc6@cdc.gov"
<vzc6@cdc.gov>,
"cjy1@cdc.gov" <cjy1@cdc.gov>,
"kdI8@cdc.gov" <kdI8@cdc.gov>, "Kathryn.Delaurentis@fda.hhs.gov"
< Kathryn. Delaurentis@fda.hhs.gov>,
"dtd7@cdc.gov" <dtd7@cdc.gov>,
"DSNS-Teamroom@cdc.gov"
<DSNS- Teamroom@cdc.gov>,
"dhe1@cdc.gov" <dhe1@cdc.gov>,
"Joseph.Foster@hhs.gov"
<Joseph.Foster@hhs.gov>,
"kkg2@cdc.gov" <kkg2@cdc.gov>,
"huq2@cdc.gov"
<huq2@cdc.gov>,
"kXh9@cdc.gov" <kxh9@cdc.gov>,
"rzh7@cdc.gov" <rzh7@cdc.gov>,
"mlh2@cdc.gov" <mlh2@cdc.gov>,
"kah1@cdc.gov"
<kah1@cdc.gov>,
"anh5@cdc.gov" <anh5@cdc.gov>, "hhh1@cdc.gov" <hhh1@cdc.gov>, "mai9@cdc.gov" <mai9@cdc.gov>,
"czk7@cdc.gov"
<czk7@Cdc.gov>, "lpI3@cdc.gov" <lpI3@cdc.gov>, "clo2@cdc.gov" <clo2@cdc.gov>, "frh6@cdc.gov" <frh6@cdc.gov>, "stm2@cdc.gov"
<stm2@cdc.gov>,
"hok4@cdc.gov" <hok4@cdc.gov>,
"bbo9@cdc.gov" <bbo9@cdc.gov>,
"rcoO@cdc.gov" <rcoO@cdc.gov>, "scr1@cdc.gov"
<scr1@cdc.gov>,
"bsrO@cdc.gov" <bsrO@cdc.gov>, "dmzO@cdc.gov" <dmzO@cdc.gov>, "fzi6@cdc.gov" <fzi6@cdC.gov>, "byy3@cdc.gov"
<byy3@cdc.gov>,
"gqw6@cdc.gov" <gqw6@cdc.gov>, "ahe8@cdc.gov" <ahe8@cdc.gov>,
"zoz8@cdc.gov" <zoz8@cdc.gov>,
"cIi9@cdc.gov"
<cIi9@cdc.gov>,
"rsw2@cdc.gov" <rsw2@cdc.gov>,
"eocevent42@cdc.gov"
<eocevent42@cdc.gov>,
"eocafteract2@cdc.gov"
<eocafteract2@cdc.gov>,
"klq4@cdc.gov" <klq4@cdc.gov>, "esz2@cdc.gov" <esz2@cdc.gov>,
"hsz3@cdc.gov" <hsz3@cdc.gov>,
"debra.blog@health.ny.gov"
<debra.blog@heallh.ny.gov>,
"vxj1@cdc.gov" <vXj1@cdc.gov>, "jfv3@cdc.gov" <jfv3@cdC.gov>, "jiclead@cdc.gov"
<jiclead@cdc.gov>,
"CheryI.Star1ing@cdph.ca.gov"
<CheryI.Slar1ing@cdph.ca.gov>,
"Jason.Baker@cdph.ca.gov"
<Jason.Baker@cdph.ca.gov>,
"dqc5@cdc.gov" <dqc5@cdc.gov>,
"Joseph. Cordova@dhs.wisconsin.gov"
<Joseph. Cordova@dhs.wisconsin.gov>,
"Lisa.Pentony@dhs.wisconsin.
gov" <Lisa. Penlony@dhs.wisconsin.gov>,
"jill.taylor@health.ny.gov"
<jill. taylor@heallh.ny.gov>,
"elizabelh.cavosie@heallh.ny.gov"
<elizabelh.cavosie@heallh.ny.gov>,
"ape8@Cdc.gov" <ape8@cdc.gov>,
"jbf7@cdc.gov" <jbf7@cdc.gov>, "Tabatha.Offutt-Powell@slale.de.us"
<Tabalha.Offutt-Powell@slale.de.us>,
"peler.shull@slh.wisc.edu"
<peler.shull@slh.wisc.edu>,
"hnq9@cdc.gov" <hnq9@cdC.gov>,
"Juan. Ruiz@cdph.ca.gov" <Juan.Ruiz@cdph.ca.gov>,
"Monica. Gamez@dshs.slate.lx.us"
< Monica. Gamez@dshs.slale.lx.us>,
"lisa. comel ius@dshs.state.lx.us"
< lis a .comelius@dshs.stale.tx.us>,
"S leve. Hannem ann@dshs.state.lx.us"
<Steve. Hannemann@dshs.slale.lx.us>,
"Linda. Kaufman@sanantonio.gov"
< Linda.Kaufman@sanantonio.gov>,
"melinda. hergert@dshs.state.tx.us"
< melinda .hergert@dshs.slate.lx.us>,
"Junda. Woo@sanantonio.gov"
<J unda.Woo@sanantonio.gov>,
"emcGowan@astho.org"
<emcGowan@aslho.org>,
"AniI.Mangla@sananlonio.gov"
<Ani I.Mangla@sanantonio.gov>,
"Donnie. Diaz@sananlonio.gov"
< Donnie. Diaz@sanantonio.gov>
Cc: "Cruz, FranciscoJ" <Cruz.FranciscoJ@epa.gov>,
"Ryan, Shawn" <Ryan.Shawn@epa.gov>,
"Calfee, Worth" <Calfee.Worth@epa.gov>,
"Sayles,
Gregory" <Sayles.Gregory@epa.gov>,
"Nalipinski, Mike" <Nalipinski.Mike@epa.gov>,
"Mclain, Jennifer" <Mclain.Jennifer@epa.gov>,
"Reaves,
Elissa" <Reaves.Elissa@epa.gov>,
"Rosenblatt, Daniel" <Rosenblatt.Dan@epa.gov>,
"Housenger, Jack" <Housenger.Jack@epa.gov>,
"Cheatham,
Reggie" <chealham.reggie@epa.gov>,
"Tulis, Dana" <Tulis.Dana@epa.gov>,
"Andreadis, Joanne (CDCIOPHPRlOD)" <jsa9@cdc.gov>, Angela Weber
1 <amw1@cdc.gov>

Good Evening Everyone,

As a follow up to the conference call held this afternoon, I wanted to reach out and share with you a draft application
package that you can use to apply for the FIFRA crisis exemption to use an unregistered pesticide for anthrax
decontamination. EPA's intention is for applicants to use this document as a plug and play form that will expedite the
process for participating State Agencies. The most direct process for decontamination would be for the states to use
products currently registered for use against Bacillus anthracis. However, the State can declare a crisis exemption under
FIFRA for use of ethylene oxide, paraformaldehyde, hydrogen peroxide, peracetic acid, and sodium hypochlorite. The
httos~lImall.oooola.com/malt/Lial?uI~2&lk=68925163Od&view=ot&a=duowav%2Oa-rthrax&as=true&search=OU9'V&th=

14ddee5A40000a13&siml=

14ddeA5A406hAa13

?/.

1219i2G15

Slate ri Utah Mail. Fwd: EPA Exempli'"

Update

attached Word file has an example of how to ask EPA for such a crisis. It has a few placeholders for the state agency to fill
in and then send back to EPA Office of Pesticide Programs. The outline in the file has the details on the products and use
directions that would need to be followed for use of these products for the decontamination of anthrax spores.

EPA does not typically prepare the applications for a state or federal agency to fill in, but we are trying to do everything we
can to expedite the process so that labs can reopen as soon as possible while still abiding by applicable regulations. If
anything needs to happen this weekend, the states/applicants can e-mail Dan Rosenblatt at rosenblatt.dan@epa.gov or call
his mobile at 703-939-7565.

The background regulatory context on this is that under section 18 of the Federal Insecticide, Fungicide, and Rodenticide
Act and in accordance with 40 Code of Federal Regulations (CFR) 9166.40 the head of a Federal or State agency, the
Governor of a State, or their official designee, may issue a crisis exemption in situations involving an unpredictable pest
emergency.

In accordance with 40 CFR 9166.43, the State or Federal Agency issuing the crisis exemption must notify the Administrator
in advance of utilization of the crisis provisions. If states would like to decontaminate labs under the crisis provision
from June 5, 2015 through June 7, 2015. the state can e-mail their crisis declaration to, Dan Rosenblatt. Deputy
Director of the Registration Division. Office of Pesticide Programs (Rosenblatt.Dan@epa.gov).
If the state will be
declaring the crisis exemption after June 7, 2015 the state can e-mail MarionJohnson.Chief of the Minor Use and
Emergency Response Branch (Johnson.Marion@epa.gov). In accordance with 40 CFR 9166.45 the crisis exemption may
be authorized for as long as is necessary to control the conditions causing the emergency; but no longer than 15 days.

If additional time is needed the state should contact the EPA, Office of Pesticide Programs regarding an application for a
specific, quarantine, or public health exemption for this use.

I hope you find this information useful in expediting the process.

Best,
Erica
htIps 1/mail.googIe.comJmail/u'O/?lJl =2&Ik= 589251630d&vlew= pl&q= D..9Wey%2Oa1thrax&qs= true&seerch= query&lh= 14ddee5a4OObaa13&slm 1=14ddee5a4OObaa13

3/4

121912015

State t1 Uta'1 Mell Fwd: EPA Exemplloo

Update

Erica Canzler
Director, CBRN Consequence

Management Advisory

Division

Office of Emergency Management


U.S. EPA

(0) 202.564.2359
(c) 202-431.3146
canzler.enca@epa.gov

Aliyn K Nakashima, MD
State Epidemiologist
Bureau of Epidemiology
Utah Department of Health
PO Box 142104
Salt Lake City. Utah 84114.2104
Tel: (801) 538-6191
Fax: (801) 538-9923

,;f] Example of State Crisis Declaratlon.docx


44K

htt..'llmon nt'YVtl,. NVnlm>'llilll

li11nI ,1='.\IIr=AAQ?"1~..,Ij:lW=nf,ll,n:r11It'l1oVAVCV
?OAnthrR
..,ltM~trl p"ltoqAArr.h=nllRf'V,ll,lh=

1~1AA.;i

m 1= 1~1~

4/4

1211lr.2015

Slat9 of Utah Mall. R.: NUIT""""" other lots of B. arrthrllCls sorrl to

Allyn Nakashima

<anakashlma@utah.gov>

Re: Numerous other lots of B. anthracis sent to


1 message
Wed. Jun 17. 2015 at 3:31 PM

To: Allyn Nakashima <anakashlmalg/ulah.gov>


I don1 thunk that one Is in

On Jun 17. 2015. at 2:13 PM, Allyn Nakashima <anakashima@utah.gov>

wrote:

No. Do you want to approach them?


Allyn Nakashima. MD
State Epidemiologist
Utah Department of Health
On Jun 17. 2015, at 10:05 AM.

HI Allyn. have you had a chance to contact the

On Jun 11. 2015. at 6:51 PM. Allyn Nakashima <anakashima@utah.gov>

wrote:

Did you listen in on today's CDC conference call on recommendations


specimens?

for disposition of B. anthracis

I have attached the recommendations and thR Ii"t of specimens sent to the _.
.'here are apparently
a lot of these. Should we meet with .
. about this and plan proper disposition If she still has the
specimens stili In storage? Robyn, many of the lots had been tested and tested negative. The one of
greatest concem are the "positive. and "not tested" lots. I assume.
I am concemed because we are still dealing with the lab clean up and I will be out for 2 weeks starting on
Saturday.
- ..__

_~

..

112

1=15

S_

a Utah Mall.

Ro: Num ous other lols cJ B.lnthracls

sent to

Allyn

Allyn K Nakashima, MD
State Epidemiologist
Bureau of Epidemiology
Utah Department of Health
PO Box 142104
Salt Lake City, Utah 84114-2104
Tel: (801) 538.t1191
Fax: (801) 538-9923

._._ - IMPORTANT

MESSAGE

_._.

This message, including any attachments, may contain confidential information Intended for a specific
individual and purpose, and is protected by law. If you are not the intended recipient, delete this message,
including from trash, and notify me by telephone or email.
If you are not the intended recipient, any distribution or copying of this message, or the taking of any action
based on its content is strictiy prohibited.

<Disposition

_._.-

of Comtaminated

IMPORTANT

Aliquots from Dugway Lab.11June2015.docx>

MESSAGE

._._

This message, including any attachments, may contain confidential information intended for a specific individual and purpose, and is
protected by law. If you are not the intended recipient, delete this message, including from trash, and notify me by telephone or email.
If you are not the intended recipient, any distribution or copying of this message, or the taking of any action based on Its content is
strictly prohibited.

212

-- ..

121912015

State ci Utah Mall. RE: Dugway EventArittrax

PI call m

Allyn Nakashima <anakashlma@utah.gov>

RE: Dugway Event Anthrax Please call me.


1 message
Thu, Jun 11.2015 at 2:13 PM

To: Shelly Jensen <sbjensen@utah.gJv>


Cc: Allyn Nakashima <anakashima@utah.gov>,
Hi Shelly,

I would prefer it if this document was specific to our situation: spot cleaning a BSCwith a 10% bleach solution (pH 7). We will not be fumigating
and therefore we will not be performing air filtering and testing.

However, if it will make the process go quicker you can submit as is.
Thank you,

From: Shelly Jensen (mailto:sbjensen@ulah.gov]


Sent: Thursday, June 11, 2015 9:55 AM

To:
Subject: Re: Dugway Event Anthrax Please call me.

https"i/mail.google.com/mali/ulOl?ul<2&lk<68925163Od&vlow<pt&q<a_ax%2Odugway&qs=true&soarch<query&tIF

14d0441c1Jdbaae51&slml<14d0441c1Jdbaae5f

1/3

121912015

State rj Utah Mall. RE: Ougway Event AntITax Pleas. call me.

It is not on letter head yet or final.

On Thu, Jun 11, 2015 at 9:30 AM,


Hi Shelly,
Do you think I could look over a draft of the FIFRACrisis Exemption before you send it off?
Thanks,

From: Shelly Jensen [mailto:sbjensen@utah.gov]


Sent: Wednesday, June 10, 2015 3:26 PM

To:
Subject: Dugway Event Anthrax Please call me.

I just heard about your need to clean your lab this Friday. I have already been in contact with EPA.
Thank You
Shally Jensen
Utah Department of Agriculture
Phone 801.538-7185
Fax

801-538-7189

httos:J/mail.oooole.can/malilliOl?uI=2&Jk=689251

630d&vlow=ot&o=antnrax%2OdUClNav&os=truo&soarch=auerv&lh=

14de441dOdbaao5f&slm 1=14de441dOdb0a05f

213

lfs

Stat. d Utah MoIl- RE: Dugway Event AnltTox PI

call m .

rhank You
3helly Jensen
'hone 801-538-7185

'ax

801-538-7189

Example of State Crisis Declaration Anthrax.doc

117K

moll.googlo.comJmoll/uIOI?ul=2&1k=68925163Od&vlow= pl8q=onltTox%2Odugway&qs=truo&soarch=quory&th=

14de44ldOdbaao5f&slml= 14de441dOdboao5f

313

'2i9I2015 ,

State ci Utah Mall. Fwd: Dugway Event Anthrax Plaasa call ma.

Allyn Nakashima <anakashlma@utah.gov>

Fwd: Dugway Event Anthrax Please call me.


1 message
Allyn Nakashima <anakashlma@ulah.gov>
To: Shelly Jensen <sbjensen@utah.gov>

Thu, Jun 11. 2015 at 4:14 PM

Hi Shelly,
Has this gone forward to Dan Rosenblatt of EPA today?
Please let me know.
Thanks,
Allyn
--Forwarded messaoe --From:
Date: Thu, Jun 11, 2015 at 2:13 PM
Subject: RE: Dugway Event Anthrax Please call me.
To: Shelly Jensen <sbjensen@utah.gov>
Cc: Allyn Nakashima <anakeshima@utah.gov>, I

Hi Shelly,
I would prefer it if this document was specific to our situation: spot cleaning a BSCwith a 10% bleach solution (pH 7). We will not be fumigating
and therefore we will not be performing air filtering and testing.

However, if it will make the process go quicker you can submit as is.
Thank you,

https:/ImaJl.googla.can/malllulOl7lJl=2&lk=68925163Od&vlew=pt&q=cl..gway%2Oa'1thrax&qs=true&saarch=

query&th= 14de4b09b6521d66&s1m 1=14de4b09b6521 d68

1/4

S-

121912015

01Utah Mall. Fwd: Dugway Event Anthrax Pi call m.

From: Shelly Jensen [mailto:sbjensen@utah.gov]


Sent: Thursdav, June 11, 2015 9:55 AM
To:
Subject: Re: Dugway Event Anthrax Please call me.

It is not on letter head yel or final.

On Thu, Jun 11, 2015 a19:30 AM, .


Hi Shelly,
Do you think I could look over a draft of the FIFRACrisis Exemption before you send it off?
Thanks,

From: Shelly Jensen (mailto:sbjensen@utah.gov]


Sent: Wednesday, June 10, 2015 3:26 PM
To:
Subject: Dugway Event Anthrax Please call me.

httM

"/m

1:11
r IYYY'II R fYYT'l/m Ril

I, lInJ?J.II =?Jt Ik~ liAA?S1 R.?flliA.vIAW=

nt&o=

ciJowAVo/tl2OAnthrax&os= trUA&SeRrch=ouerv&!h=

14de4b09b8521

d68&si

J= 14de4b09b8521

d68

214

''12!912015

Stale of Utah Mall- Fwd: Dugway Event Anthrax Please call me.

pt&q=dugway%2Oanthrax&qs=true&search=query&th=

14de4b09b6521d6ll&slm 1=14de4b09b8521,

I just heard about your need to clean your lab this Friday. I have already been in contact with EPA.
Thank You
Shelly Jensen
Utah Department of Agriculture

801-538-7189

Phone 801-538-7185
Fax

Thank You
Shelly Jensen

801-538-7189

Phone 801-538-7185
Fax

Allyn K Nakashima, MD
State Epidemiologist
Bureau of Epidemiology
Utah Department of Health
PO Box 142104
Salt Lake City, Utah 84114-2104
Tel: (801) 538-6191
Fax: (801) 538-9923

httpsJlmall.google.com/mali/liOl?ul=2&Ik=68925163Od&vlew=

'.."'.'Vh .

.'!!J

httl"ll:

State d Utah Mail. Fwd: Dugway Event Anthrax Please call me

Example of Slate Crisis Declaration Anthrax.doc


117K

.Ilm AU l'llYlnIA .r.trn/mAll/uIl'lI?uI

= 'R.ik= fiAQ?fi16.ni&vlAY.r=

ot&o=

dJOW

avo/n2OwlthrAX

&as=

trUA&.sARrch:= OUQrV&th= 14de4b09b8521 d68&si m 1=14de4b09bR521 r168


414

,21912015

Slate

a Utah Mall.

Emergency Us. Authorization for anthrox lab do>::onta"ninationIn Utah

Allyn

Nakashima

<anakashlma@ulah.gov>

Emergency Use Authorization for anthrax lab decontamination in Utah


1 message
Allyn Nakashima <anakashima@utah.gov>
To: rosenblatt.dan@apa.gov

Fn. Jun 12, 2015 at 3:50 PM

Hi Dan.
The lab in Utah
. that received the anthrax specimens from Dugway is still awaiting emergency use authonzation for 10% bleach,
adjusted to pH 7.0 (w penacetic acid) for use in spot cleaning their lab. The Utah Department of Agnculture (Shelly Jensen) should have sent this
request to you yesterday.
Please send me documentation that you have approved this request so they can begin their clean up process.
Thanks.
Allyn
(P.S.

I also left you an email that you can disregard if you see this email firs!.)

Allyn K Nakashima, MD
State Epidemiologist
Bureau of Epidemiology
Utah Department of Health
PO Box 142104
Salt Lake City, Utah 84114-2104
Tel: (801) 538-6191
Fax: (801) 538-9923

httpsJ/m.ll.googlo.com/m.ll/u'OI?ui=2&1k=68925163Od&vlf1N=pl&q=<I.\lWoyo/.2Oanthrox&qs=true&soarch=query&lh=

14do9c 1046a04fod&sl m 1=14do9c1 046a04I0d

111

12J912015

Stat. of Utah Mail. RE: Dugway Event Anthrax. Utah Department of Agrlcultur

.m Food
Allyn

Nakashima

<anakashlma@ulah.gov>

RE: Dugway Event Anthrax. Utah Department of Agriculture and Food


.,. - .... To: Shelly Jensen <sbjensen@utah.gov>
Cc: Allyn Nakashima <anakashima@ulah.gov>

Fri, Jun 12, 2015 at 4:01 PM

Thank youl

Was there an attachment,

or just the forwarded

message?

From: Shelly Jensen [mailto:sbjensen@ulah.gov]


Sent: Friday, June 12, 2015 3:58

PM

To:
Subject:

Fwd: Dugway Event Anthrax - Utah Department

of Agriculture

and Food

Per the attached you can move forward with the clean up. Using the EPA approved sodium hypochlorite.

See attachment

from the EPA.

"ttncl"/I,." "II !"W"YV'II~ I""l'YTl/m ,,1111


Jon. 11=,.ItIIt:: AAQ?~1
~vll'Ml=

nt.\n=

rIIll"JWAVOfr.?ORnthrAll'

R.m=trl

JAR.!lRAr~h=

nUAf"v&mso= 14dAAcA82AA22d 1e&si m I:: 14de9ca82ea22d1e

1/4

1219i2015

Stat. of Utah Mall. RE: Dugway Evant AI1tIvax. Utah Department of Agrlcultur.1I'ld

Food

--Forwarded message --From: Johnson, Marlon <Johnson.Marion@epa.gov>


Date: Fri, Jun 12, 2015 at 1:45 PM
Subject: RE: Dugway Event Anthrax - Utah Department of Agriculture and Food
To: Shelly Jensen <sbjensen@utah.gov>, Scott Oldham <soldham@utah.gov>, Robert Hougaard <rhougaard@utah.gov>, "cburgess@utah.gov"
<cburgess@ulah.gov>
Cc: "Housenger, Jack" <Housenger.Jack@epa.gov>, "Lewis, Susan" <Lewis.Susan@epa.gov>, "Mclain, Jennifer" <Mclain.Jennifer@epa.gov>,
"Rosenblatt, Daniel" <Rosenblalt.Dan@epa.gov>, "Reaves, Elissa" <Reaves.Elissa@epa.gov>, "Maignan, Tawanda" <Maignan.Tawanda@epa.gov>,
"Canzler, Erica" <Ganzler.Erica@epa.gov>, "Cruz, FranciscoJ" <Cruz.FranciscoJ@epa.gov>

Dear Ms. Jensen:

The Environmental Protection Agency (EPA)would like to quickly acknowledge and concur upon the crisis exemption request under the
provisions of section 18 of the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA)that was received from the Utah Department of
Agriculture and Food on June 12,2015, for decontamination of described surfaces in laboratories that may have processed Bacillus anthracis
(anthrax). This crisis program will allow the use of the sole active ingredient sodium hypochlorite, as requested, to assist in ensuring that
responders have effective antimicrobial products for these decontamination purposes.
You are reminded that this crisis exemption will be effective for up to fifteen days to commence on June 12, 2015, as requested, and will
expire on June 27, 2015. If additional time is anticipated for the need and utility of this pesticide beyond the expiration date, it is recommended
that you contact me well ahead of the expiration date, so that further discussions can ensue regarding an application for a public health emergency
exemption. As a matter of major importance, you should also resubmit a revised/corrected version of your crisis exemption that includes a
signature from a designated person of authority in your state and that removes the additional active ingredients In paragraph one that you are
not requesting to use at this time for this particular crisis exemption situation.
In addition, in accordance with 40 CFR166.50, you should be aware that a brief summary of the results of the treatment under the crisis
exemption must be submitted to the agency (i.e., Ms. Tawanda Maignan, Emergency Response Team Leader) within 3 months from the last date of
treatment. However, if you have further questions, please do not hesitate to contact me at the number below, or Ms. Tawanda Maignan
(Emergency ResponseTeam Leader) at (703) 308-8050.

Regards,

hlIpsJ/mail.googla.can/m

ail/ullJflul= 2&1k= 68S25163Od&vlf1N= pt&q= c>.gway%2Omthrax&qs= lrua&search= query&m sg= '4da9ca82ea22d 1&&sImi = '4da9ca82ea22dl.

214

1=15

Stat. of Utah M.II-

RE: DlqNay Event Anthrax - Utah Department

ci ~rlculllJr. a'1dFood

M. J. Johnson

Marion J. Johnson, Jr.


Chief, Minor Use and Emergency ResponseBranch
U.S. Environmental Protection Agency
Office of Pesticide Programs
Registration Division
(703) 305-6788 (teL)
(703) 308-0029 (fax)
johnson. marion@epa.gov
visit: http://www.epa.gov/pesticides

From: Shelly Jensen [mailto:sbjensen@utah.gov]


Sent: Friday, June 12, 201S 1:31 PM
To: Johnson, Marion; Scott Oldham; Robert Hougaard; cburgess@utah.gov
Subject:

Dugway Event Anthrax - Utah Department

of Agriculture

and Food

Marion
Thank you for working so well with the changes that the lab here In Utah requested.

Please find two attachment

with our request.

I look forward to hearing from you.

hHTI"l;'lImAII nrrrllA tnTl 1mAUIlIIOnl ri=?R.fk: AA.qJl51A.Tld&vlew= ot&a= OJowRVO/n2OwrthrAX&m = true&search= ouerv&m so= 14de9ca82ea22d

1e&slm I:: 14de9ca82ea22d1

3/4

1mao15

State of Utah Mall. RE: Dugway Evant Anthrax. Utah Department of Agriculture and Food

Thank You
Shelly Jensen
Phone 801-538-7185
Fax

801-538-7189

Thank You
Shelly Jensen
Phone 801-538-7185
Fax

801-538-7189

httpsJlmall.google.comlmall/L>'Ol?uI=2&1k=6SS25163Od&vlf1N=pt&q=dugway%2OantI1rax&qs=trl.e&saarCh=quary&msg=

14da9ca82aa22dla&slml= 14da9ca82aa22d1e

414

The {list authorized agency in state declaring the emergency} hereby issues crisis exemptions
under the provisions of section 18 of the Federal Insecticide, Fungicide, and Rodenticide Act.
The {list authorized agcncy in state declaring the emergency} is authorizing the use of multiple
products containing the following active ingredients: ethylcne oxide, paraformaldehyde.
hydrogen peroxide, peracetic acid, and sodium hypochlorite to inactivate Bacillus amhracis
(anthrax) spores on interior and exterior inanimate, non-food contact surt~1cesin laboratories that
processed potentially viable Bacillus anthr({cis spore-containing samples originating from
Dugway Proving Ground's Lot
These crisis quarantine exemptions will ensure
that responders have effective antimicrobial pesticide products for decontamination.
{list authorized agency in state declaring the emergency} has determined that an emergency
condition exists and a crisis exemption is necessary, according to 40 C.F.R S I66.40(b).

2.

I.

When fumigation is complete, air filtering and testing will be conducted to ensure that
levels of the decontamination chemicals remaining in the air arc at acceptable Icvels prior
to allowing re-entry by unprotected persons.

'Ibe public will not be permitted in areas undergoing treatment or allowed to re-entcr areas
until the anthrax decontamination is complete.

Therefore, {list authorizcd agency in state declaring the emergency}, herby authorizes thc use of
ethylene oxide, paraformaldehyde, hydrogen peroxide, peracetic acid, and sodium hypochlorite
to decontaminate the following facilities (provide name and location of each lab to be
decontaminated). This crisis program will be conducted under the following conditions:

3.

Decontamination Workers conducting decontamination activities will wear Personal


Protective Equipment (PPE). At a minimum, workers will wear the following to prevent
skin contact and inhalation of Bacillus ({nthracis spores:

NIOSH-approved half-face e1astomeric respirator with an appropriate cartridge or


a filtering facepiece respirator (e.g. N95)1
Indirect vented goggles
Disposable uncoated Tyvck@ (or similar) suit with integrated hood and booties
Rubber or nitrile gloves.

All PI'E will be uscd in accordance with OSHA regulations found at 29 CFR 1910 Subpart
I (Personal Protective Equipment). Workers will receive training on and demonstratc an
understanding of whcn to use I'I'E; what PPE is necessary; how to properly put on. usc,
take off, properly dispose of, and maintain PPE; and the limitations of I'PE. Any rcusable
PPE will be properly cleaned, decontaminated, and maintained afterlbetween uses. Filter
cartridges will be discarded after use.
Respirator use will follow a completc respiratory protection program in accordancc with
the OSHA Respiratory Protection standard (29 CFR 1910.134) and other requirements.

I Note that the use of sporicides and sterilizers may pose a chemical hazard. Therefore. appropriate PPE. including
elastomeric respirators with combination particulate/chemical
cartridges. may be necessary to protect workers from
exposure to the chemicals in addition to Bacillus anthracis spores. Disposable N95 respirators and certain cartridges
for elastomeric respirators may be adversely affected by an increase in moisture and spray from certain work tasks.
This may include the cleaning and decontamination process when significant amounts of liquid sporicidcs and
sterilizers are used. In such instances, or during other tasks to improve worker comfort, a powered air purifying
respirator (PAPR) equipped with appropriate cartridges may be an alternative.

Page 2 of6
Staff wearing NIOSH-approved respirators will be medically-cleared, trained, and fittested for respirator use. Detailed information on respiratory protection programs,
including fit testing procedures, can be accessed at OSHA's Respiratory Protection eTool.

6.

5.

4.

The EPA registered product label and this order will be in the possession of the user at the
time of application.

The Crisis Exemption expires on (list date 15 days from start of program).

Use of the products will begin (list date in which first decontamination will take place).

Applications will be made using the EPA registered products and decontamination use
directions found in the tables I and 2 below.

Any additional PPE required for the use of the product as listed on the EPA registered
product label must be worn.

7.

Page 3 of6

Tables I and 2 below list the liquid and gaseous/vapor products, respectively, which are supported by available safety and efficacy data and
which may be used undcr the crisis exemptions declared. The last column of these tables details the requircd dircctions for decontamination
usc undcr thcsc crisis cxemptions. Use of all products will be in accordance with all applicable precautions and dircctions specified on the
registercd labels and the requirements listed above.
TABLE I.
Usc Directions

for Liquid

Antimicrobial

Pesticides

for Inactivation

of Bacil/lls allthracis (Anthrax)

Spores

(limited to pre-dealled,

hard, lIollporolls slIrfaees alld items)


Product Name
Oxonia Active

Vortexx

2.

EPA
Registration
EPA Reg. No.
1677-129

EPA Reg. No.


1677-158

Companv

Active Ingredient(s)

Ecolab Inc.

Ecolab Inc.

Hydrogen peroxide and


peracetic acid

Directions for Decontamination


Dilute 9.7 oz. of product per gallon of water to obtain a 7.6%
solution. Apply by fine mist or flood the surface. The
minimum contact time is 60 minutes at 68 F, with
reapplication as needed to keep the surface wet.'
Dilute 30 oz. of product per 4 gallons of water to obtain a 6%
solution. Apply by finc mist or 1100dthe surface. The
minimum contact time is 30 minutes at 68 F, with
J
reapplication as needed to keep the surface wet.

Source: EPA (2009), "Evaluation of Liquid and Foam Technologies for the Decontamination of B. alllhraci" and B. sub/iii" Spores on Building
and Outdoor Materials," EPA/600/R-091I50.
3. Source: EPA registered label for Vortexx.

Page 4 of6

TABLE I. (col/t'd.)
Use Directions

for Liquid

Antimicrobial

Pesticides

for Inactivation

of Bacillus al/t!lracis (Anthrax)

Spores

(limited to pre-cleal/ed,

!lard, I/ol/porous surfaces al/(I items)

l. For immersion applications - immerse items in undiluted


product for a minimum contact time of30 minutes at 68 F.'
Spor-Klenz Ready !EPA Reg. No.
o Use
1043-119

STERIS Corporation

Hydrogen peroxide and


peracetic acid

2.

For surface decontamination applications - Apply the


product as a fine mist spray or flood the surface. The
minimum contact time is 30 minutes. The surface must
remain wet for the entire contact time, reapply as
necessary.

4. Sources: (a) EPA registered label for Spor-Klenz (b) M. Worth Calfee et al (2011). Lab-Scale Assessment to Support Remediation of Outdoor Surfaces
Contaminated with Bacillus anthracis Spores. Journal of Bioterrorism and Biodefense, 2 (3), 1-9. (c) EPA/6001R-I 0/087 (2010) Biological Agent
Decontamination Testing

Page 5 of6

CAS No.
7681-52-9

Bleach

Use of an EPA
registered product

Sodium hypochlorite
5.25%-6%)

Products with (5.25%-6% sodium hypochlorite should be


diluted with 5% acetic acid (white vinegar) and water I: I:8.
Bleach should not be mixed directly with acetic acid, but
rather diluted with water (add the one part bleach to 5
parts water) then add the one part vinegar. then bring to
total volume (or correct pH) with remaining water
Measure with lIach test to assure I'll = 7. Apply by pouring,
wiping or spraying. The minimum contact time is 10-60
minutes at 68'F.' Reapply as needed to keep surface wet.
If the sodium hypochlorite concentration in the product is
greater than 6%, adjust the pH accordingly to assure a pH=7.
Bleach products are not effective on wood or heavily soiled
surfaces.

TABLE

2.

Usc Directions

for Gaseous/Vaporized

Antimierohial

Pesticides

of Bacillus Imtllracis (Anthrax)

for Inactivation

Spores (limited to

pre-clealled porous, or combillatioll of porous alld fUJI/pOrOUS,


surfaces and items)

Ethylene oxide
100%

I EPA Reg. No.


36736-2

ARC Specialty
Products Balchem
Corporation

Ethylene oxide (gas)

Sterilization/fumigation must be performed only in vacuum


or gas tight chambers and must be applied by commercial
applicators. Follow the manufacturer's
manual. On the

5. Sources: (a) Unpublished EPA data from 01'1' Microbiology Laboratory, 2002. (b) EPA (2006), "Technology Evaluation Report, Evaluation
of Spray-Applied Sporicidal Decontamination Technologies." (c) EPA/600/R-06/146. EPA (2009), "Evaluation of Liquid and Foam
Technologies for the Decontamination of B. amhraeis and B. subfilis Spores on Building and Outdoor Materials," EPA/600/R-09/I50. (d) "Lab
Scale Assessment to Support Remediation of Outdoor Surfaces Contaminated with Bacillus anl/wacis spores" Calfee et al (20 II) Journal of
Bioterrorism and Biodefense (e) "Systematic investigation of liquid and fumigant decontamination efficacy against Biological agents deposited
on test coupons of Common indoor materials" EPN600/R-II/076 (20 II) (I) "Efficacy of liquid spray decontaminants for inactivation of
Bacillus anlhracis spores on building and outdoor materials" Wood et al. (201 I) Journal of Applied Mierobiology

Page 6 of6

E"nv,rosystems
.

Ethylene Oxide
Sterilant

EPA Reg. No.


58779-5

Corporation

Oxyfume 2002

EPA Reg. No.


67470-2

Honeywell
Intemational, Inc.

SunPac

EPA Reg. No.

Paraformaldehyde (gas)

4972-43

Protexall Products,
Inc.

Heat paraformaldehyde to achieve a concentration of at least


10.6 glm' (0.3 gift') for 2-4 hrs'-

EPA Reg. No.


58779-4

STERIS
Corporation

Hydrogen Peroxide
(vapor)

For sterilization of empty, pre-cleaned, sealed enclosures, up


to 40 ft', apply 2.2 grams of product per minute for
90 mins'.

Vaprox
Hydrogen
Peroxide Sterilant

completion of fumigation ventilate fumigated equipment to


open air for at least 12 hours before reuse 6. Please referto
report listed in footnote for specific time/temperature ranges.

STERIS

6. Source: "Evaluation of Ethylene Oxide for the Inactivation of Bacillus an/llrae!s" EPA/600/R-13/2201 December (2013)
7. Source: FIFRA Quarantine Exemption issued by EPA to the U.S. Army Medical Research Institute for Infectious Diseases (USAMRlID),
September, 30, 2008. EPA # 08-00-01.
8. Sources: (a) "Systematic investigation of liquid and fumigant decontamination efficacy against Biological agents deposited on test coupons of
Common indoor materials" EPA/600/R-I 1/076 (2011) (b) U.S. EPA. "Evaluation of Hydrogen Peroxide Fumigation for HVAC Decontamination."
U.S. Environmental Protection Agency, Washington, DC, EPA/6001R112/586 (2012) (c) U.S. EPA. "Determining the Efficacy of Liquids and
Fumigants in Systematic Decontamination Studies for Bacillus anthracis Using Multiple Test Methods." U.S. Environmental Protection Agency,
Washington, DC, EPA/6001R-10/088 (2010)

121912015

Stat. of Utah Mail. RE: Emergency UsoAutl1a1za11'" lor ..,ltTax lab docontamlnatl",

In Utah

Allyn

Nakashima

<anakashlma@utah.gov>

RE: Emergency Use Authorization for anthrax lab decontamination in Utah


Hendricks Walters. Katherine (Kate) (CDC/OID/NCEZID) <kah1@cdc.gov>
To: "Nakashima, Allyn (CDC utah.gov)" <anakashima@utah.gov>

Sat, Jun 13. 2015 at 3:21 PM

Moving forward. 0 Kate


From: Nakashima, Allyn (CDC utah.gov)
Sent: Friday, June 12, 20157:32 PM
To: rosenblatt.dan@epa.gov;
Hendricks Walters, Katherine (Kate) (CDClOID/NCEZID)
Subject: Re: Emergency Use Authorization for anthrax lab decontamination in Utah
We just received the email approval from the Department of Ag.
Thanks,
Allyn
On Fri. Jun 12, 2015 at 3:50 PM, Allyn Nakashima <anakashima@utah.gov<mailto:anakashima@utah.gov
wrote:
Hi Dan,
The lab in Utah'
_
that received the anthrax specimens from Dugway is still awaiting emergency use authorization for 10% bleach,
adjusted to pH 7.0 (w periacetic acid) for use in spot cleaning their lab. The Utah Department of Agriculture (Shelly Jensen) should have sent this
request to you yesterday.
Please send me documentation that you have approved this request so they can begin their clean up process.
Thanks,
Allyn
(P.S.

I also left you an email that you can disregard if you see this email firs!.)

Allyn K Nakashima, MD
State Epidemiologist
Bureau of Epidemiology
Utah Department of Health
PO Box 142104
Salt Lake City, Utah 84114.2104
Tel: (801) 538-6191
Fax: (801) 538.9923<tel:%28801 %29%20538-9923>

https:J/mall.googl . com/mall/li\ll?ul=2&1k=68925163Od&vl<m=pt&q=dJgway%:2O<rt.t1rax&qs=true&5aarch=query&m

5g= 14deecc2b40a315a&slm I= 14deecc2b40e3 150

112

121912015

Stat. of Utah Mall- RE: Em gency Us. Authorization for anltT"" lob decontamination In Utah

Allyn K Nakashima, MD
State Epidemiologist
Bureau of Epidemiology
Utah Department of Health
PO Box 142104
Salt Lake City, Utah 84114-2104
Tel: (801) 538-6191
Fax: (801) 538-9923

.._ ....IMPORTANT

MESSAGE

*..

This message, including any attachments, may contain confidential information intended for a specific individual and purpose, and is protected by law.
If you are not the intended recipient, deiete this message, including from trash, and notify me by telephone or email.
If you are not the intended recipient. any distribution or copying of this message, or the taking of any action based on its content is strictly prohibited.

wlnmall.dat

11K

httM 'JIm Pli1/YY')l']IA.r.nm/m

All/i ill1I?t II = ~Aik= AAQ?fi1 R.n1&ViAW= otR.n= rl.ow AV%?OAnthrAx&nq=

trlJAP.Cl;AArr.h= OtJArVP.rn !ilO= 1~?h4l1A.l1

fiA&.~1mI= 14t1~::>h4t"lA.l1!'iA

'f?

-:

1;w1.io15

Stat. of Utah Mall- RE: DU\1Nay Evant Mthrax - Utah Department ci Agrlc:ultur.lnl

Food

Allyn Nakashima <anakashlma@utah.gov>

RE: Dugway Event Anthrax.

Utah Department of Agriculture and Food

1 message
-

Mon. Jun 15, 2015 at 9:38 AM

To: Shelly Jensen <sbjensen@utah.gov>


Cc: Allyn Nakashima <anakashima@utah.Qov>,

Hi Shelly,
I noticed the EPAwants a revised crisis exemption that removes the active Ingredients we did not use. For your convenience, attached is a draft
that is specific to our situation.

Also attached is a brief summary of the treatment for submission to the Emergency Response Team Leader.

Thanks for your help.

-'.;.~---

From: Shelly Jensen [mailto:sbjensen@utah.gov]


Sent: Friday, June 12, 2015 4:03 PM

https:J/m,;l.google.can/m';Vli\lI7IJl=2&Jk=68925163Od&vlew=pt&q=cl.qNay%2Oenthrax&qs=lrue&search=query&lh=

14df7dee512cfe3d&slm 1=14df7dee5I 2c1c3d

116

1VS12015

State of Utah Mall- RE: Dugway Event Anthrax. Utah Department of AgrlculllJrol1d Food

..

.\

Subject: Re: Dugway Event Anthrax - Utah Department of Agriculture and Food

I forwarded his emai. I am leaving for the day, so I just copied to this email to be safe.

Dear Ms. Jensen:

The Environmental Protection Agency (EPA)would like to quickly acknowledge and concur upon the crisis exemption request under the
provisions of section 18 of the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA)that was received from the Utah Department of
Agriculture and Food on June 12, 2015, for decontamination of described surfaces in laboratories that may have processed Bacillus
anthracis(anthrax). This crisis program will allow the use of the sole active ingredient sodium hypochlorite, as requested, to assist in ensuring that
responders have effective antimicrobial products for these decontamination purposes.
You are reminded that this crisis exemption will be effective for up to fifteen days to commence on June 12, 2015, as requested, and will
expire on June 27, 2015. If additional time is anticipated for the need and utility of this pesticide beyond the expiration date, it is recommended
that you contact me well ahead of the expiration date, so that further discussions can ensue regarding an application for a public health emergency
exemption. As a matter of major Importance, you should also resubmit a revised/corrected version of your crisis exemption that includes a
signature from a designated person of authority in your state and that removes the additional active ingredients in paragraph one that you are
not requesting to use at this time for this particular crisis exemption situation.
In addition, in accordance with 40 CFR166.50, you should be aware that a brief summary of the results of the treatment under the crisis
exemption must be submitted to the agency (i.e., Ms. Tawanda Maignan, Emergency Response Team Leader) within 3 months from the last date of
treatment. However, if you have further questions, please do not hesitate to contact me at the number below, or Ms. Tawanda Maignan
(Emergency Response Team Leader) at (703) 308-8050.

Regards,

M. J. Johnson

hHM .11ml'tlI t"It'YY1l.,.

rt"'I'n

1mAIIII.tr'II?lII = ?R.11c=~1

Ft::w'HA"I,."",= nt.\n= t1..Jn'WA\I%?OAnth'AX &M= trlJAA.!U~A,r.tr-nuwv&th= 14df7d9A512cfc3d&.gj m 1=14df70Ae512dc3d

2IS

":.

1219t.!o15

Slate of Utah Mall. RE: Dugway Event Anthrax Utah Deper1ment ci AgrlculMellld

On Fri. Jun 12, 2015 at 4:01 PM.

Food

.> wrote:

Thank youl

Was there an attachment,

or just the forwarded

message?

From: Shelly Jensen [mailto:sbjensen@utah.gov]


Sent: Friday, June 12, 2015 3:58 PM
Subject: Fwd: Dugway Event Anthrax - Utah Department

of Agriculture

and Food

Per the attached you can move forward with the clean up. Using the EPA approved sodium hypochlorite.

See attachment from the EPA.

-Forwarded message -From: Johnson, Marlon <Johnson.Marion@epa.gov>


Date: Fri, Jun 12, 2015 at 1:45 PM
Subject: RE: Dugway Event Anthrax. Utah Department of Agriculture and Food
To: Shelly Jensen <sbjensen@utah.gov>, Scott Oldham <soidham@utah.gov>, Robert Hougaard <rhougaard@utah.gov>,
<cburgess@utah.gov>
httpsJ/mail.google.ccm/mail/l>'lY?ui=2&ik=68925163Od&vlew=pt&q=dugwey%2OSlthtax&qs=true&seerch=query&th=14df1dee512cfc3d&slm

1=14df1dee512cfc3d

.cburgess@utah.gov"

316

State of Utah Mall. RE: Dl.IJW9yEvent Anthrax. Utah Department of Agriculture and Food

121912015

CC: "Housenger, Jack" <Housenger.Jack@epa.gov>, "Lewis, Susan" <Lewis.Susan@epa.gov>, "Mclain, Jennifer" <Mclain.Jennifer@epa.gov>,
"Rosenblatt, Daniel" <Rosenblatt.Dan@epa.gov>, "Reaves, Elissa' <Reaves.Elissa@epa.gov>, 'Maignan, Tawanda"
<Maignan.Tawanda@epa.gov>, "Canzler, Erica' <Canzler.Erica@epa.gov>, 'Cruz, FranciscoJ' <Cruz.FranciscoJ@epa.gov>
Dear Ms. Jensen:

The Environmental Protection Agency (EPA)would like to quickly acknowledge and concur upon the crisis exemption request under the
provisions of section 18 of the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA)that was received from the Utah Department of
Agriculture and Food on June 12, 2015, for decontamination of described surfaces in laboratories that may have processed Bacillus anthracis
(anthrax). This crisis program will allow the use of the sole active ingredient sodium hypochlorite, as requested, to assist in ensuring that
responders have effective antimicrobial products for these decontamination purposes.
You are reminded that this crisis exemption will be effective for up to fifteen days to commence on June 12, 2015, as requested, and will
expire on June 27, 2015. If additional time is anticipated for the need and utility of this pesticide beyond the expiration date, it is recommended
that you contact me well ahead of the expiration date, so that further discussions can ensue regarding an application for a public health
emergency exemption. As a matter of major importance, you should also resubmit a revised/corrected version of your crisis exemption that
includes a signature from a designated person of authority in your state and that removes the additional active ingredients In paragraph one
that you are not requesting to use at this time for this particular crisis exemption situation.
In addition, in accordance with 40 CFR166.50, you should be aware that a brief summary of the results of the treatment under the crisis
exemption must be submitted to the agency (i.e., Ms. Tawanda Maignan, Emergency Response Team Leader) within 3 months from the last date
of treatment. However, if you have further questions, please do not hesitate to contact me at the number below, or Ms. Tawanda Maignan
(Emergency Response Team Leader) at (703) 308-8050.

Regards,

M. J. Johnson

Marion J.Johnson,Jr.
Chief,Minor Useand EmergencyResponseBranch
f 11iIOI?ul = 2AI k= 6A.QIl51 fi."iOr1&vlaw = ot&a= cLow AVo/.2OAnthrRX

httl"R .lIm;:lll_mooIA_cnnfm~1

&m= trlJA&sARrch=

OUA"V&th=

14df7dAA51 ?cfc..1riJtc;1 m 1=14df7d~

1?r.frA1t1

4Jl;

"

1219J:!015

Stateof UtahMall. RE:O_ay EventAnthrox.UtahOepartmentci AgricultureiV1dFood

U.S. Environmental Protection Agency


Office of Pesticide Programs
Registration Division
(703) 305-6788 (tel.)
(703) 308-0029 (fax)

johnson. marion@epa.gov
visit: http://www.epa.gov/pesticides

From: Shelly Jensen [mallto:sbjensen@utah.gov)


Sent: Friday, June 12, 2015 1:31 PM
To: Johnson, Marion; Scott Oldham; Robert Hougaard; cburgess@utah.gov
Subject: Dugway Event Anthrax. Utah Department of Agriculture and Food

Marion
Thank you for woriking so well with the changes that the lab here in Utah requested.

Please find two attachment

with our request.

I look forward to hearing from you.

Thank You
Shelly Jensen
Phone 801.538-7185
Fax

801-538-7189

htIps'1lmall.google.CQTl/m
a1l1l>'01?u1
=2&Ik=68925163Od&vleN=
pt&q=dugwayo/.2Omthrox&qs=truo&search=quory&th=
14df7de05
12clc3d&slm1=14df7de05
12c1c3d

516

121912015

State of Utah Mail. RE: DlIJ'VOY Event Anthrax - Utah Department of Agriculture end Food

."

Thank You
Shelly Jensen
Phone 801-538-7185
Fax

801-538-7189

Thank You
Shelly Jensen
Phone 801-538-7185
Fax

801-538-7189

2 attachments

.'!!)
~

State Crisis Declaration AnthrllJC_


91K

1.doc

RD.130B_Blosafety_Lab_Experlmental_Record_BSC

459K

Decon for Dugway recall_June 12 2015.doc

httnq .'Jm::til_OOrrJIA.mm/mAjI/LiOl?ul~:?&'jk=68Q25163Od&,,1~=ot&o=cLowRVo/~AX&os=trU9&search=Duerv&th=

14df7dee512cfc3d&siml=

14c1f7dee512cfc3d

616

.,.

condition

The Utah Department of Agriculture and Food hereby issues crisis exemptions under the
provisions of section 18 of the Federal Insecticide, Fungicide, and Rodenticide Act. The Utah
Department of Agriculture and Food is authorizing the use of multiple products containing the
following active ingredients: ethylene oxide. para formaldehyde, hydrogen peroxide, peracetic
acid, and sodium hypochlorite to inactivate Bacillus anthracis (anthrax) spores on interior and
exterior inanimate, non-food contact surfaces in laboratories that processed potentially viable
Bacillus anthracis sporc.containing samples originating from Dugway Proving Ground's Lot
'hese crisis quarantine exemptions will ensure that responders have effective
pesticide products for decontamination.
antimicrobial

The Utah Department of Agriculture and Food has determined that an emergency
exists and a crisis exemption is necessary. according to 40 CF.R
I66AO(b).

The public will not be permitted in areas undergoing


until the anthrax decontamination is complete.

Therefore, the Utah Department of Agriculture and Food, herby authorizes the use of Nil, I~n~
f1:tiJt!!,paffifeFHulltfel:lyde. h,SFegt!11 p~f~e.l-'lefE!:et'tie
aeid. aAd sodium hypochlorite to.mm
decontaminate;!tfle
felle jAg faeilitie5l3iological SafelY Cabinet (aSC) at (pfe, id~ Rilme aAa
lotlutien ereach laa ie ee at!t!SAttilfliAatt!a)Biotirc Diagnostics in Salt Lake City, UT. This crisis
program will be conducted under the following conditions:
I.

trealment or allowed to re-enter areas

2.

Wh~A fHlnig~tien is eemrlet~. air filtefing uml tt!sting \, iIIet: etJAd1:leteate eAsltre-lflttt
Ie, e15 sf the deeontal1'liAatieA eheAlieals remainiflg if! tl:le air aft: at aeeepta13le Ie ,.els rriof
Ie al!ewiflg f~ t:Alr:, By 1:lAJ3releetearefsefls.

Indirect vented goggles

'

..

~;;1~--..Deco~tarniiiatjori.Wo~ke~s.~~~.d~~ti~gdecontamfri~t'foii
'~~tI~ftf~sw"iii. wea;:j'ersonai. .. ..,_.....

Rubber or nilrile gloves.

Disposable

Protective Equipment (PPE). At a minimum, workers will wear the following La prevent
skin contact and inhalation of Bacillus anthracis spores:

NIOSfI-approved haJt~face elastomeric respirator with an appropriate cartridge or


a filtering facepiece respirator (e.g. N95)1

uncoated Tyvek@ (or similar) suit with integrated hood and booties

All PPE will be used in accordance with OSHA regulations found at 29 eFR 1910 Subpart
I (Personal Protective Equipment). Workers will receive training on and demonstrate an
understanding of when to use PPE; what PPE is necessary; how to properly put on. use.
take off, properly dispose of, and maintain PPE; and the limitations of PPE. Any reusable
PPE will be properly cleaned, decontaminated, and maintained after/between uses. Filter
cartridges will be discarded after use.

I Note that the use ofsporiddes and sterilizers may pose a chemical hazard. Therefore, appropriate PPE. including
elastomeric respirators with combination particulate/chemical cartridges, may be necessary to protect workers from
exposure to the chemicals in addition to Bacillus anrhraci~ spores. Disposable N95 respirators and certain cartridges
for e1astomeric respirators may be adversely affected by an increase in moisture and spray from certain work tasks.
This may include the cleaning and decontamination process when significant amounts of liquid sporicidcs and
sterilizers are used. In such instances. or during other tasks to improve worker comfort, a powered air purifying
respirator (PAPR) equipped with appropriate cartridges may be an alternative

fonnatted:~ta*r:~
formatted: Normal,Indent:Left:
line; 0"

0", first

-l.:J.

Page 2 of5
Respirator use will follow a complete respiratory protection program in accordance with
the OSIIA Respiratory Protection standard (29 erR 1910.134) and other requirements.
Stall wearing NIOSII~approved respirators will be medicallYMcicarcd, trained. and filtested for respirator USc. Detailed infonnation on respiratory protection programs,
including fit testing procedures. can be accessed at OSIIA's ~ir-J1Qry
Protection cloo!.

expires on Friday. June 26, 2015.

usc

Any additional PPE required for the use of the product as listed on the EPA registered
product label must be worn.
Applications will be made using the EPA registered products and decontamination
directions found in the tables I and 2 below.

The Crisis Exemption

;i,--l. Usc of the products will begin Friday. June 12,2015.


t->-;~_

-7,~ The EPA registered product label and this order will be in the possession of the user at the
time of application.

..

Page 3 of5

Tahles

l-ttntl-2

below

list the liquid

above.

precautions

Page 4 of5
unJ ~US!C!l:lt;lS./\'tiPtlf products.

and directions

--

EPA

---

Company

Use oran
registered
~rodllct

re.;petlli.

on the registered

el). which

labels

are

and the

of 8(1cillu.f (l1I/hraci.f
!iurfilCes ami items)

for Uc(..onlaminalion

---

. '-.

.-

yj!!~&.WI and water I: I :8. Bleach


should nol
be mixed directlY with acetic acid. but
rather diluted with water (add the one part

troducts with (525%-6%


sQ!-iium hypochloritc
should be diluted with S(Vi, <!.~ticacjd (white

Dircclions

for Inacli\':,lion

Sodium
hypochlorite
(5.25%-6%)

~!!g~~!Cl'!(~L
_

AClh'c

hartl, nonporous

Peslicides

specified

supported
by available safety and efficacy data and which may be used under the crisis
exemptions
declared.
The last column of these tables details the required directions
for
decontamination
use under these crisis exemptions.
Use of all products will be in accordance
listed

with all applicable


requirements
TABLE I.

CAS No.
7681 -52-9

EPA
I{cgislralion

Usc I>irections for Liquid Anlimicrobial


(,\nthrax) Spores -(/imi/eel/o pre-clel/llell.

I'roducl
~amc

!llllih

ble<lch to 5 parts water) then add the one


pal1 vinegar.
then bring to total volume (or
correct pH) with remaining
water :\1ea!Ourc
with IIl'1ch tC\llo a'mlrc nil = 7. Applv by
lXluring wiping or spraying
The minimum
contact time is I 0-60 minutes at 68F 2
Rcu[lplv as needed to kccp surface wet.
If the sodium hypochlorite cuncentration
in the
product is greater lhan 6% adjust the pH
accordingly to assure a 011=7.
llIeach products are not ellectiye on wood or
beavilv _SQiled :'iurfa~es.

2. Sources: (3) Unoublished


E1)A d:lla from orr Microbiology
Laboratorv. 2002 lb) EPA
(2006), "Technology Evaluation Report. Evaluation QfSprav.Annlicd
Sporicidal
Deconta_mination Technologies."
(c) EPA/60Q/R.Q6/146. EPA (2009) "Evaluation ofLiqujd
and Foam Technologies
for the Decontamination
of B anthrads and B. sliblilis Spores on
Building and Outdoor Materials"
EPAf600/R.091150
(d) "Lab Scak Assessmcnt 10 SUDJ){)rt
Remcdiation of Outdoor SurfaccWlltaminated
with Bacil/lls anlhracis spores" Calfee C'l al
(2011) Journal of Bioterrorism and I3iodcfcnsc (el "Systematic investigation ofliquid ami
fumigant decontamination
etlicacy against Biological agents deposited on test coupons of
Common indoor materials"" Ell N6QOfR- 11/076 (2011) (0 "EIJicacy of 1ig.Y.idspray
dccuntaminants
for inactivatiun of Bacillus anlhracis snores un building and outdoor materials"
W(lud et 31.(2011) Journal of Apnlied Microbiology

M
,

Formatted: Left: 1~,Right: l~, Top: O.8l


Bottom: 0.81", Width: as, Height: 11"

Formatted Table

ree),'

'-,
'0"

.-

::~-

Page 5 of5

II, aregefl ~ere.title Bile


peracetic IiciJ
P

......

'"",-

--{ Formatted:
Tab stopS: -OS, Left + 0", left
+ 1", left + 2", Left + 5.99", left

eShlaet time ef3g minutes at

Formatted:
i",left+

Formatted

Tab stops: -0.5", left + 0", left


2", left + S.99",Left

Table

Formatted:
Space Before: Opt, Mer: Opt,
Tab stops: -OS, Left + 0", Lett + i",left+
2", Left + 5.99", Left

Illinimuffl

te

ttfl6.tI.utea ~Fetlliel ffir a


~;

PP"

..,.

Rp e fi~ed-A-fl ti-IH-iff6-itift-l--P.estieifles----f6.t'-httlet iYftOOfl flf Eli eN/us


pN! ele.,,':red PiN"OIlS, (N' eomiJiHHlio>'l o/pOtmP.rdHd

.. -

-h\ lUX
fltb)
Use I)ireelians fer 6iquid-Anflfltie-robitti-Pestieides--f6i'-l-ttttetiYfltiml
of 8aeUIHHfnl-ltffleis
fAn.hfa",) Sll6Fes fliml."ed hJ JJi t' elf'tUlt'''', /ffll't/,fl(l}tphfOlI!J' su':ftnev (
"l ifem!ii)

ft Se6 u s/\'

""'8~
Yse-D iFee ti e ns fe r C
SJl(}FeS

(Um#ed.to
itt..
,f-S)

(n'h .,weis (Anthrax)


:Wltpth tHiS, ts"'rfhct!!J'.m..'

2. Seufees. (a) EPA Fegi~lefetllll\:lel for 8J'lef Klenz (lollM. 'i/llflfl-Gttl.ftle et til (2QII). 6a'" Seale AS.lt!S.lmeAt
H~peft Remetliatien efOultleef
Sl:lffaees CeutamillateEl with BaeiUl:ls 81lthfoeis Sl'leres. lemuel of
BieteFfefism lind RietlefenJe, 2 (3), 1 9. (e) HPA'6QQ1R IQIQ87 (2m-g) Biolegieal AgeAt geeentamiAIltitlll

IAnthnr/lnitiator

O;:OIOeol
Annroval,
_
Form Pu~se:

I Ucsoonsiblc

,I

Date
11/13/08

OA
I

Form RD.130B
Rev: 01
Dnle EITeclivo:: 11114'08

DIlle

other details, and results. Always

11113/08

Cui and place in notebook wilh date. specific protocols/dilutions,

i\1an8fJcr

Biosafety Lab ~xp"erimental Record

Date

11/13/08

N/A

N/A

',\' !'..,
711~1.;'i~.'J

\t

,II alll'I'A
~l!I,lo.:n:\l pn..Juu

'--.

"1\11\1111h\ p"l:hll 'nil.'


152~~rh".1

II,u.l,

~,,,,l ,.'~1.",_- ,. IO.f.1l

.,

II',,,,!,,, " ,\ "IL, - ...!~"


.. ,,", ~,JIlII" h:.l.
hl.
k .h"IIIJ
d ,I ,1",1 \\ ,Ih . '" .11, ,1,,11 \1 l"l\ \ 11I~I.'..11
I amJ I' _ll..' I. I .11
~ \rll'!\ h\ Il'IIUlllf:.
It",. 10,lI"'IlU' pll
"1.1""''''''''''11,

,1I'll

"I Ih. I' . tll,:1 I,

.1' ", .1.:,1'.' h',,!, .1;11,,_ "d

I 10,.luiuUIIlllll

h~p....:hl .",; ':"1\_, .,1.,1"'"

I,K I Kr'll'ph

'" "
~,,''l""~
'''r
l\llII"',,-,,~

It .h, ~."I."'ll

i, . ,'I' ".~,J 1'1 h,.," ,I> .,. d .d

111,'1111
;1,.,1,,~.,~ h' .,,~I"
1\I, .' ..111"' ,,1"l;I~ .t51:111,1dk';l

cr,';,II'1 'h.m h'o .. loli'I"

',llrao.:t .~.

,
,

. and is confidential.
is prohibited without written authorization.

.'

The Utah State Department of Agrigulture has applied and been approved for a FIFRA
crisis exemption for the use of EPA registered sodium hypochlorite products (CAS no.
7681-52-9) to perform spot decontamination of hard nonporous surfaces

Considering the source material, concentration and material handling procedures the
CDC/El' A guidance documents recommend the decontamination of the BSe. Therefore,
we will decontaminate the BSC whcre the sample was opened and processed in accordance
with the CDC/EPA Interim Decontanlination Recommendations.

While we do not believe we've had a contamination cvent because all our BSL2
procedures wcre followed without incident and there is no detectable Ba nucleic acid in the
laboratory, we will follow the CDC interim decontamination recommendations for
laboratories that opcncd and processed Ba spore samples from 000

On May 26, 20 IS Bacillus anthracis Spore Samples from 000


were
-manipulated in the BLS2 laboratory in a certified Biological Safety Cabinet (BSC) by
scientists wearing PI'E (double gloves, disposable lab jacket and booties). No spills or
other aerosol-gencrating events occurred. The CDC has analyzed a specimen from our
sample and believes it had low colony counts.

This is a site-spccific decontamination plan based on the "Interim Decontamination


Recommendations for Laboratories that Opened and Processed Bacillus anthracis Spore
Samples from 000
' provided by the CDC and EPA.

This is a generic form 10 usc for all biosafcty lab experiments.


include lot numbers and ex Iralion dates if a~nlicablc.

Purposc/Project:

Organism(s)
Dilution (Lot #
and cone.)and
Notes:
Sample Type/
Source and
Notes:
Prep Kits/
Components Lot
#'s and Notes:
~

('If

Decontamination ocrforrned on 6/12/15 by:

This document is pronprt-v


Reproduction or use outside of

."

Biosafety Lab Experimental Record


Other I Protocol I peR Setu Notes:

Anthrax

----~~--

S 4-'OS PM

Fonn RD-130B

Rev: 01
Dale Effective: 11/14108

You are reminded that this criSiSexemption will be effective for up tofJfteen days to commence on June 12. 2015. as requested, and wlllexp.re on June 27, 2015.
time ISantICIpated fortt1e need and utl/ltyofthlS pestlclde beyond the expiration date, It:15recommended
that you contact me well ahead of the expiration date. so that
diSC;USSlonscan ensue regarding an application for a public health emergency exemptIOn. A!.a matter of major ImportanCE', you should also resubmit a revised/conectl!'d
your crisis t'xt'mptiOtl that Indudt's a signature from a deslgnatf'd pl!rson of authority In vour state and thai removes the additional active Ingredients In paragraph one
not reques.tlnl to use at this time for this particular (rlsls exemption s.ituatlon.

If addItional
further
version of
that VOU are

The En..
ironm@ntatProtectionAgency(EPA)would
like to Quidt.1yacknowledge and concur upon the crisis exemption request undt>r thE>pro ..
isions of section 1801 tht!' fed@ra!
InsectiCide. fungicide, and Rodentldde AC1lflfRA)
that was received from the Utah Department of Agncvlture and Food on June 12. 2015. for decontamination
of described sUffices
If'llaboratorles that may have processed Bod/Ius onthrocts{anthrax).
this aisls program will allow the use of the sole active Ingredient sodium hypochlorneo, as requested. to assist In
ensuring that responderl have effectllle antlmlaoblal products for these demntamlnatlon
purposes.

----

ShellyJensen<sbjensen@utah.gov>

Frl6.121201

FIFRA Crisis Exemption to lise bleach for disinfection:

J. Joh",on,

Jr

Regards,

for Laboratories

M. J. Johnson

Recommendations

of Biological Safety Cabinets

Bacillus

llfltlrracis

Spore S~lmplcs

spores from Lot AGD0001667

that Opened and Processed

In addition, In accordance with 40 CFR 166.50, you should be aware that a brief summary of the results of the treatment
under the crisIS exemption must be submttted to the
agency (I.e., Ms. Tawanda Malgnan, Emergency Response Team luder)
within 3 months from thl' last datI' of treatment.
However, If vou haVE"further questions, pll'ase do not
hesitate to contact me at the number below, or Ms. rawanda Maignan (Emergency Response Team leader) at (703)308-0050.

Mlrlon

Interim Decontamination
from DoD

Decontamination

Laboratories that performed work with samples containing Bacillus anthracis

Treat porous materials that were inside the sse during the sample opening or processing as waste or

previously described procedures.

Decontaminate the inside of sse where the sample was opened and processed in accordance with the

inside a biological safety cabinet (SSe) should use these recommendations:

and is confidentiaL
prohibited without written authorization.

sterilize them using appropriate procedures before re-use. Porous materials include laboratory
notebooks, papers and laboratory supplies.1

This documen t is proof'....


' .
(
Reproduction or use outside of

Biosafety Lab Experimental

is pron"'rtv of)

Record

and is confidential.
is prohibited without written authodzatioll.

Date

Rev:

01

Fonn RD-130B
Dale EITtive: 11/14/08

sse SIN 05740573 spot decontamination:

Preliminary Notes: No porous material were in the sse. Waste container was previously managed as biological
waste.

Prepare bleach solution: (50 mL bleach + 50 mL water + 50 mL white vinegar) + 400 mL water. pH with
calibrated pH meter. pH = 7
SSL room temperature =
Wipe down sse and contents with water
Apply bleach solution to sse and contents
Wait 15 minutes, reapplying bleach solution as needed to keep surface wet
Wipe sse and contents dry
Wipe sse and contents down with water

Signature

This document

Reproduction or use outside of

Date shipped

Order/MIPR#

Locality

Civ (C)/

Shipped to

Mil (M)

UT

11-Mar-13

AGDs/Lot#

Strain

1151

Ames

1331

mes (ve!

1331

mes (ve!

822

BAOO18

858

BA1015

862

BA1035

576

elta Sterr

950

K3

I _,, __

11-Mar-13

UT

18-Dec-12

UT

~
11-Mar-13

UT

,
,

f"""

11-Mar-13

UT

"

-:.

"

-' -,

r
,

,{. U

.,

"~-r-"-"

,
I

,...

.
11-Mar-13

UT

! '

....

UT

- -

..

,.
,

----

,
18-Dec-12

,
..... ~ - .....

"

iI'

;"

--

'

......... "..,.
.

",'

"

-- -' .. ,
. ....
-- .:.

'--'

.. ,'

,'---,

'~

',',-

',"

..-.
11-Mar-13

UT

r-"---'_~
L

-r~, __

-1!'

._-

, :/4:..,
' ___ .;u;....~~.

-- ,

: ,_

. .1

,
1l.Mar-13

UT

- - - ...

UT

ll-Mar-13

ll-Mar-13

UT

- .

...

..

... -

1039

Ohio

774

PAK-1

1035

Pasteur

1451

steur (ve

778

RA3

1335

Sterne

954

urkey #3:

830

770-NPlI

1435

0-NP1R {\

....

..

_. .
.

ll-Mar-13

UT

..
ll-Mar-13

UT

-..

.-

~
ll-Mar-13

UT

C
.-

ll-Mar-13

UT

.
.

.. -' --..

'

.. -

UT

,
1:.

...
"

.
.",',

"

' I

..-

i -:
,

ll-Mar-13

'.

,
UT

.. -

-, ~'"

~
ll-Mar-13

_.

,
"
,"'

:j

, -

'.

-,

..
11-Mar-13

UT

.-

-.

-.

C
~

UT

l-Apr-13

648

1331

...

UT

29-May-13

29-May-13

5-May-15

UT

UT

.-

,
.

,~

<
~"

;_

- ...

-'

UT

5-May-15

...

..

UT

5-May-15

11-0ct-05

..

UT

UT

UT

~.

.'

- ...

..

,.

'~l:\.
!':Is

.' .' . .

.1.

'.

, ,

.-.

,'

..

..

..

,,

-f-'
-

..

29.Nov-05

It

'-

...

,J

mes (veE

C
;

Vollum 1

1151

Ames

1331

mes (ve!

1667

Ames

1035

Pasteur

830

770-NP-l

515

Ames Ve,

32504

Ames

999

Ames

,
14-Apr-Q9

'

..

12-Jan-09

UT

27-May-09

UT

4-May-09

UT

27-May-09

UT

4-May-09

UT

UT

UT

..

12-Jan-09

'

O'

..

...

--

31-Jan-06

UT

OApr09Crud

Ames

JApr09Wash

Ames

..

Apr09Wash

Ames

515

mes (Ve

515

mes (ve~

- ..

--

-.

"

-~

~--- -

-'-,,-

- ..
,
.- -

Ames

- ... .

, .- . -

.0

UT

OApr09Crud

..

..
23-May-12

Ames

. .

14-Apr-09

999

'r' .~~ i

i_-.J

~
-

.4

...

1151

...::1
I

69

Tles Spar

515

Ames Vel

I.
31-Jan-06

UT

.,

'0

UT

8-Nov-11

1-0et-07

UT

1-0et-07

UT

UT

.'
-

..

_ ..- . --

mes (veg

1151

Ames

910

Ames

515

Ames

1151

Ames

515

Ames veg

,.

r !

_ ...- ..._----.
_.

UT

~-. -"---

1331

0'

-.--'

--,

17-Nov-09

.,<
,

17-Nov-09

- ,.

..

.1

~
,

..

.I".

17-Nov-09

UT

23-Mar-06

UT

'

.-

"

Nollisted

A Vollum

....

z
--i

....
a

....

....

z
--i

....

-<

-<

....

-<

....

-<

....

--i

-0

'"~
::T
0

"":J
'"
n
'<
--.
0

'"

0
~

e:

'"
..c"

'<
--. c.
--. '"

C.

::T

~ '"
~
'"'" z '" 0~
""
n
--i ~
'
"
~

'"
E:;
z
'"
~

.c
~

..o

l1Il
1tI

ID
.-t
,
ID

o
Cll

1tI tn

:J

Cll

III

~.-t
0.0

Cll

tJ
Cll

Cll

a:l ~>

f-

...

...

...

f-

...

f-

f-

f-

Z
Z

f-

f-

f-

...
...

...

...

...

!!'

00

_.

-<

-<

-<

...

...

...

'"

...

-<

-<

...

-<

...

-<

...

-<

...

...
-<

Z
Z

...

>-

...

>-

>-

...

>-

>-

...

>-

...

>-

...

...

>-

>-

>-

0
...

IV

z
-l

-<

...

-<

...

-<

'"

'"

-<

IV

-<

...

-<

...

-<

. 1219/20;5

State of Utah Mall- RE; Ocq,vay Event Anthrax Utah Department c( Agriculture !rod Food

Allyn Nakashima <anakashlma@utah.gov>

RE: Dugway Event Anthrax.

Utah Department of Agriculture and Food

1 message

.-

Mon, Jun 15, 2015 at 11:34 AM

To: Shelly Jensen <sbjensen@utah.gov>


Cc: Allyn Nakashima <anakashima@utah.gov>,

Resending attachment.

I originally attached the draft summary of treatment instead of the scanned/signed copy.

Sorry for the confusion I

From: Cheryl Baird


Sent: Monday, June 15, 2015 9:38 AM
To: 'Shelly Jensen'
Cc: 'Allyn Nakashima';
. _".',' __..
Subject: RE:Dugway Event Anthrax. Utah Department of Agriculture and Food

Hi Shelly,
I noticed the EPAwants a revised crisis exemption that removes the active ingredients we did not use. For your convenience, attached is a draft
httpsJlmail.googlo.canJmell/u'lll7ul=2&Ik=68925163Od&vlow=pl&q=c1.gway%2OalttYax&qs=true&soorch=quory&tlF14df8494b3593151&51

m 1=1_4

94b3593 151

1fT

121912015

State of Utah Mall-

RE: Dug,vey

Event Anthrax.

Utah Department

of Agriculture

end Food

that is specific to our situation.

Also attached is a brief summary of the treatment for submission to the Emergency Response Team Leader.

Thanks for your help.

From: Shelly Jensen [mailto:sbjensen@ulah.gov]


Sent: Friday, June 12, 20154:03 PM
To:
Subject: Re: Dugway Event Anthrax - Utah Department of Agriculture and Food

I forwarded his emai. I am leaving for the day, so I just copied to this email to be safe.

Dear Ms. Jensen:

The Environmental Protection Agency (EPA) would like to quickly acknowledge and concur upon the crisis exemption request under the
provisions of section 18 of the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA)that was received from the Utah Department of
Agriculture and Food on June 12, 2015, for decontamination of described surfaces in laboratories that may have processed Bacillus
anthracis(anthrax).
This crisis program will allow the use of the sole active ingredient sodium hypochlorite, as requested, to assist in ensuring that
responders have effective antimicrobial products for these decontamination purposes.
httos:l/mel'.QOOQle.com/m

ell/u'1lI?u1 =2&lk= 689251 630d&vlew=

Ol&c= ci.owev%2OentI1r

ax&as= lrue&search=

auerv&th=

14d1ll494b3593151

&51m 1=14d1ll494b35931 51

2n

1219i2015

Stat. of Utah Mail- RE: Dug,vey Event Anthrax - Utah Department ri ~rlcultur.

and Food

You are reminded that this crisis exemption will be effective for up to fifteen days to commence on June 12, 2015, as requested, and will
expire on June 27, 2015. If additional time is anticipated for the need and utility of this pesticide beyond the expiration date, It is recommended
that you contact me well ahead of the expiration date, so that further discussions can ensue regarding an application for a public health emergency
exemption. As a matter of major Importance, you should also resubmit a revised/corrected
version of your crisis exemption that Includes a
signature from a designated person of authority In your state and that removes the additional active Ingredients In paragraph one that you are
not requesting to use at this time for this particular crisis exemption situation.
In addition, in accordance with 40 CFR 166.50, you should be aware that a brief summary of the results of the treatment under the crisis
exemption must be submitted to the agency (i.e., Ms. Tawanda Maignan, Emergency Response Team Leader) within 3 months from the last date of
treatment.
However, if you have further questions, please do not hesitate to contact me at the number below, or Ms. Tawanda Maignan
(Emergency Response Team Leader) at (703) 308-8050.

Regards,

M. J. Johnson

On Fri, Jun 12.2015 at 4:01 PM,

~.-_ .. -

_ .._ .

./ "'-

_ ..

Thank youl

Was there an attachment,

or just the forwarded

message?

hllps JlmaH .googte.com/m all/l>'G'7UI=2&1k=689251 B:lOd&vlew= pI&q= c1Jgwll}'%2Olnl1rax&qs= lrue&searc:h= qyery&th= 14d11l49403593151&slm 1=14d11l49403593151

317

",

1-

Biosafety lab Experimental Record


- - ... -. __ .. _-. -.Protocol ~~pprmah

"

..\ III hllrlln i ri,lllII-

h~
m I"uI'POW":
Thi, i, ,I :-'~'h . il. li'l'" I,'

Ii

---

nail-

IJ".'

,'Ill

t{"'I'IlIl",ihlt' 'llI.!!."g~'r

3-- -

.Iff hl" .I~,"1\Llh '"\f'\'llllldll'

'11'1'1. 1;"0

I:,"

0.\

U"h:

11
..1.' I 'h"",'

I~.uh'

II 11111<0

(III illld 1~1;l':\'illl,,,,d"~,,,~ ','111.


,1.11, '1'lt.".:JfI,' pi '!". "I. d,h'Tl,'lh

I '

----

,'lh,'1 d.':.lil". ;Ill.ll~"\":,

\1\\,1'

I "), ill,'" I". Ullin!>" ~ .1'1:1 "1,'11 .il"'/! " lk' II "I'l'.l! . ll>~\:
PllrpO~C Pru.k"."l:
This i~.1 ~ill'-"'I~l.:ith:
dCl'Olltamillalioll
plan hased on the "Interim Dcnlnt.
tlninatiutl
I
Rl.'~Plmnclldalions
tIll" l.ahnratoric::-i that 0pl.'lH.'d
and Pnll...'cs:-'t..'d /lucll/us Cll1lhJ"(/('is
Sp\\rc

Saml'''''

li'"m DoD L(lt

prm id~d h~ th~ CJ)(' and 1'.1':\.

On \bv ~(). 201 ~ Hacil/lls (l1II/,mels SpIII'e Sampks from D,.I) Lot
~ \\~rc
nwnipuiat,"d in th~ IlLS~ lahllfator) in a c~rtilied Biol"gi~al Safety Cahin~t IBSC) hy
scic"nti,ts \\~aring I'I'E (douhl~ glolcs. disposahle lah .1a,'kct and hO(lti~s), t\o spilb or
plher at...ro~\lI-gC'ncrating events occurred. Th~ CDC has analY"'lcd a spc..:im~1l fr(lln our
sampll' and hdi~\ l'S it had low ~olonL,ounts.
\\ hi k" \\ c d" not hc-Ii,"\'l"\\'~ 'Il' had a ,'onlaJllnlal;lln 1'1 c"nt hccmlS," all our IlS L~
pr,,~~dure, \\~I'C t"lh'll'~d with,'ut incident and there is no ddcctahk
Ba nuckie add in th~
lah,'rator). \\~ will li)lIow the CDC interil11 de~(\ntamination
recommendations
lior
lahorah)ri~, that "pcned and pnl("~,,~d Ila spore samples Irom DllD I.llt
l."tllll'l'lItri.ltiull and tnalt.'rial
handling prncedures the..'
r~c'<lI11l11cndthe de~Onlal11inati,lIl "rth~ RSC. Therd,'r,,,
\\ e \\ ill dl'l"llntaminat~ lh~ BSC \\'her~ Ih~ sample was "pcneu and pnlCessed in aC~llrdancc
wilh th~ CDC EPA Interim D~eontal11inati,lll Re~(lnlJllendati"lls.

('ullsid .'ring thl..'SOUI('\.'

tnatcrial.

CDC I'I'A gllidan~~ uocum~nts

The l'l:dl Statc Ikpal1m~nt "f/\gngllllllJT


has appli~d and h~~Jl apprO\~d li.'r a FIFR/\
cri,i, '"\l'mpti'lJ1 IiJr th~ us~ of EPA regIStered souium hypo~h")rite prodUds (CAS no,
7(,XI-S~-<)II"
p~rf(lnn SPilt dcc(Jnt:nnination of hard Ih)np"n'us surl:lces

Organism(s)

~,
K \

Di!lllifHl tl (\{ ".


mJ n'lle)

and

~n(cs:
--_.~~

: Sample Typ~
, Sourc~ and
t\olcs:

"\
..

Pr~p Kils!
lOl11p"nems 1."t
~ It"s nnd Notc~.

1,11","-11

rI

I
\'"

"!\

'"

"1. ,_",

I ..,

~f' I

I' \

I . r~.,;,..
1 I

~."

h, ..,
,

".,III

I.t<~I'

".".

,.11

,,1 "II' 'I p,~I,lo


.. '
I,.f

011 (),

1""1" .. '"

.,11

I~' I) hy:
'.

I hl~
h"'pn

.hJflIOllttl

rip,

!l111(,1L1IS

11'ol' "lIl~Jdt

pi tJlw,
"f

1\ fll

".,,'

JIi

1\ h, P'"

PW

"- ~',

p('rf')J"Jn~d

I" .,1,11.

11/ 1

'1- _I.'; l<I .1",11

D'"C"lllamillatioll

I,

I ""

~,
"prulllhlll'd

' I-lnd l'i I 11l)III1cul1al


\\1lhIl1);

1\",1111'11 ,-'IlIIH,!

1/<-111"11

I"

"'!

.'r

Other i Pro'ocol

Biosafety Lab Experimental Record


/ peR Setup :'-Joles:

FIFI{A, Criltiis .:\t"mpliull 10 1I~1'blt'lIclt for disillfeclion:

J.,nlhroll(

fortt\.n
dt'cont."'Ill'lall(ll"l

purpmrs.

1""11 Kj}-1.1UII
K,;\ (II
1t-lrl-n~,"1.\t,;;11 IHno

n,f' [nvlronflWntltl
Pmllnflfll"l A.i"ncv I[PAI would hlo:
tn ~ll,,*"" ;ulr:no .
'*d.".0(1 to"lCUI upon th. tnll\ ""'rfitln ,qll",t "'!'Ill"" tn" pro .
lilOn of WI:!'INl ,. of ltv hd~
tt',H'etlCl(i", h,;"'C1d~ nd RodtnltCJdf Act lFiFRA} '''It wu t'f.tf'II/f'd fromt'- Ulan O,p'l"tInI!nl 0' AlrJO.;!tl.lf.and Food on Juflt 12. 201!t. for df!tonllll"linlitiOn oi dncrlbu """aa~
In ~bof;lto'It'S lhat m.y "III. prO(II!5Sl!dBoclttoJJontrJraCls(anthraxl. 1hiS(I'lSKpropm
\vlIlalloVllh. U~ 0' th. wi. aetl\lt Ingr.(lIlPnt s()(llumhypoctllortte,'s
r@questtd.tO.lUl3t1rl

1t"'I,;'''''1Ihat~spon~rs "'.
I! .fl."I\,I. 1r'lllmiaobialproductt

0'

You '(11' rrmil'ld .d t!l4tt thiS ens" "umptlOn will bl' H"CfI"" tOf '"P tofl~."l c:I.~to c.omITI'!nCl' DnJunl' 12. 2OIS.IS r.Q"nt.d.
and wlll pif. 01'\J"ne 27.1015. If IOdUoI'\.al
1.me IS ilIntlt/p<llell
for the J'lel!'OIJ'lt1u1ltltv (II thi~ pp,tldde beyond ~
e_plnttlCn "I~e. It 11reconf"lIPndeCl thet you Contllct m. WIPIIAh .ad 0' the IPlI:plriitlon datII', 50 that further
c:l!St\oSSlonscan eMue rl'lilardlnSlin 8pplitation for a p\.ob1ichealthe"'K!flll!nCYIP'1ll'mption.
A.~I matt.,
major lnlportanrf', you ,houlc:l also fl!.ubn'!1 a ,rnwd/ronIMtPCl"""Wo1'
of
'fOur crl" mplion til.' 1m 'ud,., I IJsnlhl~ trorn" dt>,ipar d p.nan of lIuthority In your ltllt. ,,"d thillt,.n~,
lh Addltlon,,1 aeti".lnenodl nt\ in par3glaflh on th.lf you If!!
not f'l!qUt',tinIID u"," ~ ttll, tin, . for this pllrtltulM crisl nlptiDn ,ittYtlon.

..

of Biological

Safety Cabinets

Il t'OIllIllt.'ndaliolis for Lahul-a.uric, IhaC OpcJll'd lind Pn){'e!li!lot.'d/JudJlu,\ alllhrud.~ Spore S8I1lplt."s

In additIon, In ac.eordlt'\Cl' .
ith40 CFR.:.66.:;o. you shoold tw awe that I bntf WrTlmlrr of the rt'5ults of tht> Irl'Mmenl Lmcierthf! crl~'SelCerlptlOfl must be ,,,,bmlt1t'd totl".e
aRE'nry [I.. Ms_ Ta..
ano. VIlgnaR. E~riency
Q.sponsp Tl!amlPlt1erl wIthin 31'1'\orothsfromthp 13, dale oftru1m.nt.
Howe",pr. It' V[ll! hl''''l! fLrthpr qtltstlOf'ls. ple.se aD not
htomat. to conlan ~ at tM "lImber belo .
or M$..Tlo'l.nd. Maigl'lltn (Emert:ency Il.etpon,e Team l der) 1\ lllL1J J{ti fI(Nl.

Il1lerim O('conlalllina'itllt

from !loll Lot

Decontamination

Decontaminate the inside of BSCwhere the sample was opened and processed in accordance with th~ ,\, \,:;;:.
previously described procedures. k S"L. +\' "I'\;\~"/('_,.I",u..J. wt ""
,) \,J,-{...,'I4)-C..h..c" I\\''>I{''

spores from Lot

fJ

al.lthori7 .f11ioll.

is ('onHdelllia1.
n \\'11h01l1 writh'1l

HIIlI

Treat porous materials that were inside the BSCduring the sample opening or processing as waste or
sterilize them using appropriate procedures before re-use. Porous materials include laboratory
notebooks. papers and laboratory supplies J.;- ,1/.(>..

Laboratories that performed work with samples containing Bacil/us anthracis


inside a biological safety cabinet (BSe) should use these recommendations:

-TlUfi dtJ<'unwlll is prOperlY uf ...


RqHodul'ticm or use outsidt' of . '

~r---.---

_..
_-

Biosafety lab Experimental


sse SIN 05740573 spot decontamination:

,\Z- \7

..,/ll.

Record

prohibited

r-

III

l11n

1411~

J.'

I '\llU 1<1

1);)1.: !-Ik,'li\,'.11

Jl ~'\

_.- --=l

lnd is confidential.
without \\Tit1("ll HUlhonzation.

~;?.2//y-

Date
................~

(;/I;/,--:-

Preliminary Notes: No porous material were in the BSe. Waste container was previously managed as biological
waste.

~
"').

/~

I\-H~MIW~

Prepare bleach solution: (50 mL bleach + 50 mL water + 50 mL white vinegar) + 400 mL water. pH with
calibrated pH meter. pH = 7.08
\
BSL room temperature = 7;;;>""
\0
Wipe down sse and contents with water
)6
Apply bl'1ilM.~llo0luliOnto sse and contents
WaiL1.8"rtli'n'l:lle,f. reapplying bleach solution as needed to keep surface wet
Wipe BSe and contents dry
Wipe BSe and contents down with water

Signatlih._'

,
I

This (!Iwum('nt 1~prmWfl\' nf

Reproduction or mw outside 01

"

.:

"

.....

.,

Statea UIllh Mall- 8M: Nalficatlon R__ dlngUT lBbaatory

1219<~15

Allyn Nakashima <anakashlma@ulah.gov>

SM: Notification Regarding UT Laboratory


1 message
Wei Hou <whou@uteh.gov>
To;
Cc: Rooyn Atkinson <rmatKlnson@utah.gov>, Melissa Dimond <melissastevens@utah.gov>,

Tue, Jun 16, 2015 at 1:55 PM


Allyn Nakashima <anakashlma@utah.gov>

Good afternoon '


I hope this email finds you well!
We were Just notified that DoD Is performing a second round of sample testing, during which viable spores were detected In a new lot that was previously listed as NT. Please see
below for more information about this lot (also highlighted In yellow In the spreadsheet attached):
Date shipped: 11-Mar.13
Oroer/MIPR#: .
AGDsILot#:
So, it would be great if you could complete the attached CDC questionnaire regaroing this particular lot. I believe they are looking for answers to the general questions on page 1, and
risk assessment of workers on page 2 (oOly If samples from !hIs cartlcular lot was used wjthin the cast 60 days " and questions about cleaning on page 3.
Please let us know if you have any questions.
And THANK YOU SO MUCH for your assistance!!
Thanks.
WalHou

801.538-6261

On Tue, Jun 16, 2015 at 11:57 AM, Allyn Nakashima <anakashlma@utah.gov> wrote:
HiWal,
Can you please followup on this and see If wa need to do anything?
Thanks,
Allyn
Allyn Nakashima. MD
State Epidemiologist
Utah Department of Health
Begin forwaroed message:
From: CDC IMS DoD INY Med Care and Countermeasures <eocmcctfops@cdc.gov>
Date: June 16, 2015 at 1:52:51 PM EDT
httosJlmall.aooale.com/m
a1llti01'1ul
=2&lk=68925163Qd&vlew=
pt&q=cl..9Way%2Oanthrax&qs=
true&saarch=query&t!F'14dfdf14a8327be5&sim
1=14dfdf14a8327be5

114

121912015

Stateof Ulah Mall. 8M: NctlficationR__ dl,...UT I..atuatory


To: "Nakashima. Allyn (CDC utah.gov)" <anakashima@utah.gov>
Cc: CDC IMS DoD INY Med Care and Count.rm.asures <.ocmcctfoPS@cdc.gov>. "CDC IMS DoD INY EpllLab" <eoc.v.nt105@cdc.gov>.
Envlronm.ntal H.a1th' <eoc.nvlron@cdc.gov>. "OSAT Controll.r (CDC)" <eoc.v.nt28@cdc.gov>
SubJect: NoUncatlon Regarding lIT Laboratory

Stat. P.rtn.rs

"CDC IMS DoD INV

In Utah (Dr. N.k.shlm.).

000 is doing a second round of t.sting on sampl.s at Dugway that us.s a more s.nsitiv. protocol that allows th.m to d.tect vl.bl. spores land takes long.r to
perform]. Based on this t.stlng. th.y h.v. v.ry rec.ntly informed us of anoth.r nonmilit.ry laboratory In your stat. that has rec.ived a lot of B.clllus .nthrecls th.t
m.y be Incompl.tely inactivated. W. b.li.v. the nsk to workers who may have rec.ntly used th.s. sampl.s outside the confin.s of a biosal.ty cabin.t to be v.ry low.
but not zero. In respons. to this fluid situation. we are changing our process.
" Th. Departm.nt of Def.ns.
laboraton.s

(DoD) is notifying these laborelor1.s direclly that th.y have rec.ived lh.s.

sampl.s. Th.y are performing nsk ass.ssm.nts

lor military

" Th. Cant.", for Dls.as. Control and Prev.ntion (CDC) Division of S.I.ct Ag.nts and Toxins (DSAT) has already contact.d all of th.s.laboratones
to discuss the
dlspos~lon of "hot" and "not hot" lots. Dunng th.lr calls. th.y ass.ssed last us. date for known "hot" lots. Sine. this n.w lot was not known to be "hot" at that tim e
last use date - with Its Implications for worker safety and decon - was not elicited for this shipment/strain.
" As DoD tells us of new lots that are growing Bacillus anthracls. state and local health departments are again being asked to assess heanh nsk in Iaborator1.s that
have used any of th. newIIy Implicated lots In th.last two months (I.. 60 days). There Is no redundancy - as these laborator1es will not be called by DSAT for this

issue.

Oat. shipped
oro.rIMIPR#
Locality
Shipped to
AGDsILot#
Strain
# of aliquots
B. growth DoD second check

11-Mar-13

hltosJlmall.ooool.comlmallllM'lY1uI=2&1k=68925163Od&vlew=OI&o=d.owav%2Oanthrex&as=true&saarch=0UQ'V&1h=
14dfdf14a8327ba5&slml=
14dfdf14a8327be5

214

Stateof UtahMall- SM: NolIflcatial Rega-dlngUT ~atory

". " 1219J:2015

We have ettached a Mef risk assessment tool that you can use to assass human risk and decontamination Issues for the laboratory. These data are relevant to public
health Interventions that may be needed and for state and federal situational awareness. It has three parts:

general Information about the shipment


a risk assessment that should be usad for anyona who worked with/around the implicated 10Usin the last 60 days (this page can ba copied for multi pia workers)
decontamination quastions If the sample was used slnca June 1, 2014

Please send your risk assessment for this lot (attach the form please) to aoceventl05@cdc.gov<mailto:aoceventl05@cdc.gov>:
cdc.govaocmcctfops@cdc.gov>; aocenvlron@cdc.gov<mellto:eocenvlron@cdc.gov>

aocmcctfops@cdc.gov<mailto:

Kate
Hendricks, MD, MPH&TM
Medical Officer
Bacterial Spacial Pathogens Branch
Division of High Consequence Pathogens and Pathology
Centers for Disease Control and Prevention
1600 Clifton Road, MS A-30
Atlanta, GA 30329-4027
Office: 404.639.3153
Fax: 404.315.2488
emali: kahl@cdc.gov<mallto:kahl@cdc.gov>
EOC: 770.488.7100
<Initial Notification Ltr State V2_2015 08 08b.docx>

IMPORTANT MESSAGE _ __
This message, Including any attachments, may contain confidential Information Intended for a spaclfic Individual and purpose, and Is protected by law. If you are not the Intended
recipient, delete this message, Including from trash, and notify me by telephone or email.
If you are not the intended recipient, any distribution or copying of this message, or the taking of any action based on its content Is strictly prohibited.

...IMPORTANT MESSAGE
This massage, including any attachments, may contain confidential information Intended for a spacific individual and purpose, and is protected by law. If you are not the intended
recipient, delete this message, Including from trash, and notify me by talephone or email.
If you are not the Intended recipient, any distribution or copying of this message, or the taking of any action based on Its content Is strictly prohibited.
2 attachments
"!D

Initial Notification Ltr State V3_2015 08 18 (1),docx


21K

@ 15K

DugwaySpeclmensRecalved,11June2015

(2),xlsx

hllpsJlmall.google.com/malllulOl?ul=2&lk=68925163Od&vlew=
pt&q=dugway%2Oanthrex&qs=true&search=query&lh=
14dfdf14a8327be5&siml=
14dfdf14a8327be5

3/4

121912015

httl"J!ll'lfmAII.onnnIA.cnmfm;tIIAiO/?uI=2&lk=

State of Utah Mall. 8M: NolI!calon Raga-ding UT L.atxratory

6AA25163Od&vlew=ot&a=liJowavo/

2ORnthrex&os=true&sMrch=ouerv&lh=

14dfctf14a8327be5&.slml=

14dfdf1488327be5

414

. ..

Date shipped

Order/MIPR#

Locality

ll-Mar-13

11-Mar-13

-----~-

Civ (C)/

Shipped to

Mil (M)

UT

UT

,,

,
18-Dec-12

11-Mar-13

11-Mar-13

UT

UT

UT

rr

UT

Strain

11S1

Ames

1331

mes (ve!

1331

mes (ve!

822

BAOO18

858

BAlO15

862

BA1035

576

elta Ster

11-Mar-13

AGDs/Lot#

....

-'.

..~

,
18-Dec-12

--

UT

- -.

.
11-Mar-13

UT

- --

..-

950

- .-

K3

,
UT

Il-Mar-13

_.-

..

_"

-_.~-_ ..

'"

1039

Ohio

774

PAK-1

1035

Pasteur

1451

steur (ve

778

RA3

1335

Sterne

954

urkey #3:

830

770.NPlI

1435

0-NP1R (\

..

Il-Mar-13

--

UT

- ._-_

...

--

---

__ .............

..._--,

..
Il-Mar-l3

UT

Il-Mar.l3

UT

ll-Mar-13

UT

Il-Mar-13

UT

-_ __ ...
...

.'

..

I-

ll-Mar-13

UT

,
..

e'

ll-Mar-13

UT

..

--

C
..

Il-Mar-13

UT

,~

..
I

VT

l1-Mar-13

. - -- . -

648

Wollum 1

VT

1-Apr-13

VT

29-May-13

. --

_ ... _ ..

,
VT

5-May-15

VT

VT

1151

Ames

1331

mes (vel

1667

Ames

1035

Pasteur

830

770-NP-1

515

lAmes Vel

32504

Ames

999

Ames

"'.

_ -,

_._1""

...

, . "". , ..

5-May-15

mes (vel

I
29-May-13

1331

..

,,

'"

--

- ---+ -_ __ ...

",..

---

_.

~_:

..

C
:

5-May-15

VT

29-Nov-05

VT

11-0ct-05

VT

14-Apr-09

VT

___

__

___

___

'

_.,

."

._

- .-

... _.

"

-'

.,

.-

12-Jan-09

UT

27-May-09

UT

4-May-09

UT

27-May-09

UT

4-May-D9

UT

UT

UT

.. ,"

..

_.-

999

Ames

OApr09Crud

Ames

OApr09Crud

Ames

OApr09WashE

Ames

OApr09Wash

Ames

_.

"

- - .. _.._--

. -r}--'~--"-

,.-_ ..

__

-"r_

.. -

..

-.
-

14-Apr-09

-.'

-.

...

- ..

..

515

mes (Ve!

515

mes (ve

.12-Jan-09

-- ..

UT

23-May-12

31-Jan-06

[.

UT

- -

I
X

,I

- ..

I
31-Jan-06

UT

..

1151

..

t~ 69

nes Spor

515

Ames Ve,

_.,

_.

-'. - --

.
I

--

8-Nov-11

UT

... -

.....

1331

mes (vel

1151

Ames

910

Ames

515

Ames

1151

Ames

515

Ames vel

Not listed

AVolium

..

UT

17-Nov-09

.-

...- -~,
1-0ct-07

UT

1-0ct-07

17-Nov-09

UT

UT

C-

..,

-.

.:~

':II

aooaI

__ -0

...

__

".

..
C

..

17-Nov-09

UT

I
23-Mar-06

UT

- -

..

Z
--i

..

..

..

Z
--i

..

-<

-<

..

-<

..

-<

..

--i

III
III

0-

."

-.,
::T
0

;=;'

""III
:J

--

'<
~

.,

.5'
0:

0-

III

0-

III

Z III
--i n

Z
0

::T

~
""0

'-"
'< .,
-- '"
-'" -- -- -

.c

...

3o

tl.O
l'll

a:l

I--

ID

,
o

ID

"0
l'll

It\

CIl
...

:J

"0
0.0

....

....

I--

....

I--

....

I--

....

I--

....

I--

....

I--

....

I--

....

z
0;;
~

_.

...

-<

...

-<

IV

-<

--i

'"

...

IV

-<

IV

-<

...

-<

z
--i

z
--i

...

-<

...

-<

...

-<

>-

.-<

>-

>-

.-<

>-

>-

.-<

>-

.-<

>-

.-<

>-

>-

.-<

.-<

>-

IV

Z
--i
Z

....

-<

....

-<

<n

-<

-<

IV

-<

....

-<

....

<n

-<

t~15'

State of Utah Mail. Record afOispositioo-Ougway

Ba sporo m_jaJ

Allyn

Record of Disposition-Dugway

Nakashima

<anakashlma@utah.gov>

Sa spore material

1 message

t.

Thu, Jun 18, 2015 at 4:17 PM

To: "Self. Joshua S. (CDC/OPHPRIDSAT)"

Cc::

Christensen <kchriste@utah.gov>,

<dnzO@cdc.gov>,

Allyn Nakashima

"gvr1@cdc.gov"

<gvr1@cdc.gov>
" Wei Hou <whou@utah.gov>,

Kimber1y

<anakashima@utah.gov>

Hi Joshua,
Attached is a spreadsheet

listing Ba spore material we've received from Dugway and a record of its disposition

by autoclave on 6/17/2015.

Regarding the use of Ba spore materials, with the exception of AMES lot
, we have NOT manipulated any Ba spore materials since bafore June 1,
2014. I would estimate the time frame was in the year 2013 and prior. A risk assessment for the use of AMES lot
,as baen completed by UT

DOH.

To my knowledge, we have never transferred any Ba spore material outside of

Best,

httpsJlmall.googlo.can/mail/uJO/?ul=2&lk=68925163(lj&vlew=

pt&q= dl.9Way%2Oanthrax&qs=trL.e&search= query&th= 14e08b1!1Ob561


doc&sl m I= 14e08bIOOb561doc

1/4

121912015

Stat. of Utah Mell- Record of Dlsposltioo-Dugway

From: Self, Joshua 5, (CDClOPHPRIDSAT)


Sent: Friday, June 12, 2015 12:05 PM
Subject: DOD Anthrax Investigation

Sa spore meterlal

[mailto:dnzO@cdc.gov]

Greetings,

I have official CDC guidance conceming all irradiated lots of SA from Dugway (the only exception is the Steme strain). Please find attached the
document and respond appropriately.
If you have not been able to find the material and have not yet responded via email, please do so. Also, if your
entity has ever transferred the anthrax material of concem to another entity, please, provide me that information to me ASAP if you have not already
done so.

Also, if you have not provided the answers to the fOllowing questions beiow, please do so ASAP.

If you have thank you very much.

o Entity Name
o Address
o Contact Name
o Contact Work Phone
o Contact cell
o Contact Email

Agent
o

Lot

Antigen

received
Date and description of material?
FedEx?
o Dry Ice?
o
o

Possession and work performed with Antlgens(Y/N)


o Method of Disposition (AutoclavelTransfer)
o Work with material (YIN)?
o Date Last Used Work performed with material (Aerosol?)
o # of people involved in work

httos:l/maJ I.oooale.com/m all/ulOl?ul =2&Jk=68925163Od&vlaw = 01&0=duow av%2OMthrax&as= trua&saarch= ouerv&th= 14e08bf50b561 dec&sl m 1=14e08bftlOb561 dec

214

1'2tsI2015

State of Utah Mall. Record of Disposition-Dugway Sa spore m_iel

Medical Follow-up

Transferred to another facility (YIN)


o Facility Name
o Facility Contact Info
o Transfer Date
o Package Date
o Shipper Name
o Receipt Verified (YIN)

Material Retained (YIN)


o Reason for retaining material
o If the PI is registered the agent under your entity's current registration as your entity is a registered entity
o Location
o Security
o Method used to ensure material is not used

Please do not hesitate to contact me with any questions or concems.

Best,

Joshua Self
Microbiologist
DSAT/CDC

'23

OugwaySpeclmensRecleved

11June2015Jnventory

and disposition

record_17June2015.pdf

htipsJlmall.google.comlmall/ulQ/?uI=2&lk=SS925163Od&vlow= pt&q=dugway%2Oanthtax&qs=true&search=query&lh= 14008bf60b061dec&slm1=14008bf60b061doc

314

121912015

Stat. of Utah Mall. Rocad aI Dlsposltioo-D_oy

Sa spore mat.laI

1306K

httos:llmalt.oooole.can/maIlJuIOI?ul=2&lk=68925163Qd&viaw=

ot&o=duowav%2OanthrBX&as=true&search=auerv&~

14e08bf60b561 dac&slml=

14e08bf60b561dec

4/4


l 01 :

lVPl1torV of B.l Material

Received from Dugway

U~d~tt:d
h""'17, 201::' b\

OItP"~~IDprd Otdior/M1PRt

In('llllfY

~I1OW(h

ely 1(1/ Mil

Shipped t(l

'M)

AGD1./lo,a

P.Jthnlf'niC
IV/N)

Sualn

'of
1IliQuots

dft@'ct.d
(V/N/NT

(Not

Te\tedll

Inventory ""us
(COllsumed,retutnt'd,
qu,rll'lilnood)

Date
Autoc~~

Q!.\t: of Detlrurl!M:

I
I ~ :\,.

lOr

,,...

1~"'l' 1)

lO'

r-

lOT

II...
,-\;

':'IM;1\'l~

'ft

,of

AU~OCI~\'t!
6CI
mi"uU~3
,te)'TI/~I.n":. :(. ,,.,,/'IlItM d",

-~'"

i!

.. -

"

,
..

"

V~U'" H"

I', ..-

A~,

,
, ,." ... 1.:,

~f..O.nrl'..Kf.!Q!!,

._.

"

.~

I:

1-=

~,

",/fIV!'y!)rl

'./I1;;'(',!',

..""

M~>

,.'

.'

"

I,

nl1f1

i1 ,'()t'~"",.;

~:.tx.~
10

JI...,.JOf:'
AV'lt'll;o~o:l. 1 Jloo::l ~

A'j'('O("I_'"

1,1(\<"1'Ii

""f7f~!\l"

,'!2"1~

i
w. ____

.:../:;1101~

Si.nill~uT:

6or~1:Z(lI!.

\.
J

("<rQ

.."'"'\OU"

1101

Al/'~

-'

1
d 4Z

1'tq,J""'\

....~
~

.......,

.ton.X

.
~u~J~_.1t'l'
."GrIW"

' I ~f'll',

6/111,0[3

lIiJU;ClS

IP{l((j('

h1tS/15

I!AJl))S

'_"~,.

f,

irun W'I"'JIJl~l. N~e;H"'.;

'"
~

C.l<":,,ll'Chr.. 81.5:00 l;;1

Namfof hnon Dl>grny!~~I:


".,tac:r~oI"I!!J ~l:('U

"'IQO,("'~

'"

Mrr~O')fj:

S881)(, lllpJWv
I!,OW!!"I

,
N

1..

,IoQIA>U

-,
""k.)

".Ud<lltol'l

II ""-13

Wlll~'{Il:;

t;'
'I'> II,, I' ...{

r--

I
;

,<

1---

1-'

>

"

--"

"

,..
'.

<

~
~. ~

'..'-

"-i

..

J
~

..

..

<

..

!:i!

'.

"

:~

.. - -

"

>

'i

"

.,

<

<

..

'"

<

..

",~

..

'.

'

..

_. - -- ,

~~ ~
..
..

..
,

..

.a
l

~\

~
c

~
j
~

~'

"

"

;
, "~
.'

~
,

~
~
"
~

..

"

"

---~

::

;if

~
z

.'"
~

3
,
"

'!'

l, ,3

G
f.

~
>

~'

"

;.

~
;
~

1-;

,a
1
1

\r,l

St

"

..

<

J
<

~
<

'"

,
3'

'.

"

3-

..s:::

..alr
,,\/I

~
~

--

I I,
>

.,

"

.,
~,

,
.t
"
1

.,

..
,

1
j

<

,,

,-

-;;

<

"

~.'
~- ,ji ,
-,
.;

::

-"-z

~
E
~
0

-,

~
[

<

-,
~

~
~
~

.,.

E
W

<

i'

"
\

"~
~

"

F
t

-'

"
~

"
~

<!!
i

..
L

",

~
J

.3

>

<

.,
,~

"
~

~
f;

~.
>

;.

~-

Ii

0;

-j

"

~
,';.

"
z

"

~.-

.,~

"

i'

<

r.
~
~

~,

"~

j
z

:;

<

~
~

,-

'z"

~
z

~
>
~

"

;;

"l

~
"~
g
p

1
1

}
~

F
~

"

~
Is

:>

,,- "

.
~
! 1,
z

!f
>
~
~
~
~

"-

-~1=15.

S-

of UtahMail - Fwd: Noliftcati<X1


of DugwayAnthraxSamplesIn YClJrStat&'Territory(sent<X1
beha~01Dr. Dan 5051n)

Allyn Nakashima

<anakashlma@utah.gov>

Fwd: Notification of Dugway Anthrax Samples in Your StatelTerritory (sent on behalf of Dr. Dan Sosin)
1 message
Robert Rolfs <rrolfs@ulah.gov>
To: Allyn Nakashima <anakashima@ulah.gov>
Cc: Cristie Chesler <cchesler@ulah.gov>, Jennifer Brown <jennlferbrown@utah.gov>

Mon, Jul27, 2015 at 11:26 AM

FYI - I suspectlhis was also senl out to CSTE contacts, but couldn' tell from lhls email. II doesn' sound like we need to do anything If I underslood
the email correctly.
Bob

Robert T. Rolfs, MD, MPH


Deputy Director, Chief Medical Officer
Utah Department of Health
801-538-6111
-FOlWarded message -From: Monroe. Judith A. (CDC/OSTL TS/OD) <fsu6@cdc.gov>
Date: FIi, Jul 24, 2015 at 3:24 PM
Subject: Notification of Dugway"Anthrax Samples In Your StateITerritory (sent on behalf of Dr. Dan Sosln)
To: "jay.butler@alaska.gov" <jay.butler@alaska.gov>,
"Donald E. Williamson, MD (CDC adph.stale.al.us)" <Don.williamson@adph.state.al.us>,
"Smith, Nathaniel (CDC arkansas.gov)" <nathaniel.smith@arkansas.gov>,
"cory.nelson@azdhs.gov"
<cory.nelson@azdhs.gov>,
"Chlist, Cara (CDC
azdhs.gov)" <cara.chlisl@azdhs.gov>,
"karen.smith@cdph.ca.gov"
<karen.smith@cdph.ca.gov>,
"larry .wolk@stale.co.us" < larry. wolk@stale.co.us>,
"Jewel Mullen (CDC ct.gov)" <jewel.mullen@ct.gov>, "Iaquandra.nesbitl@dc.gov"
<Iaquandra.nesbitl@dc.gov>,
"Ratlay, Karyl (CDC slate.de.us)"
<Karyl. Ratlay@stale.de.us>, "J ohn .Armstrong@f1heallh.gov" <J ohn.Arrns lrong@f1health.gov>, "brenda. filzgerald@dph.ga.gov"
<brenda.fitzgerald@dph.ga.gov>,
"glnny.pressler@doh.hawaii.gov"
<ginny.pressler@doh.hawaii.gov>,
"Clabaugh, Gerd (CDC idph.iowa.gov)"
<gerd.clabaugh@idph.lowa.gov>,
"Elke Shaw-Tulloch (CDC dhw.idaho.gov)" <shawe@dhw.idaho.gov>, "Nirav.Shah@illinois.gov"
< Nirav. Shah@illinois.gov>, "jeadams@isdh.in.gov" <jeadams@isdh.ln.gov>, "smosler@kdheks.gov" <smosier@kdheks.gov>,
"stephanlek.mayfield@ky.gov"
<stephaniek.mayfield@ky.gov>,
"jtlane@la.gov" <jtlane@la.gov>, "Monica.bharel@state.ma.us"
<Monica. bharel@stale.ma.us>, "Van.Mitchell@maryland.gov"
<Van.Mllchell@maryland.gov>,
"kenneth.albert@maine.gov"
<kenneth.elbert@maine.gov>, "morans@michigan.gov" < morans@mlchlgan.gov>, "ed.ehllnger@state.mn.us" <ed.ehllnger@state.mn.us>,
"gall.vastelilng@health.mo.gov"
<gail.vasterling@health.mo.gov>,
"Currier, Mary (CDC msdh.ms.gov)" <mary.currier@msdh.stata.ms.us>,
"ropper@mt.gov" <ropper@mt.gov>, "danny.staley@dhhs.nc.gov"
<danny.staley@dhhs.nc.gov>,
"Dwella, Terry (CDC nd.gov)" <ldwelle@nd.gov>,
"Bobinsky, Marcella (CDC dhhs.state.nh.us)" <Marcella.j.boblnsky@dhhs.state.nh.us>,
"mary.o'dowd@doh.state.nj.us"
<mary.o'dowd@doh,stale,nj.us>,
"retta,ward@stale.nm.us"
<retla.ward@state,nm.us>,
"Green, Tracey (CDC health.nv.gov)" <tgreen@heallh.nv.gov>,
"howard.zucker@health.ny.gov"
<howard.zucker@health.ny.gov>,
"Cline, Terry (CDC health.ok.gov)" <terryc@health.ok.gov>,
"lillian.shiliey@state.or.us"
<lillian.shirley@state.or.us>,
"karrnurphy@pa.gov" <karrnurphy@pa.gov>, "Michael Fine (CDC health.li.gov)"
<michael.fine@health.li.gov>,
"heigelce@dhec.sc.gov"
<helgelce@dhec.sc.gov>,
"Klm.malsam-rysdon@stale.sd.us"
<Kim .malsamhlIps1/mail.google.canJm
ail/uIOI?ul
=2&Ik=68925163Od&vl"",=
pt&q=dugway%2(mthrax&qs=true&search=
query&th=14ed08d996711111
&slm1=1_1

1111

1/4

121912015

State of Utah Mail- Fwd: Notiflcatlen of D_ay

Anthrax SamIJos In Yoor StatEiTerrltory (sent en behalf of Dr. Dan 5os1n)

rysdon@state.sd.us>,
'john.dreyzehner@tn.gov"
<john.dreyzehner@tn.gov>,
"Kirk.Cole@dshs.state.tx.us"
<Klrk.Cole@dshs.state.tx.us>,
"dpalton@utah.gov"
<dpalton@utah.gov>,
"Levine, Marissa (CDC vdh.virginia.gov)" <marissa.levine@vdh.virginia.gov>,
'phyllis.wallace@doh.vi.gov"
<phyllis. wallace@doh.vi.gov>,
"harry .chen@state.vt.us"
<harry .chen@state.vt.us>,
"jmwiesman@doh.wa.gov"
<jmwiesman@doh.wa.gov>,
"karen. mckeown@wisconsin.gov"
<karen.mckeown@wisconsin.gov>,
'Rahul. Gupta@wv.gov" <Rahul.Gupta@wv.gov>,
"wendy. braund@wyo.gov"
<wendy.braund@wyo.gov>,
"Gillan, James (CDC dphss.guam.gov)" <James.gilian@dphss.guam.gov>,
'anarius@salud.pr.gov"
<anari us@salud.pr.gov>
Cc: "michele.jones@adph.state.al.us"
<michele.jones@adph.state.al.us>,
"stephanie. wiiliams@arkansas.gov"
<stephanie. williams@arkansas.gov>,
"J anet. mullen@azdhs.gov"
<Janet.mullen@azdhs.gov>,
"Daniel. Kim@cdph.ca.gov"
<Daniel. Kim@cdph.ca.gov>,
"kathleen.billings ley@cdph.ca.gov"
<kathleen. billingsley@cdph.ca.gov>,
"karin.mcgowan@state.co.us"
<karin.mcgowan@state.co.us>,
"Kathari ne.lewis@ct.gov"
<Katharine.lewis@ct.gov>,
"Brian.Amy@dc.gov"
<Brian.Amy@dc.gov>,
"crystal. webb@state.de.us" <crystal. webb@state.de.us>,
"Kim _Bamhill@doh.state.fl.us"
<Kim _ Bamhi II@doh.state.fl.us>,
"james.howgate@dph.ga.gov"
<james .howgate@dph.ga.gov>,
"keith.yamamoto@doh.hawaii.gov"
<keith.yamamoto@doh.hawaii.gov>,
"BerrethT@dhw.idaho.gov"
<BerrethT@dhw.idaho.gov>,
"Conover, Craig (CDC
illinois.gov)" <Craig. Conover@illinois.gov>,
"jduwve2@isdh.in.gov"
<jduwve2@isdh.in.gov>,
'mreece@kdheks.gov"
<mreece@kdheks.gov>,
"Humbaugh, Kraig (CDC ky.gov)" <kraig.humbaugh@ky.gov>,
"beth.scalco@la.gov"
<beth.scalco@la.gov>,
"Eileen.m.sullivan@state.ma.us'
< Eileen. m.sullivan@state.ma.us>,
"iaura .herrera@maryland.gov"
<Iaura.herrera@maryland.gov>,
"christine.zukas@maine.gov'
<christine.zukas@maine.gov>,
"robinsonm 18@michigan.gov" <robinsonm 18@michigan.gov>, "jim .koppel@state.mn.us"
<jim .koppel@state.mn.us>,
"Thomas.Dobbs@msdh.ms.gov"
<Thomas.Dobbs@msdh.ms.gov>,
'Harwell, Todd MPH (CDC mt.gov)" <tharwell@mt.gov>,
"chris.hoke@dhhs.nc.gov"
<chris.hoke@dhhs.nc.gov>,
"asmith@nd.gov" <asmith@nd.gov>, "Miller, Jacquelyn D. (CDC nebraska.gov)"
<jenifer.robertsjohnson@nebraska.gov>,
"arturo.brito@doh.state.nj.us"
<arturo. brito@doh.state.nj.us>,
"Lynn. Gallagher@state.nm.us"
<Lynn. Gallagher@state.nm.us>,
'mwherry@health.nv.gov"
<mwherry@health.nv.gov>,
"sue.kelly@health.ny.gov"
<sue. kelly@health.ny.gov>,
"Julie. Walbum@odh.ohio.gov"
<J ulie.Walbum@odh.ohio.gov>,
"JulieK@health.ok.gov"
<JulieK@health.ok.gov>,
'priscilla.m .Iewis@state.or.us"
<priscilla.m.lewis@state.or.us>,
"mraniowski@pa.gov"
<mraniowski@pa.gov>,
"Green, Leonard <RI> (CDC health.ri.gov)"
<Ieonard.green@heaith.ri.gov>,
"Davis L@dhec.sc.gov" <DavisL@dhec.sc.gov>,
"Tom .martinec@state.sd.us"
<Tom .martinec@state.sd.us>,
"david.reagan@tn.gov"
<david.reagan@tn.gov>,
"Mike.Maples@dshs.state.tx.us"
<Mike.Maples@dshs.state.tx.us>,
"Rolfs, Robert <UT> (CDC
utah.gov)" <rrolfs@utah.gov>,
"Trump, David (CDC vdh.virginia.gov)" <david.trump@vdh.virginia.gov>,
"Tracy.Dolan@state.vt.us"
<T racy. Dolan@state.vl.us>,
"dennis .worsham@doh.wa.gov"
<dennis. worsham@doh.wa.gov>,
'Charles. Warzecha@dhs.wisconsin.gov"
<CharlesWarzecha@dhs.wisconsin.gov>,
"Anne.A.Wiliiams@wv.gov"
<Anne.A. Williams@wv.gov>,
"Stickley, Christine (CDC wyo.gov)"
<christine.stickley@wyo.gov>,
"Sosin, Dan (CDC/OPHPRlOD)" <dms8@cdc.gov>

Dear colleagues:

We are writing to alert you to the discovery that a laboratory in your state or tenritory has received samples of inactivated Bacillus anthracis (anthrax)
spores that were found to contain small numbers of live anthrax spores. These samples were prepared by Dugway Proving Ground.

Earlier this year, you may have been notified that other laboratories in your state received a sample with live anthrax spores. Today's notifications are
being sent because CDC has learned that the National Guard's Civil Support Teams received these materials for use in proficiency testing of their
ability to detect and report a positive result for anthrax correctly.

CDC's Select Agent Program is reaching out to affected laboratories to ensure they secure and destroy all samples sent to Civil Support Teams. These
httos:/imell.aooale.can/meiliulOl?ui=2&lk=68925163Od&vlew=ot&o=dl.<Jwav%2Oanthrax&os=true&search=auerv&th=

14ed08d99671fll1&slm 1=l4ed08d99671tf 11

214

State of Utah Mall. Fwd: Notiflcatl!Xl of Dugway Anthrax Samples In Your Stata'T ."tory (sent !Xl beha~ ci Dr. Dan 5os1n)

1=15

laboratories will also determine whether there has been any use of these materials within the past year. If CDC identifies a laboratory in your state or
territory that has used these samples in the past year, we will notify you. We will also work directly with you to assess the need for workers to receive
prophylaxis, as well as the need for facility decontamination. None of the laboratories contacted by CDC as of today had used samples from the
affected production lot in the past year. There has been no need for follow-up with these facilities since that determination.

At the present time we are stili trying to reach the Civil Support Teams In PRo IA, KY, NM, and SC. as well as a military facility In NC. If CDC
has not made contact with your state or territory's Civil Support Team yet, we would appreciate your assistance in reaching out tD these entities. You
can contact CDC's Emergency Operations Center at 404-488-7100 for additional information about the laboratory in your state or territory that has not
been reached. If you are able to reach the laboratory in your state, please direct the laboratory to contact CDC's Emergency Operations Center. For
states with laboratories already In contact with CDC, we do not anticipate the need for further actions or follow-ups to this notice at this time.

If you have any questions about the current situation, please contact Von McClee with CDC's Select Agent Program (404-293-7420;
VMcClee@cdc.gov).
You can also contact me at any time about this situation.

Sincerely,

Daniel M. Sosin, MD, MPH, FACP


Deputy Director and Chief Medical Officer
Office of Public Health Preparedness

and Response

1600 Clifton Road, NE Mailstop D-44


Atlanta, GA 30329-4027
404-639.7405
DSosln@cdc.gov

_._.IMPORTANT

MESSAGE

This message, including any attachments, may contain confidential information intended for a specific individual and purpose, and is protected by law.
If you are not the intended recipient, delete this message, including from trash, and nDtify me by telephone or email.
If you are not the intended recipient, any distribution or copying of this message, or the taking of any action based on its content is strictly prohibited.
hllps:l/mall.googlacomfmall/ulOf?ul=2&lk=68925163Od&vlew=

pt&q=dugway%2Oanthrax&qs=trua&search=query&lh=

14ed08d996711111&slm1=14ed08dS9671t11

314

121912015

httos:/Imafl.oooal

State of Utah Mall-

e.com/m all/u'Ol?ul:: 2&lk= 68925163Od&viS'oN=

Fwd: Notiftcatioo of Dugway AntI1rax Sam pi as In Your Stat&'T "lory (sent 00 bahalf of Dr. Dan Scsln)

01&0= duO'Nav%2Oanthrax&as=true&search=

ouerv&th= 14ed08d99671

f111 &sf m 1=14Ad0Rd.Q9671 f111

did

l2l9/2lJ1S

State of Utah Mail. Re: GRAMAroquost r. Erl1I1rax

Allyn Nakashima

<anakashlma@utah.gov>

Re: GRAMA request re anthrax


1 message
Robyn Atkinson <nnatklnson@utah.gov>
To: Tom Hudachko <thudachko@utah.gov>,
Cc: BMttany Huff <bMttanyhuff@utah.gov>

Tamara Hampton <thampton@utah.gov>,

Tue, Oct 20, 2015 at 10:42 AM


Allyn Nakashima <anakashlma@utah.gov>

Tom.
Was this shared with Allyn? She did a bulk of the communication about this Issue with CDC. I will need some help from BMttany to detennine what I
can shara and what I can~ In regards to documents I have from CDC.
Tammy.

do we ever waive fees as they are requesting?

Robyn
On Wed. Oct 14, 2015 at 3:57 PM, Tom Hudachko <thudachko@utah.gov>
Hi Robyn,

wrote:

Attached is a GRAMA request we received for records detailing anthrax shipments to labs In Utah from the Dugway Proving Ground since 2005 and for
any records of communication regarding the Inadvertent shipments that were recently in the news. see attachment for details on the request
I'm going to assume If we have any records regarding shipments that they are going to be protected. Not sure if you have any records on the
inadvertent shipments?
Let me know your thoughts. Cc'lng Brittany for any legal input she may have.
Tom
-Forwarded message --From: Betsy Finan <bfinan@utah.gov>
Date: Wed, Oct 14, 2015 at 2:05 PM
Subject: Fwd: GRAMA request ra anthrax
To: Tom Hudachko <thudachko@utah.gov>

Betsy Finan
httpsJlmall.googlacantmalllt>'lY7lJl'2&lk=68925163Cl:1&vieN=pl&q'cI..\lWay%2Oanthrax&qs.truo&soarcIFquory&lh=

1506621~feO&slml'

1506621cc3d04foO

1/3

121912015

State of Utah Mall. Ro; GRAMA roq<.est ro B'Tth",,,

Executive Director's Office


Utah Department of Health
288 N. 1460 W.
POBox 141000
Salt Lake City, UT 84111-1000
(801) 538~111

bfinan@utah,go\'
-Forwarded message --From: <enckson.steve1@comcast.net>
Date: Wed, Oct 14, 2015 at 2:00 PM
Subject: GRAMA request re anthrax
To: bfinan@utah.gov

Please find attached a GRAMA request. Thank you.


Steve Erickson 801-554-9029

_*_n

"*

IMPORTANT

MESSAGE .....

'IIt " .

This message, including any attachments, may contain confidential Information Intended for a specific individual and purpose, and Is protected by
law. If you are not the intended recipient, delete this message, including from trash, and notify me by telephone or email.
If you are not the Intended recipient, any distribution or copying of this message, or the taking of any action based on Its content is strictly prohibited.

Tom Hudachko I Director of Communications


Utah Department of Health
(0) 80 1-53~232
(m) 801.560-4649
www.health.utah.gov
www.twitter.com!utahdepofhealth
https :!!www.facebook.com!Utah

DepOfHealth

--_ IMPORTANT

MESSAGE .... _

This message, including any attachments, may contain confidential information intended for a specific individual and purpose, and is protected by
law. If you are not the intended recipient, delete this message, including from trash, and notify me by telephone or email.
httosJlmall.aooalo.com/m

oll/l>'Ol7\Jl= 2&lk= 66!l251 630d&vle.v= ot&o=clJcw av%2OanthrBl<&os=trUO&.oorch= auorv&th= 1508621cc3d04feo&sl m 1=1508621 cc3d04reo

213

121912015

State of Utah Mall- Ro: GRAMA request ro mthrox

If you are not lhe inlended recipient, any distribution or copying of this message, or the taking of any action based on its content is strictly prohibited.

Robyn M Atkinson-Dunn, PhD HCLD/PHLD


Director
Utah Public Health Laboratory
4431 S. Constitution Blvd.
Taylorsville UT 84129
Main number: (801) 965-2525
Direct number: (801) 965-2424
rmalkinson@ulah.90V

_ _._.

IMPORTANT

MESSAGE

_._._

This message, including any attachments, may contain confidential information intended for a specific individual and purpose, and is protected by law.
If you are not the intended recipient, delete this message, including from trash, and notify me by telephone or email.
If you are not the inlended recipient, any distribution or copying of this message, or the taking of any action based on its content is strictly prohibited.

hIIpS:l/mall.googIo.com/malI/LiG'7ul- 2&1k- 689251630d&vl"",- pt&q- cl.Jgway%2Oa:1tIlrox&qs-truo&soarch:qyory&1IF

1508621cc3d04foO&slm I- 1508621cc3d04foO

313

State ci Utah Mall. Ro: GRAMA roquosl rolllhrax

-12191201~

Allyn Nakashima

<anakashlma@utah.gov>

Re: GRAMA request re anthrax


1 message
Tom Hudachko <thudachko@utah.gov>
To: Allyn Nakashima <anakashima@utah.gov>
Cc: Robyn Atkinson <nmatkinson@utah.gov>

Tue, Oct 20, 2015 at 4:25 PM

Allyn,
The request is attached. It requests documents "pertaining to anthrax shipments received by laboratories in Utah from the U.S. Army Dugway Proving
Ground (DPG) since 2005, and all records of communications with DPG, USAMRIID, and the Centers for Disease Control (CDC) regarding the Inadvertent
shipments of live anthrax since January 1, 2014."
Not sure if you feel thE

lcuments would be entailed?

Tom
On Tue, Oct 20, 2015 at 11:06 AM, Allyn Nakashima <anakashima@utah.gov> wrote:
Hi Tom,
Let me know what yOU need as far response from us. CDC did the investigation of the Dugway facility without much input from us at all. We worked
with the
that received some of the specimens to ensure safety to their workers, proper disposal of samples, and decontamination of the
lab.
Allyn Nakashima, MD
State Epidemiologist
Utah Department of Health
On Oct 20, 2015, at 10:42 AM, Robyn Atkinson <rmatkinson@utah.gov>

wrote:

Tom Was this shared with Allyn? She did a bulk of the communication about this issue with CDC. I will need some help from Brittany to
detenmine what I can share and what I can~ in regards to documents I have from CDC.
Tammy - do we ever waive fees as they are requesting?
Robyn
httpsJlmall.googlo.canJmallll>'Cl'?ul=2&Ik=68925163Od&vlew=pI&q=d.9Way%2Oanthrax&qs=truo&search=query&lh=

150875c1OC2758b3&siml=150875c10C2758b3

114

1219l2015

State of Utah Mall. R.: GRAMA r&qlJ8St r.l<1thrax

On Wed, Oct 14, 2015 at 3:57 PM, Tom Hudachko <thudachko@utah.gov>


HI Robyn,

wrote:

Attached Is a GRAMA request we received for records detailing anthrax shipments to labs In Utah from the Dugway Proving Ground
since 2005 and for any records of communication regarding the inadvertent shipments that were recently in the news. See attachment
for details on the request.
I'm going to assume if we have any records regarding shipments that they are going to be protected, Not sure if you have any records
on the inadvertent shipments?
Let me know your thoughts. Cc'ing Brittany for any legal Input she may have.
Tom
-Forwarded message -From: Betsy Finan <bfinan@utah.gov>
Date: Wed, Oct 14, 2015 at 2:05 PM
Subject: Fwd: GRAMA request re anthrax
To: Tom Hudachko <thudachko@utah.gov>

Betsy Finan
Executive Directors Office
Utah Department of Health
288 N. 1460 W.
POBox 141000
Salt Lake City. UT 84111.) 000
(801) 538-6111
bfinan@utah.gov
-Forwarded message -From: <erickson.steve1@comcast.net>
Date: Wed, Oct 14, 2015 at 2:00 PM
Subject: GRAMA request re anthrax
To: bfinan@utah.gov

Please find attached a GRAMA request. Thank you.


Steve Erickson 801-554-9029
hllDS:llmell.oooole.com/mell/u'Ol?ul=

28Jk= 68925163Od&vlew= ol&o= <lJawev%2Oanthrax&as= trt.e&searCh=auerv&th= 15067501OC2758b3&slm 1=15087501OC2756b3

2/4

State 01 Utah Mall- R.: GRAMA request r. <nthrax

-121912015

-"'***--IMPORTANT
MESSAGE -_ _This message, including any attachments, may contain confidentiallnfonmation intended for a specific individual and purpose, and Is
protected by law. If you are not the Intended recipient, delete this message, including from trash, and notify me by telephone or
email.
If you are not the Intended recipient, any distribution or copying of this message, or the taking of any action based on its content is
strictly prohibited.

Tom Hudachko I Director of Communications


Utah Department of Health
(0) 801-538-6232
(m) 801-560-4649
www.health.utah.gov
www.twitter.com/utahdepofhealth
htlps ://www.facebook.com/UtahDepOfHea

ith

-*-_ .

IMPORTANT MESSAGE
This message, including any attachments, may contain confidential infonmation intended for a specific individual and purpose, and is
protected by law. If you are not the intended recipient, delete this message, Including from trash, and notify me by telephone or
email.
*.***-

if you are not the Intended recipient, any distribution or copying of this message, or the taking of any action based on Its content is
strictly prohibited.

Robyn M Atkinson.Qunn, PhD HCLD/PHLD


Director
Utah Public Health Laboratory
4431 S. Constitution Blvd.
Taylorsville UT 84129
Main number. (801) 965.2525
Direct number. (801) 965-2424
nmatkinson@utah.gov

httP5:JlmaJl.google.can/mall/u'Onul=2&1k=68925163Od&vlfffl=pl&q=cilgway%2Oanthrax&qs=trua&saarch=quary&lh=

15087501OC2758b3&siml= 150875010<:2758C3

314

State ct Utah Mall- R.: GRAMA req..esl ,. _,ex

1=15

._ _. IMPORTANT

MESSAGE ._**

This message, including any attachments, may contain confidential information intended fo, a specific individual and purpose, and is
protected by law. If you are not the intended recipient, delete this message, including from trash, and notify me by telephone or email.
If you are not the intended recipient, any distribution or copying of this message, or the taking of any action based on its content is
strictly prohibited .

,,_ IMPORTANT

MESSAGE

This message, including any attachments, may contain confidential information intended for a specific individual and purpose, and is protected by
law. If you are not the intended recipient. delete this message, including from trash, and notify me by telephone or email.
If you are not the intended recipient, any distribution or copying of this message, or the taking of any action based on its content is strictly prohibited.

Tom Hudachko I Director of Communications


Utah Department of Health

(0) 801-538-6232
(m) 801-560-4649
www.health.utah.gov
www.twitter.com/utahdepofhealth
https://www.facebook.com/UtahDepOfHealth
_ _._.

IMPORTANT

MESSAGE

_._

This message, including any attachments, may contain confidential information intended for a specific individual and purpose, and is protected by law.
If you are not the intended recipient, delete this message, including from trash, and notify me by telephone or email.
If you are not the intended recipient, any distribution or copying of this message, or the taking of any action based on its content is strictly prohibited .

.l!!!.J GRAMA to DoH ra anthrax.docx


15K

https:llm.ll.oooql . com/mali/ulOl?ul=2&lk=68925163Od&vlrm=ot&Q=cMlwav%2Oanth,ex&Qs=true&saa,ch=auerv&lh=

150B7501Oo2758b3&simi=150875010027581>3

4/4

UClou~r .l:>J i.V.l':>

of Health

Act (U.c. 63), we hereby

of Health pertaining to anthrax shipments

Records Access and Management

bfinan@utah.gov

Joe Miner, MD, Executive Director


P.O. Box 14100

Utah Department
Salt Lake City, UT 84114-14100
c/o Ms. Betsy Finan via email:

Dear Director Miner,


Under provisions of the Utah Government
request all records in the possession of the Department
with DPG, USAMRIID, and the Centers for Disease Control (CDC) regarding

in Utah from the U.S. Army Dugway Proving Ground (DPG) since 2005, and all

is a SOl (c) (3) nonprofit

educational

organization which seeks truth and justice for

group that watchdogs military activities in Utah and the West.

shipments of live anthrax since January 1, 2014.

records of communications

received by laboratories
the inadvertent

Downwinders

Citizens Education Project is a volunteer

we request will

and education only. As such, we request a waiver of any and all fees

nuclear tests and an end to all nuclear tests. The information

be used for public information

survivors of atmospheric

If a fee waiver is not

will exceed $50.00.

sought is in the public interest.

to Mr. Erickson.

granted, please advise us in advance if the cost of providing this information

associated with this request, as the information

Please send all enquiries and information

Preston J Truman

Respectfully,

Downwinders
Malad,ID

Steve Erickson
Way

Citizens Education Project


444 Northmont
Salt Lake City, Utah 84103
(mobile)

eri ckson .steve l@comcast.net


(801) 554-9029

State of Utah Mall. Re: GRAMA request re l<1thrax

121912D15

Allyn Nakashima

<anakashlma@utah.gov>

Re: GRAMA request re anthrax


1 message
Allyn Nakashima <anakashima@utah.gov>
To: Robyn Atkinson <rmatklnson@utah.gov>,

Tue, Oct 20, 2015 at 11:06 AM


Tom Hudachko <thudachko@utah.gov>

Hi Tom,
Let me know what you nead as far response from us. CDC did the Investigation of the Dugway facility without much Input from us at all. We worked
with the
I that receivad some of the specimens
to ensure safety to their workers, proper disposal of samples, and decontamination of the lab.
Allyn Nakashima, MD
State Epidemiologist
Utah Department of Health
On Oct 20, 2015, at 10:42 AM, Robyn Atkinson <rmatkinson@utah.gov>

wrote:

TomWas this shared with Allyn? She did a bulk of the communication about this issue with CDC. I will need some help from Brittany to
determine what I can share and what I can~ in regards to documents I have from CDC.
Tammy - do we ever waive fees as they are requesting?
Robyn
On Wed, Oct 14, 2015 at 3:57 PM, Tom Hudachko <thudachko@utah.gov>

wrote:

HI Robyn,
Attached is a GRAMA request we received for records detailing anthrax shipments to labs in Utah from the Dugway Proving Ground since
2005 and for any records of communication regarding the Inadvertent shipments that were recently In the news. See attachment for
details on the request.
I'm going to assume if we have any records regarding shipments that they are going to be protected. Not sure if you have any records
on the Inadvertent shipments?
Let me know your thoughts. Cc'ing Brittany for any legal input she may have.
hltpsJlmaJl.google.ecmJm aJl/liOI?U= 2&Ik= 68925163Od&v'",,= pl&q= cl.Jgwayo/.2OMttTax&qs=true&search= query&ltF I 508637046421d8d&si m 1=1508637046421d8d

1/3

state of Utah Mall- Re: GRAMArOC/JOSt relnlt1rax

121912015

Tom
--Forwarded message -From: Betsy Finan <bflnan@utah.gov>
Date: Wed, Oct 14, 2015 at 2:05 PM
Subject: Fwd: GRAMA request re anthrax
To: Tom Hudachko <thudachko@utah.gov>

Betsy Finan
Executive Director's Office
Utah Department of Health
288 N. 1460 W.
PO Box 141000
Salt Lake City, UT 84111.1000
(801) 538-6111

bfinan@Utah.gov
-Forwarded message -From: <erickson.steve1@comcast.net>
Date: Wed, Oct 14, 2015 at 2:00 PM
Subject: GRAMA request re anthrax
To: bfinan@utah.gov

Please find attached a GRAMA request. Thank you.


Steve Erickson 801-554-9029

.......
IMPORTANT MESSAGE ..****-*
This message, including any attachments, may contain confidential information intended for a specific individual and purpose, and is
protected by law. If you are not the intended recipient, delete this message, including from trash. and notify me by telephone or email.
If you are not the intended recipient, any distribution or copying of this message, or the taking of any action based on its content is
strictly prohibited.

Tom Hudachko

I Director

of Communications

httosJlmaJl.aoooI . com/maJlI~=2&lk=68925163Od&vlow=

ot&o=cI.owav%2OontI1rax&os=lruo&soarch=0U3l'V&lh= 15Oll637046421d8d&slm1=15Oll637046421dad

213

Stat. cA Utah Mail. R.: GRAMA rllClJOSlr.lW1tIYax

Z.9rJl15

Ulah Department of Health


(0) 801-538-6232
(m) 801-560-4649
www.heallh.utah.gov
www.lwitter.com/utahdepofheallh
htlps ://www.facebook.com/UtahDepOfHealth
.~ IMPORTANT MESSAGE _.
This message, including any attachments, may contain confidential Information Intended for a specific individual and purpose, and is
protected by law. If you are not the intended recipient, delete this message, including from trash, and notify me by telephone or email.
If you are not the intended recipient, any distribution or copying of this message, or the taking of any action based on its content is
strictly prohibited.

Robyn M Atkinson-Dunn, PhD HCLD/PHLD


Director
Utah Public Health Laboratory
4431 S. Constitution Blvd.
Taylorsville UT 84129
Main number. (801) 965-2525
Direct number. (801) 965-2424
rmatklnson@utah.gov

_-* IMPORTANT

MESSAGE .** This message, including any attachments, may contain confidential information intended for a specific individual and purpose, and is
protected by law. If you are not the Inlended recipient, delete this message, Including from trash, and notify me by telephone or email.
***..

If you are not lhe Intended recipient, any distribution or copying of this message, or the taking of any action based on Its content is
strictly prohibited.

1tlDsJlmail.aoaol . canJmailll>'Ol?ul =2&lk= 68925163Od&vlew= pt&q= "-9Way%2Ololthrax&qs=

true&seareh= query&lh= 1508637046421 d8d&si m 1=1508637046421 d8d

313

lZw2015'

State of Utah Mall. Ro: GRAMA "",,,,,,t

ro anthrax

Allyn

Nakashima

<anakashlma@utah.gov>

Re: GRAMA request re anthrax


1 message
David Mcknight <dmcknight@utah.gov>
To: Robyn Atkinson <rmatklnson@utah.gov>,
Allyn Nakashima <anakashima@utah.gov>
Co: Tom Hudachko <thudachko@utah.gov>,
Brittany Huff <brittanyhuff@utah.gov>,
Tamara Hampton <thampton@utah.gov>.
<stephanlesaperstein@utah.gov>,
Hollie Hatch <hhatch@utah.gov>

Fri, Dec 4,2015

at 11:38 AM

Stephanie Saperstein

HI Everyone,
From Robyn's comment that Allyn was the main point of contact, it seems to me that the GRAMA records officer that works with Allyn needs to also
work on responding to this request. I thank Robyn for her help. We need to see what records Allyn's section has.
With two bureaus within UDOH having to respond to this, the records officer for each bureau will need to look for the records that meet the description
of the request. Robyn has provided what the lab has. I would ask Tom to forward a copy of the request to Allyn's section, so they can also look for
records the meet the description of the request.
As of now with the lab records, there is one that is proprietary to the private lab which UDOH can~ release. Some documents
procedures which are not what the request asks for. The remaining documents do meet the description of the request.

are protocols and

My next question to Allyn and anyone else that may know, is, did CDC or Dugway Indicate any kind of confidentiality or protective status that should be
given to any records created from this Dugway-anthrax to a private Utah lab episode. If not, I can~ find a reason under GRAMA for not releasing some
of these records. My concern for a protective status of the records from a federal level is that news reports Indicate that CDC and Dugway would not
identify the Utah Lab. Yet, I contacted another attorney within the AG's office who has specialized experience with GRAMA and her response Is that
much of our records appear to her as releasable.
Thanks everyone as we try to coordinate a response.
David McKnight. AAG
On Tue, Dec 1, 2015 at 9:35 AM, Robyn Atkinson <rmatkinson@utah.gov>

wrote:

Hi.
All of the emails that I forwarded to you are, in my estimation, compliant with the request. The request asked for all documentation regarding
conversations with CDC. That Is what I have provided. Also, it should not be lost here that Allyn was the main point of contact for the CDC on this
and she may have more email conrespondence then what I have provided.
Robyn

httpsJlmoil.googlo.comlmall/L>'Ol?uI=2&l1<=68925163Od&vleN=pl&q=d.9Way%2Oanthrax&qs=truo&soarch=

quory&lh= 151604975101084a&sl m 1=1516049751 01084a

1/8

Stat. of Utah Mall-

121912015

On Mon, Nov 30,2015


HI Robyn.

R.: GRAMA

at 3:10 PM, David Mcknight <dmcknight@utah.gov>

request r. mlhrox

wrote:

I think there is a lot of miscommunication


about the GRAMA process. This is a two step process. The first step is identifying the documents that
fall under the description of the request. This step is a factual determination not a legal determination. I dont know what most of these document
mean. Please have someone compare the list of identified documents to the description of the requested documents. Once those have been
identified by someone in your Lab you can provide them to me so we can move on to the second step,
The second step is my legal review to determine if the documents you have identified can be released under the law.
At this point. you have identified potential documents that might fall within the description of this request. Someone with the subject matter
expertise from the Department and/or Lab must make this factual decision. Until that determination has been made. we cannot go to the second
step of conduction a definitive legal review.
To recap. I cant can't do step two until someone at the lab completes
list, If they provide a description of each document.

step one. It would help me in my legal review when the lab completes

it's

Please let me know if you have any questions.


Best regards,
David McKnight. AAG
On Mon, Nov 30,2015 at 2:11 PM, Tom Hudachko
FYI - I got a media call about this today from the
story on the inadvertent shipments of live anthrax
several he filed similar requests with to have not

<thudachko@utah.gov>
wrote:
Deseret News, The requestor (Steve Erickson) is working with a reporter to write an update
from earlier this year, Steve mentioned to the reporter that we were the only agency out of
responded, So, the sooner we can resolve this the better.

Thanks
Tom
On Fri, Nov 27, 2015 at 4:15 PM, David Mcknight <dmcknight@utah.gov>
Hi Robyn,

wrote:

Thank you for the background. As I reviewed this chain of e-mails,although,therewasareferencetoattacheddocuments,


I did not get any
attached documents. Could you or your staff support send me the records that have been determined as responsive to the request. I also
haven't seen the actual request, I will ask Tom for a copy of the request. After I look at them and have comments, is there a person I can
work with who will be responding to the request.
I appreciate you raising this, so . it doesn't get overlooked.
Best,
David McKnight, AAG
On Wed, Nov 25, 2015 at 5:32 PM, Robyn Atkinson <rmatkinson@utah.gov>
wrote:
I provided all the records I have. I am waiting In someone to tell me what can be released and what needs to be redacted or not released at
hiles '/lm oll.OOlXlI . comfmallfu'Ol?ul

= 2&lk=68925163Od&vil>N=

01&0= dl.<lw ovo/.2Oantl1r ox&os= trua&soarch=ouorv&th=

1516049751 01e84a&s1 m 1=1516049751 01e84a

218

1mrzo15'

State cJ Utah Mall- Re: GRAMA request relllthrax

all .
. Robyn

On Wednesday, November 25,2015, David Mcknight <dmcknight@utah.gov>


wrote:
It appears to me that there is not a records officer identified to handle this. Whoever is best qualified to look into the type of possible
records being requested would be a good person to start with to see if there is anything to release. I am glad to help with any legal input
needed.
On Mon, Nov 23, 2015 at 1:37 PM, Robyn Atkinson <nnatkinson@utah.gov>
Is there anything else you need from me regarding this request?

wrote:

Robyn

On Thu, Oct 29, 2015 at 2:00 PM, David Mcknight <dmcknight@utah.gov>


Hi Robyn,

wrote:

The Anthrax GRAMA request was handed over to me a couple of days ago as the DCP Asst AG. I have been trying to detennine
who is the agency person handling this so I can be of assistance if they need legal input. I spoke with Tamara Hampton yesterday
and she was uncertain who in your bureau is the person acting on this. Would you have the person handling this seek an extension of
time to respond as our response lime ends today. Also, let that person know they can contact me with any legal assistance they
may need.
Thanks for your help,
David McKnight, Asst AG
On Mon, Oct 26, 2015 at 10:37 AM, Brittany Huff <brittanyhuff@utah.gov>
wrote:
Because Dave McKnight Is assigned to the DCP division, I am sending this to him.
on it so far.

I have talked to him about the work I've done

If this GRAMA request was received on Oct. 15, 2015, it is due this Thursday, October 29 so an extension probably needs to be
requested.
Robyn and Dave can coordinate to detennlne which records are releasable under GRAMA.
Brittany
On Thu, Oct 22,2015 at 10:10 AM, Robyn Atkinson
Please see the attachments.

<nnatkinson@utah.gov>

wrote:

Robyn

httpsJlmall.google.comlmalllu'Ol7ul=2&Ik=68925163Od&vlf>N=pl&q=<l.ogway%2Oanttlrax&qs=trua&saarcl1=query&th=

151684975101e84a&sim 1=151684975101e84a

318

121912015

State of Utah Mall. Re: GRAMA

r"'lJOSt re ..nt1rax

On Thu, Oct 22, 2015 at 10:01 AM, Brittany Huff <brittanyhuff@utah.gov>


Robyn,

wrote:

Instead of forwarding all the emails to me, please save the emails as PDF and then send one email to Summer Perkins at
smperkins@utah.go with all those attachments. She will organize the documents and then I can provide a legal review.
Thank you,
Brittany
On Thu, Oct 22, 2015 at 9:39 AM, Robyn Atkinson <rmatkinson@utah.gov> wrote:
r will forward all information I have. Brittany. I would like your assessment on that can be shared for this request.
Robyn
On Wed, Oct 14, 2015 at 3:57 PM, Tom Hudachko <thudachko@utah.gov>
Hi Robyn,

wrote:

Attached is a GRAMA request we received for records detailing anthrax shipments to labs in Utah from the Dugway Proving
Ground since 2005 and for any records of communication regarding the inadvertent shipments that were recently in the
news, see attachment for details on the request.
I'm going to assume if we have any records regarding shipments that they are going to be protected. Not sure if you have
any records on the inadvertent shipments?
Let me know your thoughts, Cc'ing Brittany for any legal input she may have.
Tom
-Forwarded message --From: Betsy Finan <bfinan@utah.gov>
Date: Wed, Oct 14, 2015 at 2:05 PM
Subject: Fwd: GRAMA request ra anthrax
To: Tom Hudachko <thudachko@utah.gov>

Betsy Finan
Executive Directors Office
Utah Department of Health
288 N. 1460 W.
PO Box 141000
Salt Lake City, UT 84111-1000

hItM'lImAII.0CXXlIe.com/mall/ulOl?ul=2&ik=68925163Od&vlew=ot&o=duow"av%2Oanthrax&os=true&searc~auerv&th=

1516e4975101e84a&sim

1=1516949751 01e84a

4/8

.1.lI9I2015"

State of Utah Mlil-

R.: GRAMA roql.<lSlr. Mtt1rax

(801) 538-6111
bfinan@utah.gov
-Forwarded message -From: <erickson.steve1@comcast.net>
Date: Wed, Oct 14, 2015 at 2:00 PM
Subject: GRAMA request re anthrax
To: bfinan@utah.gov

Please find attached a GRAMA request. Thank you.


Steve Erickson 801-554-9029

.. IMPORTANT MESSAGE _
This message, including any attachments, may contain confidential information intended for a specific Individual and
purpose, and is protected by law. If you are not the intended recipient, delete this message, Including from trash, and
notify me by telephone or email.
If you are not the intended recipient, any distribution or copying of this message, or the taking of any action based on its
content is strictly prohibited.

Tom Hudachko I Director of Communications


Utah Department of Health
(0) 801-538-6232
(m) 801-560-4649
www.health.utah.gov
www.twiller.com/utahdepofhea
11h
hllps :/lwww.facebook.com/UtahDepOfHealth

IMPORTANT MESSAGE

This message, including any attachments, may contain confidential information intended for a specific individual and
purpose, and is protected by law. If you are not the intended recipient, delete this message, including from trash, and
notify me by telephone or email.
If you are not the intended recipient, any distribution or copying of this message, or the taking of any action based on its
content is strictly prohibited.
hltpSl/mall.google.can/mail/liW?uI=2&Ik=68925163Od&vlew=pt&q=dugway%2Oanthrax&qs=true&seareh=query&th=

151604975101e84a&slm1=1516049751010848

518

Slate of Utal1 Mal- R.: GRAMA roquest r. nhrax

121912015

Robyn M Atkinson-Dunn, PhD HCLD/PHLD


Director
Utah Public Health Laboratory
4431 S. Constitution Blvd.
Taylorsville UT 84129
Main number. (801) 965-2525
Direct number. (801) 965-2424
rmatkinson@utah.gov

*,***,*U,***

IMPORTANT

MESSAGE ******u",*

This message, including any attachments, may contain confidential information intended for a specific individual and purpose,
and is protected by law. If you are not the intended recipient, delete this message, including from trash, and notify me by
telephone or email.
If you are not the intended recipient, any distribution or copying of this message, or the taking of any action based on its content
is strictly prohibited.

********** IMPORTANT MESSAGE **********


This message, including any attachments, may contain confidential
information intended for a specific individual and purpose, and is
protected by law. If you are not the intended recipient, delete this
message, including from trash, and notify me by telephone or email.
This email may contain information

that is covered under attorney client privilege.

If you are not the intended recipient, any distribution or copying of


this message, or the taking of any action based on its content is
strictly prohibited.

Robyn M Atkinson-Dunn,
Director
httos:l/mell.oooole.cal1/mell/ulOl?ul'

2&1k' 68925163Od&vlow'

PhD HCLD/PHLD

01&0= DJawev%2O..-rthrex&os=

In.e&seerch'

ouorv&lh'

1516e49751 01 e84a&o1 m 1'1516e49751

01 e84a

618

121912015

Stateof UtahMall. Re: GRAMA r_t

re nI1rax

Utah Public Health Laboratory


4431 S. Constitution Blvd.
Taylorsville UT 84129
Main number. (B01) 965-2525
Direct number. (B01) 965.2424
rmatklnson@utah.gov

_ IMPORTANT MESSAGE This message, including any attachments, may contain confidential information intended for a specific individual and purpose, and is
protected by law. If you are not the Intended recipient, delete this message, including from trash, and notify me by telephone or email.

If you are not the intended recipient, any distribution or copying of this message, or the taking of any action based on Its content is
strictly prohibited.

Robyn M Atklnson-Dunn, PhD HCLD/PHLD


Director
Utah Public Health Laboratory
4431 S. Constitution Blvd.
Taylorsville UT 84129
Main number: (B01) 965.2525
Direct number: (B01) 965-2424
rmatkinson@utah.gov

_.- IMPORTANT MESSAGE _ _


This message, Including any attachments, may contain confidential information intended for a specific Individual and purpose, and is
protected by law. If you are not the intended recipient, delete this message, including from trash, and notify me by telephone or email.
If you are not the intended recipient, any distribution or copying of this message, or the taking of any action based on its content is strictly
prohibited.

https:Jlmall.googJe.com/malllliOl?ul=2&ik=68925163Od&vle-N=pt&q=ciJgwSV%2Oa1thrax&os=true&search=nl.IWVAfM=

1 ~11iAdQ7"i1n1...AA

..1I'_ ._ ~ .,.~ ,,_ .

_r . _ . _.

121912015

Stat. of Utah Mall. R.: GRAMA request r. !W1tt1rax

Tom Hudachko I Director of Communications


Utah Department of Health
(0) 801-538.6232
(m) 801-560-4649
www.health.utah.gov
www.twitter.com/utahdepofhealt
h
https :llwww.facebook.com/UtahDepOfHea

Ith

...."" ".- IMPORTANT MESSAGE

ft'It'*"' ...

This message. including any attachments, may contain confidential information intended for a specific individuai and purpose, and is protected
by law. If you are not the intended recipient, delete this message, including from trash, and notify me by telephone or email.
If you are not the intended recipient, any distribution or copying of this message, or the taking of any action based on its content is strictly
prohibited.

Robyn M Atkinson-Dunn, PhD HCLD/PHLD


Director
Utah Public Health Laboratory
4431 S. Ccnstitution Blvd.
Taylorsville UT 84129
Main number. (801) 965-2525
Direct number. (801) 965-2424
rmatkinson@utah.gov

.**-'**""** IMPORTANT MESSAGE .**.***u.


This message, including any attachments, may contain confidential information intended for a specific individual and purpose, and is protected by
law. If you are not the intended recipient, delete this message, including from trash, and notify me by telephone or email.
If you are not the intended recipient, any distribution or copying of this message, or the taking of any action based on its content is strictly prohibited.

hlf'nol;'/ImRl1.nrYYJIA.t'nTl/m

Rillt iIOI?ul = '&1 k= 6A925163Od&vlew=

Dt&o= OJowAV%2Oanthr ax &m.=trua&sAAfch= ouerv&th=

1516949751 01e84a&s Im 1=1516949751 01e84a

Ml

iit9tzo15'

Stat. of Utah Mall. R FW: FOIA obout Ol.\lWay PrC71lngGrour<ls anitn"

Incident

Allyn Nakashima

<anakashlma@ulah.gov>

Re: FW: FOIA about Dugway Proving Grounds anthrax incident


1 message
Allyn Nakashima <anakashima@utah.gov>
To: "Hendricks Walters. Katherine (Kate) (CDC/OID/NCEZID)"

Tue, Dec 8, 2015 at 9:05 AM


<kah1@cdc.gov>

Thanks very much for your help with this.


Allyn
On Tue, Dec 8, 2015 at 8:29 AM, Hendricks Walters, Katherine (Kate) (CDClOID/NCEZID) <kah1@cdc.gov> wrote:
Allyn, Our group, Bacterial Special Pathogens Branch (BSPB), would not be the group with the official "list" of labs.
Division of Select Agents and Toxins (DSAT) - so am referring your Inquiry about "release of lab names" to them.

I believe that would be the

FYI, I've not been involved in a FOIA request regarding the DoD incident yet.
I've cc'd Dr. Weyant, the Director of DSAT as well as my boss Dr. Bower.

Kate

Hendricks. MD, MPH&TM


Medical Officer
Bacterial Special Pathogens Branch
Division of High Consequence Pathogens and Pathology
centers for Disease Control and Prevention
1600 Clifton Road. MS A-30
Atlanta. GA 30329-4027
Office: 404.639.3153
Fax: 404.315.2488
email: kah1@cdc.gov<mailto:kah1@cdc.gov>

From: Nakashima, Allyn (CDC utah.gov)


Sent: Monday. December 07, 20158:17 PM
To: Hendricks Walters, Katherine (Kate) (CDC/OID/NCEZID) <kah1@cdc.gov>
Subject: FOIA about Dugway Proving Grounds anthrax incident
Hi Kate,
I emalled Dan Sosln earlier today about a FOIA issue conceming the Dugway Proving Grounds anthrax Inciden!. He has not responded so I was
wondering If you could tell me what CDC is doing.
https:l/maJl.google.com/mall/Iitl'7\Jl=2&lk'=6892516:lOd&vlew=pt&q=anttrax&qs=true&seereh=q.J9f)'&th=

1518257975fdd195&s1ml = 15182579751ddl95

113

121912015

State of Utah Mail. Re: FW: FOlAalloot DL.W'ay PrC71lngGroor<Js anthrax Incident

Here is a local press article on the concems of the group requesting Information through the FOIA:
http://www.deseretnews.com/article/865642740/Feds-still.wont.say.whlch~abs.received.Dugways-live-anthrax-shipments.html?pg=all
As you recall, we only had one lab in Utah that was sent the contaminated specimens. We are also being GRAMA'd (our equivalent of FOIA) for our
information conceming the incident. However, we feel that our one lab should not be singled out for scrutiny so unless CDC is planning to release
the names of the other labs we are thinking of not releasing information on the one lab on privacy concems. If, on the other hand, CDC is planning to
release this information, then we would like to have the heads up so we can get ready for the media issues.
Very much appreciate your help with coordinating this!!
Thanks,
Allyn

Allyn K Nakashima, MD
State Epidemiologist
Bureau of Epidemiology
Utah Department of Health
PO Box 142104
Salt Lake City, Utah 84114-2104
Tel: (801) 538-6191
Fax: (801) 538-9923

~.~.~

IMPORTANT

MESSAGE

This message, including any attachments, may contain confidential information intended for a specific individual and purpose, and is protected by
law. If you are not the intended recipient, delete this message, including from trash, and notify me by telephone or email.
If you are not the intended recipient, any distribution or copying of this message, or the taking of any action based on its content is strictly prohibited.

Allyn K Nakashima, MD
State Epidemiologist
Bureau of Epidemiology
Utah Department of Health
PO Box 142104
Salt Lake City. Utah 84114-2104
Tel: (801) 538-6191
Fax: (801) 538-9923
httM' /1m AIIOCX'JOIA.com/m A1JlulOl?ui = 2&1k= 68925163Od& .i9N= ot&a= anthrax&as=true&search=

cuarv&th=

151 8257975fddf95&slm

I = 1518257975fddf95

213

1~15

State of Utah Mall. R.: FW: FOIA about D_ay

httpsJ/m"l.googl com/maIVulG'?ul=2&Ik=6892516:lOd&vlow= pt&q=anttYax&qs=true&seareh=~&th=

Pr"'I,... Grounds antrrax Incident

1518257975fdd195&sIml=1518257975fddl!l5

3'3

1=15

Stat.

a Utah Mall-

Ro: FOIA '"",""I

COlCOrriT'llDugway antt1roxIncident

Allyn

Nakashima

<anakashlma@utah.gov>

Re: FOIA request concerning Dugway anthrax incident


Allyn Nakashima <anakashima@utah.gov>
To: "Sosin, Dan (CDClOPHPRlDSAT)"
<dms8@cdc.gov>

Wed, Dec 9, 2015 at 11:44 AM

Thanks, Dan-I understand the difficult position CDC Is In, and It helps to know your policy.
At the local level, like most states, we have to respond to GRAMA requests for information,
approach.

and It helps to know our lead public health agency's

On Wed, Dec 9,2015 at 9:51 AM, Sosln, Dan (CDClOPHPRlDSAT)


<dms8@cdc.gov> wrote:
Allyn: I apologize for not responding to you, and understand that you have reached out to others in order to provide a contact at CDC for this entity.
FOIA has some special conditions with Select Agents that preclude the Federal Government from certain releases under FOIA. I was waiting to get
beller language for you to provide the entity regarding those restrictions to obviate an unnecessary FOIA request. Unfortunately, I have not found
the right place to ask and have not heard back yet.
The DoD has released a lot of Information regarding Dugway, including on their website. The standard position of the Federal Select Agent Program
is to refer requests for information about a registered entity to the entity themselves.
In this instance, it would be beller for the organization to reach
out to the Department of Defense for information on Dugway. If they make a FOIA request, it is unlikely to produce the information they are looking
for.
Thank you,
Dan
Daniel M. Sosin, MD, MPH, FACP
Acting Director, Division of Select Agents and Toxins
Office of Public Health Preparedness and Response
1600 Clifton Road, NE Mallstop A46
Atlanta, GA 303294027
404-718-2001
From: Nakashima, Allyn (CDC utah.gov)
Sent: Monday, December 07, 2015 10:54 AM
To: Sosln, Dan (CDC/OPHPRIDSA T) <dms8@cdc.gov>
Subject: Fwd: FOIA request conceming Dugway anthrax incident

httpsJ/mall.googlo.ccm/mali/liOl?ui=2&lk=68925163Od&vlow=pl&q=AnltYox&qs=~ue&s_cI1=CI-'O'Y&msg=

151880157b656do5&slml= 151800f57b656d05

1/2

Stat. r:I Ulah Mall. R.: FOIAr_t

121912015

cax:ernng DugwayanthraxInclclonl

Allyn Nakashima, MD
State Epidemiologist
Utah Department of Health
Begin forwarded message:
From: Allyn Nakashima <anakashlma@utah.gov<mallto:anakashlma@utah.gov
Date: December 7, 2015 et 8:52:33 AM MST
To: "dsm8@cdc.gov<mallto:dsm8@cdc.gov>"
<dsm8@cdc.gov<mallto:dsm8@cdc.gov
Subject: FOIA request conceming Dugway anthrax incident
HI Dan,
You may be aware that there has been an activist group here concemed about the Dugway incident. They have requested information from us under
GRAMA (our equivalent of FOIA). As you know, we only have info about the single lab receiving the specimens.
Shall we refer them to you for
questions about Dugway?
Allyn
Allyn Nakashima, MD
State Epidemiologist
Utah Department of Health
_._ IMPORTANT

SLTRIB.COM
MESSAGE ..._

This message, including any attachments, may contain confidential Information intended for a specific individual and purpose, and is protected by
law. If you are not the intended recipient, delete this message, including from trash, and notify me by telephone or email.
If you are not the intended recipient, any distribution or copying of this message, or the taking of any action based on its content is strictly prohibited.

Allyn K Nakashima, MD
State Epidemiologist
Bureau of Epidemiology
Utah Department of Health
PO Box 142104
Sait Lake City. Utah 84114-2104
Tel: (801) 538-6191
Fax: (801) 538-9923

httO."l'lImAII. oooole.can/m

AII/LiOI?uI = 2&1k= 68925163OO&"lew = 01&0= Anthrax&os = true&sewch=CltJAl'v&m

so= 1518801B7b65&1e5&qJ ml = 151 RAOI'6'1b656c1e5

,,?

You might also like